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Abstract 
Dermanyssus gallinae represents a significant threat to poultry production in the 
UK and control is typically achieved through the use of acaricides, but farmers 
are facing increasing incidence of pesticide resistance. This must be managed 
through considered application of acaricides and to facilitate this, a map of D. 
gallinae perceived resistance has been created, to which future resistance can 
be compared. Toxicity testing has shown no geographical correlations in 
resistance, suggesting farms need testing on a per farm basis to provide a best 
practice recommendation.  Additionally, a greater understanding of acaricide 
detoxification mechanisms is required. Research indicates that functional 
modification of P450s is responsible for the occurrence of pesticide resistance in 
many arthropods. In order to characterise resistance mechanisms, transcriptome 
data has been analysed and a database of putative pesticide metabolising 
sequences has been created. An attempt to develop a method for microsome 
preparation from D. gallinae was made for use with Activity Based Probes to 
identify pesticide metabolising protein sequences in the future. As well as 
identifying P450s, cytochrome b5 and P450 oxidoreductase required 
identification. P450 oxidoreductase has been putatively identified using sequence 
data analysis but not yet successfully isolated. However, cytochrome b5 from D. 
gallinae along with Rhipicephalus microplus and Ixodes scapularis has been 
successfully amplified, expressed and purified. A baculovirus expression vector 
has been created to express D. gallinae cytochrome b5, which showed no effect 
on pesticide metabolism when amplified alone. A Glutathione S-transferase gene 
has also been cloned into an expression vector to compare the different 
mechanisms of metabolism. This will allow future links between D. gallinae 
genetics and resistance to be established, facilitating real-time tailoring of 
treatment programmes to ensure maximum efficacy. 
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Chapter 1: Introduction 
1.1 Economic and Medical Importance of Acari 
The acari are a subclass of small arachnids which comprises mites and ticks 
(class Arachnida, taxon: Acari) and there are more than 45,000 species of mites 
and ticks in the world. Acari are a form of arthropod but have not shared a 
common ancestor with insects for around 500 million years (Ullmann et al., 2005). 
Acari are incredibly diverse in both form and life strategies and live in almost 
every inhabitable place on earth, including fresh water and sea water (Krantz and 
Walter, 2009; Walter and Proctor, 1999). They have a vast amount of plant and 
animal hosts that include many agricultural, domestic and human pests, hence 
they have a large influence on human life (Dabert et al., 2010; O'Reilly et al., 
2014). 
Acari have jointed legs and a chitinous exoskeleton with an open circulatory 
system, ventral nerve cord, alimentary canal and striated muscles. Unlike insects 
and other arthropods, they do not have antennae or mandibles. The body of acari 
is divided into the gnathosoma and idiosoma, which contain various structures in 
different acari species (Dhooria, 2016). Acari are adapted to feed via 
haematophagy, using specially adapted mouth parts to feed on hosts such as 
birds and mammals (Bellgard et al., 2012).  
Both tick and mite species attack humans and animals and cause damage 
through direct feeding on the host and through the transmitting of disease. Many 
tick species are of medical importance and Table 1.1 summarises some of the 
infections transmitted to humans by tick species. Ixodes ticks are shown to cause 
human ehrlichiosis, tick borne encephalitis, Q fever, tularaemia, Lyme disease 
and tick paralysis. Lyme disease is caused by Borrelia burgdorferi and occurs in 
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27 European countries as well the USA, Canada, Africa and Australia – in eastern 
USA its vector is Ixodes scapularis. Lyme disease is the most common reportable 
vector borne zoonosis in the USA, with nearly 30,000 cases of Lyme disease 
confirmed in 2007, up from 10,000 in 1991, and being principally transmitted by 
birds (Service, 2012; Dumic and Severnini, 2018). Lyme disease is a multisystem 
infectious disease which affects the skin, joints, nervous system and heart, and it 
can lead to long term sequelae if left untreated (Smit and Postma, 2015; Stanek 
et al., 2011). One recent study found the cost of Lyme disease to be between 
$712 million and $1.3 billion each year, and this is expected to rise as incidence 
of the disease increases, presenting high economic and medical burdens of I. 
scapularis as a vector of disease (Adrion et al., 2015).  
Table 1.1: Summary of vector-borne diseases transmitted to humans. 
Summary of diseases transmitted to humans and the infective agent as well as 
principle tick vectors and main reservoir hosts. Adapted from Service (2012).   
Disease Infective agent Principle tick vectors 
Main reservoir 
hosts excluding 
ticks 
Tick-borne 
encephalitis 
Flavivirus Ixodes ricinus, I. persulcatus 
Rodents, 
insectivores 
Omsk haemorrhagic 
fever 
Flavivirus Dermacentor reticulatus 
Muskrats, water 
voles 
Kyasanur Forest 
disease 
Flavivirus 
Haemaphysalis spinigera, H. 
turturis 
Monkeys, shrews, 
rodents 
Crimean-Congo 
haemorrhagic fever 
Nairovirus Hyalomma marginatum Hares, cattle, goats 
Colorado tick fever Coltivirus Dermacentor andersoni Rodents, rabbits 
Rocky mountain 
spotted fever 
Rickettsia 
rickettsii 
Dermacentor, Amblyomma 
and Rhipicephalus species 
Rodents 
Mediterranean spotted 
fever 
Rickettsia 
conorii 
Rhipicephalus sanguineus Rodents, dogs 
African tick-bite fever 
Rickettsia 
africae 
Amblyomma species Rodents, cattle 
Q fever Coxiella burnetii Ixodid species 
Sheep, goats, cattle, 
rodents 
Human ehrlichiosis 
Ehrlichia 
chaffeensis 
Amblyomma and Ixodes 
species 
Deer, rodents 
Lyme disease 
Borrelia 
burgdorferi 
Ixodes ricinus, I. scapularis, 
I. pacificus 
Birds, rodents 
Tularaemia 
Francisella 
tularensis 
Ixodid species 
Rabbits, hares, deer, 
beavers 
Tick paralysis Tick toxins 
Ixodes and Dermacentor 
species 
Not caused by 
pathogen 
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Another genus of interest is Rhipicephalus, specifically Rhipicephalus microplus, 
also known as the southern cattle tick. The southern cattle tick is a transmitter of 
babesiosis (caused by protozoal parasites Babesia bigemina and Babesia bovis) 
and anaplasmosis (caused by Anaplasma marginale). Tick borne diseases, such 
as babesiosis and anaplasmosis, cost African countries an estimated $5-$6 
million per annum, a figure which is expected to be higher when calculated in 
more up to date studies (McLeod and Kristjanson, 1999; Leger et al., 2013; 
Nyangiwe et al., 2017). This increase is due to several reasons, key ones being 
that of climate change and development of pesticide resistance within the species 
(Stone et al., 2014; Miller et al., 2007). 
1.2 Acari of Interest: Dermanyssus gallinae 
The main acari of interest to this project is Dermanyssus gallinae (De Geer, 
1778), known as the poultry red mite (PRM). PRM are an ectoparasitic mite which 
are ubiquitous as a poultry pest throughout the world (George et al., 2015; 
Kilpinen, 2001). They pose a significant threat to egg-laying hens in Europe, 
China, Japan and the USA, although northern fowl mite, Ornithonyssus sylviarum 
is more prevalent in the latter country (Sparagano et al., 2009; Wang et al., 2010).  
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    Metazoa (Animalia) 
Arthropoda 
                   Arachnida 
     Acari 
 Mesostigmata 
        Dermanyssidae 
Dermanyssus 
  Dermanyssus gallinae 
                                         Macronyssidae         
          Ornithonyssus 
   Ornithonyssus sylvarum 
     Varroidae 
        Varroa 
     Varroa destructor 
  Ixodidae 
          Ixodes 
       Ixodes scapularis 
            Ixodes ricinus 
                                             Rhipicephalus 
         Rhipicephalus microplus 
         Rhipicephalus annulatus 
 
Figure 1.1: Phylogenetic tree showing the taxonomic classification of 
Dermanyssus gallinae as well as other species of interest. Taxonomic 
classification of Dermanyssus gallinae, Ornithonyssus sylvarum, Varroa 
destructor, Ixodes scapularis, Ixodes ricinus, Rhipicephalus microplus and 
Rhipicephalus annulatus.  
Dermanyssus gallinae are members of the Dermanyssidae family, Figure 1.1, 
which are characterised by an idiosoma broadly rounded posterior and a second 
cheliceral article of female elongate which exceeds the basal segment in length. 
5 
 
Dermanyssus gallinae has a single dorsal shield that tapers posteriorly, the 
chelicerate are long and styliform and the sternal shield has two pairs of setae. A 
third pair is located posteriorly and is distinctly separate from the others. There is 
a genitoventral shield which is posteriorly rounded and bears one pair of seta and 
the anal shield has three setae (Di Palma et al., 2012). D. gallinae are a relatively 
small ectoparasitic mite being around 1.5 mm in length and change colour from 
a grey to red/brown after feeding on a blood meal (Figure 1.2).  
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Figure 1.2: External and internal morphology of PRM. A. Internal mite 
structures captured from the dorsal side at X 100 magnification on a fed mite 
(Pritchard et al., 2015). Gnth = gnathosoma (mouthparts), Os = oesophagus, Ca 
I-III = caeca I-III, Mp = Malpighian tubules, Mg = central midgut. B. External 
Mesostigmata mite morphology shown with labels detailing key external 
structures (Buss et al., 2014). 
Coxa 
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Palp Chelicera 
Sternal 
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Genitoventral 
plate 
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B. 
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The PRM digestive tract extends through the oesophagus, midgut and caeca and 
ends in the hindgut with the majority of blood digestion occurring in the expanded 
caecal pairings (Ca I-III) and central midgut. Malpighian tubules, involved in 
nitrogenous waste collection and osmoregulation, elongate along the idiosoma 
and are connected to the posterior hindgut. PRM body shape gets rounder and 
larger during blood feeding and the digestive tract completes most of the body 
cavity when full compared to an unfed mite.  
1.3 Poultry Red Mite: Life Cycle and Ecology 
The life cycle of PRM is very rapid which contributes to its status as a pest species 
(George et al., 2015). Development of PRM goes from egg to adult through one 
larval stage and two nymphal stages in approximately 2 weeks (Figure 1.3) 
(Sparagano et al., 2014).  
 
 
 
 
 
 
 
 
 
Figure 1.3: Life cycle of poultry red mite. Life cycle of poultry red mite under 
favourable conditions. Diagram adapted from Sparagano et al. (2014). 
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The process of development from egg to adult, as stated above, typically takes 
two weeks to complete, although it has been shown to take half this time at 
temperatures of between 25-37 °C, the most favourable temperature range for 
juvenile development (Maurer and Baumgartner, 1992). Females lay eggs in 
clutches of 4-8 and can lay up to eight clutches in between blood feeds. Typically, 
females will lay around 30 eggs in a lifetime in refugia where larva can remain 
without feeding before their first molt. High temperatures (10-35 °C), like those 
found in poultry housing, as well as high humidity (over 70 %) can facilitate the 
rapid reproduction of PRM which leads to the swift doubling of populations of 
infestations in egg laying facilities (Maurer and Baumgartner, 1992; Nordenfors 
et al., 1999). A more recent study has supported this, finding that the growth rate 
of the mite population increases 2 % for every 1 °C temperature increase above 
20 °C (Mul et al., 2017). Densities of PRM often reach 50,000 mites per bird but 
have been reported as high as 500,000 mites per bird in more severe infestations 
(Kilpinen et al., 2005).  
Host specificity is hard to define in mites due to them being opportunistic and 
potentially having multiple hosts during post-embryonic development (Roy et al., 
2009). PRM have a variety of host species but are widely reported to be avian 
specific, with over 30 species of wild birds reported to being infested with PRM 
(Roy and Chauve, 2007). Poultry are the natural host of PRM, with egg laying 
facilities prone to large infestations due to the slow turnover of flocks (often 
exceeding 1 year) and ideal poultry house conditions. PRM are often present year 
round but infestations can peak in hot and humid seasons (Nordenfors et al., 
1999; Mul et al., 2017). Even when flocks are changed and poultry houses are 
left empty, PRM can survive up to 8 months without blood feeding, meaning they 
can infect new flocks after long periods of time (Chauve, 1998). 
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PRM has been shown to change more readily between avian hosts than other 
species within the same genus. When removed from the hen host, PRM accepted 
canaries as a new avian host, something Dermanyssus longipes could not do 
(Roy et al., 2009). Interestingly, reports of PRM infestations on non-avian hosts 
are becoming more frequent, which is indicative of PRM’s ability to adapt and its 
potential to be a human and mammalian pest (Abdigoudarzi et al., 2014; Sengul 
et al., 2017; Gavrilovic et al., 2015).  
PRM spend most of their life away from their host and only parasitize birds in the 
darkness to feed. They can be found in all production types, ranging from small 
numbers of home reared birds to large barn systems. Mites generally find refuge 
in poultry housing and prefer to live in cracks or crevices (Figure 1.4), aggregating 
together in response to both thigmokinesis and pheromone cues (Entrekin and 
Oliver, 1982; Koenraadt and Dicke, 2010; George et al., 2015). 
Figure 1.4: Infestation with PRM. A= red mite clustering on a cage in a laying 
farm. B= Red mites in straw litter from laying hen housing unit. Photos taken from 
Flochlay et al. (2017).  
In battery cage systems mites are often found under the conveyor belts of eggs 
and under cage supports but, in free range systems, more crevices are present 
A.         B. 
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which often makes the infestation harder to control. Mites can be found under 
flooring systems, hidden in joints of nest boxes and perches, beneath troughs 
and in crevices in the walls of the housing (Chauve, 1998). Increasing mite 
infestation numbers can be, in part, attributed to the recent changes in legislation 
of housing systems in hen husbandry within EU countries (Directive 1999/74/EC). 
This directive has prohibited the use of traditional cages for poultry and has led 
to the increase in housing systems which consist of more complex environments, 
in the name of bird welfare. This increase in complexity of housing has allowed 
for increased areas of mite refuge and hence has intensified the issue of PRM 
infestations within EU countries (Flochlay et al., 2017).  
Adult female PRM locate hosts using temperature stimuli, chemical signals, 
vibrations and carbon dioxide levels (Kilpinen, 2005; Kilpinen and Mullens, 2004; 
Zeman, 1988). Once the PRM has located a bird, it will only feed for 0.5-1.5 hours 
before returning to the refuge of the poultry housing. This will only happen every 
2-4 days and is usually done under darkness, making PRM a difficult pest to treat 
(Nakamae et al., 1997). Adding to this, male PRM feed only intermittently and 
larvae do not feed (Chauve, 1998). 
Kilpinen (2005) showed that in high light intensity PRM cease movement in 
response to CO2 stimuli, which is an indication that they may have been seen by 
the host and face being eaten. When vibrations were detected by the mite it 
continued to move for the duration of the vibration, as the vibration is potentially 
an indication that the host has moved on and the risk of being eaten has 
diminished. In low light intensity, when mites would be hard to locate by the host, 
no freeze response was observed and PRM continued to search for the host to 
feed (Kilpinen, 2005).  
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1.4 Poultry Red Mite: Geographical Distribution and Prevalence 
Incidence of infestations with PRM is on the rise, in part due to the vast poultry 
farming across the world with millions of birds being raised annually (Table 1.2). 
This prevalence data will need updating for the UK and other European countries, 
as traditional metal caging has been prohibited, and prevalence of PRM in 
enriched systems is expected to be higher (Figure 1.5). Infestations with PRM 
have been found in all countries where egg laying facilities have been sampled 
and in the UK between 60-87.5 % of egg laying facilities are expected to be 
infested (Fiddes et al., 2005; Guy et al., 2004).  
 
Figure 1.5: Comparison between traditional barren cages and enriched 
cages. All cages must include access to fresh water and adequate food. Cages 
have a sloping floor to allow eggs to roll out and several hens may be kept in one 
cage. Cage size indicated space per hen when four or more hens are kept in one 
cage. Enriched cages also include 150cm2 nest box space as well as litter, 
perches and claw trimming devices. Image adapted from BBC (2002); Daniels 
(2015) and Barlow (2018).  
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In a more recent report, it is suggested that 83 % of European farms are infested, 
with PRM prevalence reaching as high as 94 % in The Netherlands, Germany 
and Belgium (Mul, 2013). Limited studies have been completed on the prevalence 
of PRM worldwide and more surveys are required to provide a complete picture 
of geographical distribution of the pest species. Prevalence in industrial poultry 
farms in Tunisia was measured and 28 egg laying facilities were tested with a 34 
% prevalence of PRM, however this study was only completed in one region of 
Tunisia (North East) and a systematic survey was recommended (Gharbi et al., 
2013). Prevalence data of PRM in other European countries is sparse or dated, 
for example data for Sweden was last recorded in 1995, finding 33 % of deep 
litter flocks to be infected with PRM upon inspection (Hoglund et al., 1995). A 
more recent study in Egypt found 40% of samples obtained were confirmed as 
Dermanyssus gallinae, however samples were only taken from three farms and 
hence true prevalence is unlikely to be represented (Eladl et al., 2018). Larger 
surveys have been completed in China, with 833 respondents sending PRM 
samples to the lab in which 64.1 % contained Dermanyssus gallinae (Wang et 
al., 2010).  
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Table 1.2: Key data for poultry production and PRM prevalence. Table shows 
countries from which information is known for PRM prevalence, the egg 
production (Tonnes) per country and the number of birds in each system (1,000 
hens) (FAOSTAT, 2016). PRM prevalence is listed per system where information 
is available. References for PRM prevalence have been provided.  
Country 
Egg production 
(Tonnes), 2017 
Enriched 
cages (1,000 
hens) 
Barn (1,000 
hens) 
Free range 
(1,000 hens) 
PRM 
prevalence (%) 
Reference 
China 31,338,856 1,260,000 126,000 14,000 64.1 (caged) 
(Wang et al., 
2010) 
Portugal 141,211 6,764 340 131 95.8 
(Waap et al., 
2019) 
Italy 740,320 40,952 17,008 2,352 
74.1  
(caged) 
(Cafiero et al., 
2008) 
The 
Netherlands 
719,564 5,103 20,940 6,881 
82 
(caged) 
83 
(barn) 
78 
(organic) 
(Mul et al., 
2010) 
UK 752,000 16,225 2,088 18,313 
87.5 
caged 
(Guy et al., 
2004) 
Sweden 137,762 1,721 4,450 882 
4 
(caged) 
67 
(backyard) 
33 
(deep litter) 
 
(Hoglund et al., 
1995) 
Poland 594,560 32,905 3,915 829 100 (Cencek, 2003) 
Romania 314,893 4,987 1,522 80 
100 
(battery-cages) 
57.14 
 (deep litter) 
(Gruianu et al., 
2018) 
Tunisia 107,100 - - - 34 
(Gharbi et al., 
2013) 
Iran 782,000 75,000 0 0 39.3  
(Yakhchali et 
al., 2013) 
Kenya 79,389 - - - 
60 
(free range) 
(Mungube et 
al., 2008) 
Turkey 1,205,075 65,000 0 0 
72.39 
(backyards) 
(Konyali et al., 
2018) 
Kosovo 33,402 - - - 50 
(Hamidi et al., 
2011) 
 
Only two surveys of mite prevalence have been completed in the United 
Kingdom. One survey had a response rate of 60 %, with 29 total farms being 
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surveyed which had a prevalence of 87.5 % and had a significantly higher level 
of both nymph and adult mites in free range systems compared to barn or caged 
systems. However, the survey was limited due to the farms being surveyed only 
from the North of England and being outdated as it was completed in 2004 (Guy 
et al., 2004). A second survey was completed in the UK which had a total of 43 
questionnaire responses with over 60 % reported infestations with PRM which 
also had a higher level of infestation with birds from free range systems (Fiddes 
et al., 2005). This is of interest as the survey was completed in 2002 and the 
proportion of birds kept in free range systems has more than doubled in recent 
years, indicating the need for a more up to date reflection of PRM prevalence in 
the UK (Figure 1.6).  
 
Figure 1.6: UK egg throughput by production method. Egg throughput is 
shown per thousand cases and four methods of production are included. Figure 
taken from Rumsey (2018). 
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1.5 Pesticide Classes 
The control of PRM is typically achieved using synthetic acaricides. The different 
pesticides classes which are commonly used to treat infestations with PRM have 
different mechanisms of action. Both carbamates and organophosphates are 
acetylcholinesterase (AChE) inhibitors whilst pyrethroids are sodium channel 
modulators. AChE is an enzyme which hydrolyses acetylcholine, a 
neurotransmitter. Carbamates and organophosphates inhibit AChE by the 
modification of the active site of the enzyme, leading to the inhibition of the 
termination of nerve impulses, causing death in PRM (Figure 1.7) (Aldridge, 1950; 
David et al., 2013; Antonio-Nkondjio et al., 2016).  
 
Figure 1.7: Inhibition of AChE. Mechanism of inhibition of AChE with 
organophosphate and carbamate pesticides. Figure recreated from Pogacnik and 
Franko (1999).  
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Pyrethroids are synthetic analogues of pyrethrins, which are botanical chemicals 
derived from chrysanthemum flowers (Ismail et al., 2013). Pyrethroids are 
structurally diverse and are traditionally split into two classes, type 1 (absence of 
α-cyano group) and type 2 (presence of α-cyano group) (Figure 1.8).  
 
 
 
 
 
 
 
 
 
Figure 1.8: Structures of pyrethroids. Structures of Type I and II pyrethroids 
used in pesticides to treat PRM. The α-cyano moiety, which differentiates 
between the type I and II structural classes, has been shaded grey in the structure 
of deltamethrin and cypermethrin. Figure adapted from Soderlund (2012).  
Pyrethroids function by blocking the voltage-gated sodium channels. Voltage 
gated sodium channels are essential for the initiation of the action potential in 
neurons and excitable cells (Dong et al., 2014). Pyrethroids bind to receptor sites 
on the sodium channels which enhances their activation and inhibits deactivation, 
resulting in prolonged channel opening and leads to death. Insect sodium 
channels are much more sensitive to pyrethroids than mammalian sodium 
Type I Type II 
Permethrin Deltamethrin 
Cypermethrin  
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channels, which make them a popular active ingredient in pesticides due to their 
specificity (Du et al., 2013; Soderlund, 2012; Silver et al., 2014; Dong et al., 
2014).   
1.6 Aims of Study   
The poultry red mite is a haematophagous, ectoparasitic pest which presents a 
significant threat to British poultry production and often leads to heavy production 
losses through the downgrading of eggs and reduced laying. Despite the 
importance of the use of acaricides in controlling populations, poultry farmers are 
faced with several problems such as the growing incidence of pesticide 
resistance and tighter legislation and restrictions on the chemicals that can be 
used. This project aims to target the issue of resistance by carrying out a survey 
of the occurrence of perceived resistance and acaricide usage across the UK, 
with laboratory toxicity testing independently verifying these observations. 
Secondly, it aims to isolate the cytochrome P450 complex, the components of 
which have been shown to be overexpressed in resistant insect strains, and to 
investigate novel ways of targeting this complex in resistant strains using a 
baculovirus expression model. 
To this end, a survey will be designed to assess the perceived effectiveness of 
the acaricidal products on the market and this effectiveness will be plotted on a 
map of the UK, which will be the first of its kind. Poultry red mite will then be 
collected from farms which show signs of resistance in order to use them in 
toxicity assays with commercial acaricides, active ingredients of acaricides and 
with synergists. 
Transcriptomic data has been provided by collaborators and will be used for 
extensive bioinformatics analysis. This aim of this analysis is to identify PRM 
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accessory protein sequences, using homology to known accessory protein 
sequences, which can then be purified from PRM for the first time. As well as this, 
a bank of PRM putative xenobiotic metabolising sequences, also based on 
homology to known metabolising sequences in other species, can be created 
which can be compared to future peptide data.  
In addition to using the PRM for toxicity testing, they will be used to make a 
microsome preparation for use in Activity Based Probe (ABP) testing. A protocol 
will need to be adapted from a protocol used for mosquito preparations, as this 
technique is novel in PRM. APBs are a chemically modified form of the acaricides 
of interest which will bind to the specific enzyme involved in the metabolism of 
the acaricide, without being metabolised. PRM will be homogenised and used to 
make a microsomal preparation which will first be tested for P450 activity using a 
resorufin florescence assay.  
As well as the isolation of cytochrome P450s, accessory proteins are essential 
components of the P450 complex. It is therefore important to isolate and express 
PRM b5 in order to assess its role in the detoxification of pesticides. As well as 
expressing PRM b5 in both soluble and membrane bound form, it will also be 
expressed from similar pest species Rhipicephalus microplus and Ixodes 
scapularis. POR is also a vital part of the P450 complex and attempts will be 
made to isolate and express this protein from the PRM. To better understand the 
mechanism of resistance in PRM, any accessory proteins which are isolated and 
expressed will be cloned into a baculovirus expression system to allow the 
generation of an in vitro cell based assay in which their role in acaricide resistance 
can be tested. A collaborator based in the Moredun institute has identified PRM 
GSTs and these will also be used in vitro in a cell based assay to compare the 
role of GST and P450 accessory proteins in the detoxification process.  
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Chapter 2: A preliminary assessment of the current state of 
resistance/susceptibility to the active compounds used in 
Acaricides for Poultry Red Mite, Dermanyssus gallinae, in the 
United Kingdom.  
2.1 Abstract  
Poultry red mite (PRM) presents a significant threat to British poultry production 
and control of PRM is typically achieved through the use of synthetic acaricides. 
However, poultry farmers are faced with the growing incidence of pesticide 
resistance. To begin combatting the issue of resistance in PRM, a survey of the 
occurrence of resistance and acaricide usage across the UK was carried out 
which produced 51 responses from 17 counties across England, Scotland and 
Wales. The survey results showed a 98-100% PRM prevalence rate and the 
products used in the survey had low perceived effectiveness in certain regions. 
Ficam (active ingredient of bendiocarb) scored 5/10 in the East Riding of 
Yorkshire but scored 10/10 in Dumfries and Galloway (scores could not be 
statistically analysed due to only receiving one response per county. The 
variability of responses shows the lack of an overall effective product on the 
market. The highest average perceived effectiveness score for a product was 
grease (9/10) which was notable due to its mechanical action and the inability for 
PRM to form resistance to it. A selection of individual farms were chosen for 
toxicity testing which indicated widespread resistance to specific commercial 
products and their actives, such as Fendona which scored and average of 
19.76% mortality across the 6 farms tested and Milben Ex which scored 21.56% 
(both products contain cypermethrin as the active ingredient) compared to Perbio 
choc (active ingredient permethrin) which scored and average of 99.7% mortality. 
As well as toxicity testing, synergists were tested on PRM from two farms, along 
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with the active ingredients in order to improve efficacy of the actives. Permethrin 
and piperonyl butoxide significantly increased mortality compared to permethrin 
and diethyl maleate (P = 0.0461) and permethrin and triphenyl phosphate  
(P = 0.0253). Individual farm testing is required to show a full picture of resistance 
and to allow for best practice recommendations. 
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2.2 Introduction 
The poultry red mite (PRM), Dermanyssus gallinae, represents a significant threat 
to poultry production throughout the UK and worldwide. Infestation rates in 
Europe average over 80 % in egg laying facilities (Figure 2.1).  
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Infographic of laying hens data. Number of laying hens per country 
in millions and the percentages of farms infested by Dermanyssus gallinae. Data 
shown from 2012. Image reproduced from Mul (2013).  
One of the main consequences of infestation with PRM is the negative impact on 
the overall health of the hens. In high levels of infestation, hens may become 
anaemic from repeated blood feeding by the mites, and in extreme cases, death 
by exsanguination has been observed (Cosoroaba, 2001; Wojcik et al., 2000). A 
22 
 
laying hen can lose 3 % of its blood volume every night, despite red blood cell 
production being increased, and reports have shown a 10 fold increase in hen 
mortality from heavy infestations with PRM as well as a 10 % decrease in egg 
laying (Cosoroaba, 2001; Wojcik et al., 2000; Van Emous, 2005). This intense 
feeding from the host results in high levels of stress within the hens and this is 
represented by a series of stress behaviours such as increased aggression, 
increased noise levels, excess grooming and feather pecking. (Van Emous, 
2005; Chauve, 1998; Mul et al., 2009; Kilpinen, 2005; Kilpinen et al., 2005). 
Impacts from such behaviours are currently being limited by beak trimming, but 
legislation on this practice is changing. Beak trimming is highly controversial. 
Austria, Finland and Sweden have already banned the practice, Germany has 
agreed to put in place a scheme to encourage the ending of the practice of beak 
trimming and the Netherlands have pledged to stop beak trimming from 
September 2018 following a review of the practice in 2017 (Beak Trimming Action 
Group, 2015).  
A study by Kowalski and Sokol (2009) has shown a 1.5 fold increase in 
corticosterone, a 22 % decrease in β globulin levels and double the adrenaline in 
the blood samples of birds infested with PRM compared to blood samples from 
control groups, which supports the theory of PRM inducing high stress levels and 
immunosuppression in hosts (Kowalski and Sokol, 2009).  
As well as being detrimental to the health of the laying hens, PRM can cause 
large economic losses for poultry farmers from a range of different issues caused 
by infestations. In large infestations, there is a negative impact on the feed 
conversion ratio as feed and water intake is increased during infestation 
accompanied by a decrease in bird growth rates (Chauve, 1998; Mul et al., 2009; 
Mul, 2013). As well as this increased cost of feed, egg quality declines during 
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infestation. Egg shells are thinned and blood spots are present on the shells, due 
to rolling over recently fed mites, which makes them unfit for sale and reduces 
productivity (Chauve, 1998; Cosoroaba, 2001). The proportion of second grade 
eggs increased 2-14 % after infestation with PRM (Zenner et al., 2009). 
The economic cost of PRM is difficult to quantify and is presumed to be 
underestimated due to the difficulty in confirming infestations and the stigma of 
infestations often leads farmers to not acknowledge the issue on surveys and 
reports. Production losses stemming from infestations with PRM have been 
estimated by Van Emous at €130 million per year in Europe, with equally large 
losses from other areas (Van Emous, 2005; Sparagano et al., 2009). This figure 
is likely to be underestimated due to the increase in numbers of laying hens since 
it was calculated. Number of laying hens in Europe in 2005 was 350 million, which 
had risen to 382.8 million in 2015 (Windhorst, 2017).  
In the 2005 study, Van Emous calculated the cost per hen of PRM infestation to 
be €0.43 (€0.14 direct cost of treatment and €0.29 indirect cost of productivity 
losses) (Van Emous, 2005). In 2017, Van Emous calculated the cost of PRM 
infestation in The Netherlands had increased to €0.60 per hen (€0.15 direct cost 
of treatment and €0.45 indirect cost of productivity losses) and overall costs 
attributed to PRM infestations is now estimated to be €231 million in Europe 
(Flochlay et al., 2017; van Emous, 2017) This rising economic cost of PRM 
highlights the necessity to successfully treat infestations.  
Additional to the detriment of the health of the birds and the rising economic cost 
of PRM is the role PRM play as a vector of disease. Absolute vector competence 
has not yet been confirmed in PRM, however the importance of PRM as a disease 
vector cannot be disregarded (Sparagano et al., 2014). The significance of PRM 
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as a pest is demonstrated by the proven ability to carry both bacterial and viral 
pathogens, a compilation of which are detailed in Table 2.2. 
Table 2.2: Bacterial and viral pathogens which are associated with 
Dermanyssus gallinae. Table recreated from Sparagano et al. (2014).  
 Pathogen Details  Associated References  
Bacteria  Salmonella gallinarum  Isolated from mites Zeman et al. (1982) 
Salmonella enteritidis  Transmission 
demonstrated 
Valiente Moro et al. (2009) 
Pasteurella multocida  Transmission 
demonstrated 
Petrov (1975) 
Chlamydia spp.  Isolated from mites Circella et al. (2011), 
Permin and Hansen 
(1998) 
Borrelia anserina  Unknown Hoffmann (1987) 
Erysipelothrix 
rhusiopathiae 
Isolated from mites Chirico et al. (2003) 
Listeria monocytogenes Isolated from mites Grebenyuk et al. (1972) 
Coxiella burnetii Transmission 
demonstrated 
Zemskaya and Pchelkina 
(1967) 
Escherichia coli  Isolated from mites Valiente Moro et al. (2009) 
Staphylococcus spp.  Isolated from mites Valiente Moro et al. (2009) 
Streptomyces spp. Isolated from mites Valiente Moro et al. (2009) 
Spirochetes  Transmission 
demonstrated 
Ciolca et al. (1968) 
Viruses Viruses Avian leucosis  Unknown Hoffmann (1987) 
Newcastle disease Isolated from mites Arzey (1990) 
Fowl poxvirus Transmission 
demonstrated 
Shirinov et al. (1972) 
St. Louis encephalitis  Transmission not 
demonstrated 
Chamberlain et al. (1957) 
Tick-borne encephalitis  Transmission not 
demonstrated 
Wegner (1976) 
Eastern equine 
encephalitis  
Transmission 
demonstrated 
Durden et al. (1993) 
Western equine 
encephalitis  
Transmission 
demonstrated 
Chamberlain and Sikes 
(1955) 
Venezuelan equine 
encephalitis 
Transmission 
demonstrated 
Durden et al. (1992) 
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Of the pathogens associated, of note is the transmission of Salmonella enteritidis. 
Infection with Salmonella enteritidis causes diarrhoea, fever and abdominal 
cramps, occasionally leading to hospitalisation, and eggs and poultry are 
recognised as major importance in the transmission of the infection. The average 
cost of an infection with Salmonella is £1000, costing the UK £39 million per year 
(Lake, 2017; Santos et al., 2011). Mites can carry Salmonella enteritidis either 
through contact with the cuticle or by feeding from the blood of birds infected with 
the pathogen (Moro et al., 2010). PRM have also been found to be a reservoir for 
Salmonella gallinarum, the cause of fowl typhoid. Bacteria can reproduce within 
the mites and survive for up to four months, using mites as a reservoir (Pugliese 
et al., 2018; Zeman et al., 1982). The bacteria could be passed on from flock to 
flock by the PRM persisting in the poultry housing after one flock and transmitting 
Salmonella gallinarum to the new flock on their first blood feed (Moro et al., 2010). 
This represents the importance of PRM as a vector of disease. 
Infestation with PRM is being increasingly associated with dermatitis and 
gamasoidosis, namely in poultry workers and people living in close proximity to 
poultry housing (George et al., 2015). In one survey of 58 farms in Southern Italy, 
19 % of farm workers reported pruritic skin eruptions after contact with PRM and 
is suggested as a cause for occupational safety concerns (Cafiero et al., 2011). 
In 1997, 7 male workers from the Mediterranean coastal plain of Israel reported 
severe itching and dermatitis after completing an early morning egg collection. 
Small, reddish lesions covered the whole body but were more intense on the 
arms, torso and back and disappeared without treatment after 2-6 days. Samples 
of mites, taken from the eggs collected by the workers as well as from the workers 
skin, were collected into small vials containing 70 % ethanol and later identified 
as Dermanyssus gallinae (Rosen et al., 2002). The reported number of cases of 
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dermatitis is increasing; in 2017 a 6 year old boy presented with a 4 day history 
of pruritic eruptions following several sparrow nests being found in the roof. Mite 
samples taken from the boy’s bed were identified as Dermanyssus gallinae upon 
inspection (de Sousa and Filho, 2018). One report tested 26 samples taken from 
subjects living in Italy and showing clinical signs of dermatitis. The mite samples 
were analysed using transmission light microscopy and out of the 26 samples, 20 
were confirmed to be Dermanyssus gallinae with abandoned bird nests (pigeon/ 
sparrow/ swallow) being close to the building (Cafiero et al., 2018). In one study, 
five members of a Serbian family were diagnosed with gamasoidosis after being 
in contact with PRM from a nearby dove’s nest, further demonstrating the ability 
of PRM to feed from humans if lacking its natural avian host (Gavrilovic et al., 
2015).  
Control of PRM is typically achieved through programs incorporating biosecurity 
measures, cleaning and the use of synthetic acaricides with the latter remaining 
as the most effective method. Biosecurity measures include foot dips before 
entering poultry housing and a change of footwear before going from one housing 
unit to another, to avoid the spread of PRM. As well as changing footwear, limited 
exposure to outside birds is a measure taken to stop the spread of PRM, both 
within a farm and between nearby farming units (Knight-Jones et al., 2011). 
Manual cleaning of the sheds in between flocks is commonplace, but has been 
proven to have little effect on the long term population of PRM due to their ability 
to survive in cracks and crevices which are almost impossible to reach via 
cleaning. Whilst this may help reduce the population and allow acaricides to be 
more effective immediately after cleaning, it is not a long term solution to PRM 
control (Huber et al., 2011). 
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Control of PRM chiefly depends upon acaricide applications but despite this there 
are very few that are permitted to be used worldwide. Organophosphates, 
carbamates and pyrethroid-based acaricides are the most widely used across the 
globe but resistance has been reported against all of them in at least one country 
(Abbas et al., 2014). As well as increased resistance to the acaricides available, 
tighter legislation means that less products are coming on to the market in recent 
years and once popular products, such as the organophosphate fenitrothion, are 
now prohibited (Fiddes et al., 2005). Many unlicensed products are still being 
used to treat PRM but quantifying numbers is difficult (Table 2.3) (Marangi et al., 
2012; Maurer et al., 2009). 
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Table 2.3: Pesticide use in European countries. The family of pesticide, the 
specific pesticide , structure, commercial names and mode of action of commonly 
used pesticides in European countries (RSC, 2019). Also included are products 
that have not been approved but are in widespread use. Table adapted from 
Sparagano et al. (2014).  
Family of 
pesticide 
Pesticide  Structure 
Commercial 
product 
Mode of 
action 
Countries 
product is 
approved for 
use 
Countries 
where 
product is 
not 
approved 
but widely 
used 
Pyrethroids 
Permethrin 
 
Perbiochoc 
Targets 
sodium 
channels 
UK 
(permethrin) 
Italy, The 
Netherlands, 
Belgium, 
Greece and 
Sweden 
Tetramethrin 
 
Cypermethrin 
 
Milben Ex 
Fendona 
Carbamate Bendiocarb 
 
Ficam 
AChE 
inhibitor 
 UK 
Phenol Chlorocresol 
 
Interkokask Lipid solvent   
Avermectin Abamectin 
 
CBM8 
Glutamate 
chlorine 
channels 
2012: UK  
Diatomaceous 
earth 
Silica 
 
Fossil shield 
Desiccation   
Hemexsan 
Neonicotinoid Imidacloprid 
 
Imidacloprid 
Targets 
nicotinic 
acetylcholine 
receptor 
  
Organo-
phosphate 
Phoxim 
 
Byemite 
AChE 
inhibitor 
2010: UK, 
France, Italy, 
Netherlands, 
Belgium, 
Denmark, 
Germany, 
Poland, 
Greece, 
Sweden 
 
Isoxazoline Fluralaner 
 
Exzolt 
Targets 
GABA gated 
chloride 
channels 
2017: EU 
wide approval 
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Only two products have entered the European market which are licenced to 
target PRM in recent years, Byemite® (Bayer) and Exzolt (MSD Animal Health). 
Byemite® is an organophosphate (phoxim) which is an inhibitor of AChE and 
resistance to organophosphates is already noted in PRM, as well as the 
challenge of resistance, Byemite® is only registered in a few countries, not 
including ones with large populations of egg laying hens such as Germany, 
Poland, Spain and the UK (Flochlay et al., 2017; HPRA, 2016; Beugnet et al., 
1997; Thind and Ford, 2007; Abbas et al., 2014). Exzolt is registered for use in 
the UK and is added to the drinking supply of the hens. The product is ingested 
by the hen and a percentage is detoxified by the bird, however a percentage 
remains in the blood stream unchanged and is taken up by the mite when blood 
feeding occurs. The aim is to have a high enough concentration in the hen’s 
blood stream to be non-toxic to the hen but provide a toxic dose when absorbed 
by the mite. This entry differs to traditional spray acaricides which function by 
being absorbed through the cuticle of the mite when they are in contact with the 
spray. Exzolt, active ingredient fluralaner, targets γ-aminobutyric acid (GABA) 
gated chloride channels and has had 100 % efficacy up to 15 days after 
administration, but this drops to 74.8 % 19 days post treatment, requiring 
stringent application (Gassel et al., 2014; Brauneis et al., 2017).  
A factor that could be contributing to pesticide resistance is the misuse of 
pesticides by farmers. Over using a product when a result is not seen 
immediately, or using products at a lower than recommended dosage in order 
to reduce costs, contributes to the exposure of PRM to the active compounds of 
the commercial products and could be allowing them to develop resistance. 
Many products which have not been approved for use are still being widely 
applied and misuse of acaricides in the treatment of PRM is widespread in 
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European countries (Table 2.3). An example of this misuse is fipronil, which was 
the cause of a food safety scare in 2017 when 26 of 28 European Union 
members found traces of fipronil in their eggs (Munoz-Pineiro and Robough, 
2018). In Europe, fipronil is permitted for use as a veterinary medicine but is 
forbidden for use on animals intended for the food chain, such as poultry. The 
maximum residue level for fipronil in eggs is 0.005mg/ kg however, misuse of 
fipronil resulted in levels of up to 1.2mg/ kg found in European eggs (Munoz-
Pineiro and Robough, 2018). This misuse is not only a risk for food safety but 
also risks under dosing (Beugnet et al., 1997; Marangi et al., 2009; Thind and 
Ford, 2007; Marangi et al., 2012). Under dosing provides a sub lethal dose to 
the mites and exacerbates the issue of resistance to products. As well as under 
dosing, uneven spraying of poultry housing can lead to sub lethal doses of 
product being applied due to the PRM living in cracks and crevices of the poultry 
housing and being difficult to access with spray.  
Recently, as the efficacy of synthetic acaricides has reduced, studies have 
emerged into the use of plant essential oils as a control method for PRM. 56 
plant oils have been tested for their toxicity in PRM and researchers investigated 
the influence of ‘time since last blood meal’ on the toxic effect of plant oils (Kim 
et al., 2004; George et al., 2010a; George et al., 2008b). However, the issue 
with using plant oils as a control method is that the oils can have differing 
chemical profiles which leads to different efficacies as acaricides. Many studies, 
which have used the same methodologies, have produced conflicting results for 
the same essential oils, which makes their future as a commercial control 
method for PRM unlikely unless more research is done to ensure their efficacy 
(Kim et al., 2004; Nechita et al., 2015; George et al., 2008a; George et al., 
2010a; George et al., 2008b; George et al., 2009).  
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It is critical that the efficacy of existing acaricides for PRM be maintained to 
ensure their continued benefit to the industry. To achieve this goal, resistance 
must be monitored/managed wherever possible through considered application 
of these acaricides. A UK map of PRM resistance/susceptibility would be highly 
beneficial to this end as the application of acaricides could be controlled based 
on which areas are already showing resistance to a particular product. As well 
as this, a map would showcase the need for new treatment options in the UK 
and provide a baseline against which future resistance/susceptibility could be 
compared. A baseline is vital for monitoring the need for new treatments over 
time as well as the effectiveness of cleaning and biosecurity measures which 
are in place. The last time a survey of this nature was completed in the UK was 
in 2005 (Fiddes et al., 2005) and this survey included both layer and parent birds, 
of which layer represented 58% of the 43 responses. The industry would benefit 
from a more complete picture of resistance across the UK and other counties 
with high numbers of egg laying facilities, with geographical comparisons being 
made possible in order to establish the best treatment specific to an area.  
This chapter presents the results of a survey, of acaricide usage and the 
occurrence of resistance across the UK, from a project aimed at addressing 
these issues in PRM. The survey was sent to farms across the UK and was 
answered by farmers who apply the products to which resistance is being seen. 
The survey questions farmers on products used as well as requesting 
information about the housing and feeding regime of the birds in order to draw 
further comparisons. The information obtained will allow for a map of perceived 
resistance to be generated for several regions across the UK that can be used 
to recommend optimal PRM treatment programmes in these areas for use by 
the farming industry. As well as this, knowledge of the products being used to 
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treat PRM means a more targeted approach can be undertaken when 
developing new products. The timing and method of usage of the products will 
be requested from farmers, which allows further study into the misuse of certain 
products and how to provide clearer instruction for use.  
As well as a survey to gain information on perceived resistance, toxicity testing 
is essential to gain a fuller picture of the resistance in PRM. To assess the actual 
resistance of PRM to commonly used products, mites will be acquired from 
several poultry units from across the UK. These mites can then be tested under 
laboratory conditions in a standardised toxicity test in order to compare the 
actual resistance found in the PRM to the perceived resistance by farmers. This 
data will be the largest collection of PRM resistance surveys in the last ten years 
in the UK and will provide an up to date insight into perceived resistance across 
different geographical locations, and whether this perceived resistance is an 
accurate depiction of actual resistance found from toxicity testing.  
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2.3 Materials and Methods 
2.3.1 Participant Recruitment 
Contact details of egg producers from across the UK were provided by Dr. Mark 
Williams of the British Egg Council. Egg producers were initially contacted via 
email and asked for cooperation in a project that would monitor the distribution 
and perceived resistance of PRM across the UK.  
2.3.2 Survey Design 
 A survey was designed which would be both short and easy to answer, based 
on colloquial farmer feedback on the type and length of questionnaire they would 
be willing to answer. The survey consisted of seven questions and was sent to 
those willing to cooperate. Questions 1-4 were aimed at gathering details of the 
farm location and name as well as contact details. Question 5 then asked for 
production methods such as flock size, number of buildings, size of buildings, 
others animals reared and lighting regimes. This question was an open box 
answer allowing the farmer to provide as much information as they could. 
Question 6 was designed as a grid to collect product information. It asked for the 
brand name of the product as well as who the product is manufactured by. It then 
went on to ask what form the product was used in, for example some products 
come in both a powder and spray form, and how frequently the product was 
applied. The next column asked for the timing of the products use, for example 
was it used on an inhabited or uninhabited shed, followed by the method used to 
apply the product; was it applied as a spot treatment to problem areas or was it 
applied to the entire shed. The final column asked the farmer to rate the perceived 
effectiveness of the product on controlling the PRM on a hedonic scale (0-10). 
The seventh question on the survey enquired which other preventative methods 
were used, such as applying grease to the roosts, as well as any extra comments 
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the participant wished to include (see appendix C for full survey). Surveys were 
emailed or posted back to Northumbria University where the data were collated 
and analysed. 
2.3.3 Statistical Analysis 
The minimum number of participants required was determined by an a priori 
power analysis. Power analysis revealed that in order for differences in samples 
to be detected (80 % chance) as significant at the 5 % level, a sample of 42 
participants would be required.  
 
      0.6 X 0.4 1.96 + 0.84 √0.8 X 0.2     2 
N=    0.6 X 0.4 
                                                               
  (0.8 – 0.6)2 
N= 42 
The data were analysed using the statistical package SPSS Version 22.0 (IBM, 
2013). Analysis of a factor with more than two response options was done using 
an independent samples Kruskal-Wallis pairwise analysis (confidence interval = 
95, significance level 0.05), with missing data excluded. For the North-South 
divide where there were only two response options, data were analysed using an 
independent samples Mann-Whitney test (confidence interval = 95, significance 
level 0.05).  
2.3.4 Toxicity Testing 
PRM were collected from poultry units for use in toxicity testing. Traps were sent 
out, originally consisting of plastic cylinders (each cylinder was 12 mm in 
diameter) fastened together and later corrugated plastic (each gap was 2 mm in 
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diameter), which were posted to participants. The traps were sent with plastic 
sealed containers which were used to post them back to Northumbria University 
as well as cable ties to secure the traps within the housing. A sheet of instructions 
detailing how to use the traps and the best place to secure the traps was also 
provided (see appendix D for instructions). Participating farms within the vicinity 
of the University were visited and mites collected from these facilities by hand. 
Plastic sealed bags were used to collect the mites, which were brushed into the 
bags using cardboard scrapers, and were transported immediately back to the 
University.  
Mites were stored at 4 °C in complete darkness prior to use within the sealable 
plastic ‘freezer bags’ in which they had been initially collected or the sealed plastic 
container they had been posted in. Mites were used in experiments within 1 week 
of procurement. Before use in the assay, mites were assessed for percentage 
viability and engorgement. Samples of mites were taken at random and tested by 
agitation with an entomological pin, movement following agitation was deemed 
as viable. Around 20 % of mites were expected to be nymphs to ensure a healthy 
reproducing population was present. If over 50 % of the mites sampled were 
viable and over 25 % appeared to be engorged, the mites were used in testing. 
Average viability of the mites was ~70 % for mites arriving by post.  
All Petri-dishes, once in use, were stored for the required period at 20 °C in 
complete darkness, after which mite mortality was assessed under magnification. 
A mite was considered dead if no movement was observed following repeated 
agitation with an entomological pin (George et al., 2010a). All products used for 
testing were stored in darkness at 20 °C prior to use.  
Six well known PRM products were acquired for testing against D. gallinae from 
all farms; Milben Ex (Schopf), Interkokask (Hysolv), Ficam (Bayer), Perbio Choc 
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(Digrain), CBM8 (Hysolv) and Fendona (BASF). The products were made up 
according to manufacturer’s instructions (see appendix E). Two local farms (Farm 
51 and Farm 52) were used for extensive testing due to being able to collect mites 
from the facility in person and hence get a higher yield of PRM to work with. These 
PRM were tested using the active ingredients of commercial pesticides 
(cypermethrin, bendiocarb and permethrin) as well as the commercial products. 
The concentration of these active ingredients used in testing was determined by 
the concentration of the active ingredient when used in commercial products at a 
working concentration; cypermethrin 4 mg/ml, bendiocarb 2.4 mg/ml and 
permethrin 6.4 mg/ml. The active ingredients were solubilised in 100 % ethanol 
to a stock concentration of 10 mg/ml before being further diluted with 100 % 
ethanol to the relative working concentration. The active compounds were tested 
with synergists (diethyl maleate, piperonyl butoxide and triphenyl phosphate) at 
the same concentration as the active product. Farm 51 was tested with synergists 
at 5 times the concentration of the active product. A negative control was 
prepared for each batch of PRM that were tested (100 % ethanol control for active 
ingredients solubilised in ethanol and water control for commercial products 
diluted in water). 
Adult female PRM were tested using a contact assay. 100 µl of the solution to be 
tested was added to 14.2 cm2 filter papers (Whatman No. 2) in a circular pattern 
and left to dry for 3 minutes in a fume hood. An ethanol negative control was 
included for every batch of mites collected. Approximately 25 adult female mites 
were added to each filter paper using a pooter and sealed in a glass Petri dish 
using polyethylene film and a glass lid. These dishes were stored at 20˚C in a 
dark storage cupboard. A minimum of 3 replicates were done for each 
concentration of product, with a maximum of 6 replicates if the yield of PRM was 
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high enough. The mites were taken out and counted after 24 hours. The mites 
were considered dead if there was no movement after agitation with a pin. 
Mortality was corrected for control using the Henderson-Tilton correction 
(Henderson and Tilton, 1955). Statistical analysis for comparison of product 
efficacy was done using a t-Test: Two-Sample Assuming Unequal Variances and 
was run in Excel.  
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2.4 Results and Discussion  
2.4.1 Survey Data Analysis 
Farmers are facing a lack of efficient products on the market to deal with the issue 
of PRM infestation. From colloquial conversation, it appears product labeling and 
marketing often leaves farmers confused about the product they are purchasing. 
If one product ceases to be effective, a new product is purchased to replace it, 
but the same active ingredient could be found in the new commercial product, 
therefore not improving the efficacy. The high prevalence of PRM on UK farms, 
as well as the lack of effective acaricidal products on the market, leaves farms 
facing large production losses. As well as this, using products with the same 
active compound as a product already showing signs of resistance could 
exacerbate the issue of resistance within PRM.  
The data generated from the survey responses has been widespread across the 
UK (Figure 2.2) comprising data from 51 farms in 17 different counties. Of the two 
previous UK surveys on PRM, both completed over a decade ago, one survey 
was only done on farms in the North of England, with 29 farms participating, and 
so gave a limited overview of resistance (Guy et al., 2004). The latest study to be 
published in the UK is from 2005, and the prevalence rate of 60 % was used in 
the a priori power analysis to ensure enough surveys were completed for 
adequate study power (Fiddes et al., 2005). Both surveys previously completed 
found a high rate of PRM prevalence of 87.5 % (29 survey responses) and 60 % 
(43 survey responses) which supports the findings of this study where prevalence 
was found to be 98 % (Guy et al., 2004; Fiddes et al., 2005). Both studies also 
found high levels of reports of resistance to used pesticides, with 63 % of 
Northern farms reporting products becoming less effective over time. One of the 
largest concerns with the studies previously completed is the move to free range 
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systems since their production. The previous research surveyed farms that were 
71 % caged systems or 45 % caged systems, compared to 0 % caged systems 
surveyed in this study. This is due to the shift in legislation (Directive 1999/74/EC) 
which has prohibited traditional cages and has led to more complex housing and 
a move to free range systems. This shift has increased incidence of PRM due to 
the increased areas of mite refuge and hence new data is required in order to 
gain an accurate picture of current PRM prevalence (Flochlay et al., 2017). Also, 
in one study, the pesticide most reported to be used was fenitrothion which has 
been banned for use since 2007 and hence survey responses are now outdated. 
In the survey completed in this study, areas such as Cumbria and North Yorkshire 
have a higher number of survey responses due to the prevalence of poultry 
farming in these regions, whilst areas such as South West England do not have 
a survey response as farming in this region focuses on cattle and sheep rearing 
due to its extensive grasslands (Union, 2014).  
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Figure 2.2: Heat map of the UK demonstrating spread of survey responses. 
Heat map representing the number of survey responses per area (N=51). 1 
response is represented by a green dot, 2-3 responses are represented by a 
yellow dot and >3 responses are represented by a red dot (N=51).  
Out of the 51 farms surveyed, 98 % reported the presence of PRM and used 
products to try and eradicate the pest species. The farm that did not report using 
any control products did not specify whether PRM were present, producing a 
prevalence rate of 98-100 %. This is a notable increase in prevalence when 
compared to a 2004 study of Northern farms which found the prevalence of PRM 
to be 87.5 % (Guy et al., 2004).  
1 
2-3 
>3 
Number of 
responses 
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The use of surveys of PRM infestations have also been used worldwide, a survey 
of ectoparasites in China found 64.1 % of commercial layer hens to be infested 
with PRM with 77.8 % relying on the use of organophosphates or pyrethroids 
alone to control the ectoparasitic infestations (Wang et al., 2010). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Heat map of number of hens per farm. Heat map to show the 
number of hens kept on each farm surveyed. 0-4,999 hens are represented by a 
green dot, 5,000-20,000 hens are represented by an orange dot and >20,000 
hens are represented by a red dot. Each dot covers a 30 mile radius surrounding 
the located farm. Where more than 1 farm response was present in the same 30 
mile radius, the farm with the highest number of hens is represented (n=50).  
0-4,999 
5,000-
20,000 
>20,000 
Number of hens 
(thousands) 
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In order to establish the scale of farms responding to the survey, farmers were 
asked to provide the number of hens on the farm. This information can be viewed 
in Figure 2.3, where it is shown that the largest scale farms were found in Cumbria 
and Nottinghamshire. This also allowed an insight in to the scale of farms affected 
by PRM, from smaller scale facilities, to large facilities with over 50,000 birds. It 
also highlights the needs for tailored PRM control to fit different sized facilities 
with different product requirements.  
The data was grouped as the UK as a whole for analysis of treatment application 
rather than per geographical location. It was revealed that there was no significant 
increase of the perceived effectiveness of each individual product if it was applied 
more often throughout the year or if it was applied by covering the shed, rather 
than doing a spot treatment on areas showing high infestation levels. This 
information could be used to help farmers reduce the money spent on acaricides 
as well as the time needed to apply products to the entire shed. Product could be 
wasted by doing 100 % coverage rather than spot treatment as well as by 
applying a product more frequently than required to achieve a high efficacy. It is, 
however, worth noting that 39 products out of the 110 listed by farmers were used 
‘as required’ rather than specifying a frequency of use which makes comparisons 
between application frequencies difficult.   
It was thought that applying products when the hens were housed could improve 
the efficacy of the product due to the increased likelihood of the mites being out 
of the refuge of the housing to blood feed from the hens. However, there was no 
significant difference in perceived product effectiveness when products were 
used whilst hens were housed in the shed or whether the product was used once 
the shed had been emptied and was in between flocks. This could be due to the 
large population of PRM still in the crevices when hens are present and therefore 
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only a small number are affected when products are applied whilst hens are 
housed and therefore this implies that the hens are effectively irrelevant in the 
subject of PRM infestations and resistance. It could also be that even though a 
product is more effective when the hens are present, the product is applied more 
thoroughly when the hens are not present which counteracts any improvement in 
efficacy. Due to this, it may be more time effective, and therefore cost effective, 
for products to be applied to an empty house due to the ease of application.  
Interestingly, there was no statistically significant difference in the perceived 
effectiveness of commonly used pesticides dependent on the location of the farm 
surveyed. Location comparisons were made at a county level and also at a wider 
regional level but no statistical difference was observed in the effectiveness of 
the products as noted by the farmers. A comparison was also made between the 
North and South of the UK as a whole using the North/South divide line (Dorling, 
2007). This divide defines Wales as Northern and results in no significant 
difference in perceived effectiveness. When a more colloquial North/South divide 
was used (from the River Humber to the River Mersey) one of the more commonly 
used pesticides, Milben Ex, was significantly more effective when used in the 
South of the UK than in the North. 
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Figure 2.4: Heat maps of product effectiveness. Maps showing the 
effectiveness of three products according to the survey responses which were 
ranked on a scale of 0-10 (0- no perceived effectiveness, 10- high perceived 
effectiveness). A. Ficam, active ingredient of bendiocarb (n=33). B. Milben Ex, 
active ingredient of cypermethrin (n=17). C. Diatomaceous earth (including 
survey responses for hemexsan, diatomaceous earth, dusting powder and fossil 
shield) active ingredient of diatomaceous earth (n=33).  
Heat maps (Figure 2.4) show the average effectiveness of Milben Ex, Ficam and 
diatomaceous earth by county, based on survey responses. Despite there being 
no significant difference in perceived pesticide effectiveness across the UK 
statistically, there are still observable differences in perceived effectiveness 
across the UK. These are noticeable when using average effectiveness results 
from each county per individual pesticide. For example, the average perceived 
 
 
 
 
A.         B.                           C.  
Perceived product 
effectiveness (0-10) 
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resistance to Hemexsan in Lancashire was 3/10 compared to Powys which had 
an average score for the same pesticide of 8/10. This score cannot be compared 
statistically as there was only one farm response from Lancashire which uses 
Hemexsan. Similarly, the average score for Ficam (active ingredient bendiocarb) 
from the East Riding of Yorkshire was 5/10 compared to Dumfries and Galloway 
which scored Ficam 10/10. Milben Ex, which contains the active ingredient 
cypermethrin, had a rating of 9.5/10 when used in Powys but a rating of 6.8/10 
when used in Cumbria. These could not be statistically analysed due to only being 
one response from each county. The differences in perceived product 
effectiveness could represent a notable difference in the ability of PRM to 
metabolise different pesticides in different locations. This data could highlight the 
spread of pesticide resistance in PRM, with certain farms struggling to control 
PRM with products that are effective in other locations, furthermore, there seems 
to be no clear geographical trend in resistance with results varying greatly per 
county. 
The lack of difference in effectiveness across different locations could highlight 
the persistently high levels of resistance in the PRM. 98 % of survey responses 
used PRM control products which is representative of the scale of PRM 
infestation in the UK compared to 60 % of farms in the previous study of Northern 
farms (Fiddes et al., 2005).  
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Figure 2.5: Active ingredients used across the UK. Map to show the active 
ingredients used on farms across the UK based on survey responses. Active 
ingredients are mapped with a different colour, areas with multiple active 
ingredients used are represented on a circular chart (N=105).  
Multiple products contain the same active ingredient, making resistance harder 
to monitor. There is a wide spread of different active ingredients being used 
across the country, as can be seen in Figure 2.5, with bendiocarb, cypermethrin 
and diatomaceous earth among the most commonly used. Use of diatomaceous 
earth is also common across all farms, and is often the pesticide of choice when 
only one product is used.  
Active ingredient 
used 
Pyrethroid 
Chlorocresol 
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Average product effectiveness across all products was 7.3/10 with one of the 
highest scoring products being petroleum jelly/grease (Table 2.4). Grease scored 
9/10 on average which is noteworthy, as it is one of the only products which mites 
cannot form metabolic resistance to, as the action of grease is mechanical. The 
grease coats the exoskeleton of the PRM causing death by desiccation (Pritchard 
et al., 2015), although using this in a commercial setting poses difficulties with 
time consuming application. The highest rated product which is used by more 
than 3 farms is Milben Ex, active ingredient of cypermethrin. Milben Ex is currently 
rated 7.74/10 but is part of the pyrethroid family. Over reliance on an effective 
product, such as Milben Ex, could lead to future resistance in the same way that 
has happened with previously effective products. Pyrethroids, such as permethrin 
and flumethrin, are an example of a product which was once effective but 
resistance is now widespread. Pyrethroids have been used for many years as 
acaricides, but resistance has been reported against them in PRM in 6 different 
countries since as early as 1984 (Abbas et al., 2014). In addition to PRM, 
pyrethroid resistance has been noted in mosquito species such as Aedes aegypti 
and Aedes albopictus, as well as in other acari such as the North American cattle 
tick, Rhipicephalus (Boophilus) annulatus, which showed resistance to pyrethroid 
insecticides with elevated levels of P450s and GST complexes in resistant 
populations (Smith et al., 2016; Ziapour et al., 2017). 
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Table 2.4: Average perceived effectiveness of products. The names of the 
products used, as taken from the survey, with the active ingredient of the product 
as well as the number of farms using the product and the average perceived 
effectiveness of that product from the survey. N/A= No score was given for that 
product. 
 
The survey provides evidence that the active ingredient is the crucial determinant 
in mite mortality rates, and that the form in which the active ingredient is supplied 
is not a factor in the effectiveness of the product. No significant difference was 
found in perceived effectiveness when a product, such as Ficam, was used in the 
powder form or in the spray form. It would therefore be more cost effective for 
farms to use whichever form was the lowest cost to buy and apply to the shed. 
2.4.2 Toxicity Testing Data and Analysis 
In order to investigate if the perceived data is reliable as a true indication of 
resistance/effectiveness status, the next step was to perform standardised in vitro 
Name of Product  
Used 
Active Ingredient  Number of Farms Using 
Product 
Average of Perceived  
Effectiveness (0-10) 
Red Mite Avian Plant essential oils 2 9.00 
Petroleum Jelly/Grease Petroleum jelly 2 9.00 
Milben Ex Cypermethrin 17 7.74 
Perbio Choc Permethrin and 
tetramethrin 
4 7.67 
Fossil shield Diatomaceous earth 5 7.60 
Diatomaceous Earth Diatomaceous earth 3 7.33 
Hemexsan Diatomaceous earth 25 7.30 
CBM 8 Abamectin and 
permethrin 
1 7.00 
Fendona Cypermethrin 1 7.00 
Decimite Propargite 1 7.00 
Ficam Bendiocarb 33 6.93 
Interkokask Chlorocresol 11 6.89 
Poultry Shield Surfactant  1 5.00 
Ecofoam Surfactant  1 N/A 
Hi GAT Lambda Plus Lambda-cyhalothrin 1 N/A 
Gat Omega Abamectin  1 N/A 
None N/A 1 N/A 
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toxicity testing, under laboratory conditions, to a range of actives on mite samples 
obtained from selected farms. Initially, traps were designed using card wrapped 
around plastic straws 12 mm in diameter. These traps were unsuccessful, likely 
due to the straws being too wide to provide refuge to PRM as previous studies 
have used traps with corrugated cardboard with gaps of 3 mm in diameter 
(Nordenfors and Chirico, 2001; Lundh et al., 2005; Barimani et al., 2016). Plastic 
traps with a corrugated plastic centre (gaps 2 mm in diameter) were sourced from 
Elanco and were sent out to participating farms which allowed for the collection 
of mites from 7 farms (Figure 2.6). Of the 7 farms, 6 sent a high enough yield of 
mites to allow for the testing of commercial products.  
 
 
 
 
 
 
 
 
 
 
Figure 2.6: A map of mite collection points. Each number on the map of the 
UK represents one farm that mites were collected from. 
50 
 
The mite traps were sent out in staggered stages to compensate for the testing 
capacity of the laboratory. A range of popular commercial products were chosen 
to be tested on the adult female mites collected. Ficam, Milben Ex, Interkokask, 
Perbio Choc, CBM8 and Fendona which were used by 33, 17, 11, 4, 1 and 1 
farms respectively. These products were tested at the manufacturer instructions 
for usage (see appendix E).  
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Figure 2.7: Results of the complete toxicity testing from 6 farms on adult 
female PRM. Data represents the mean % mortality +/- SD, corrected using the 
Henderson Tilton correction. N=3 for farms 32, 34, 35 and 47. N=6 for farms 51 
and 52 (control=water for all results shown).  
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Across the six farms tested with commercial products (Figure 2.7), Fendona had 
a consistently low mortality and Milben Ex had low mortality in all farms other than 
farm 52 where it had a mortality of 72 %. Both Fendona and Milben Ex have 
cypermethrin as an active ingredient, part of the pyrethroid family, and provides 
strong evidence for resistance to cypermethrin. To support this, both Fendona 
and Milben Ex had an average score of 7/10 on the survey of perceived product 
effectiveness, indicating both products have the same level of efficacy. Milben Ex 
was rated 7.74/10 on the survey of perceived product effectiveness, which could 
be due to efficacy dropping off in recent months due to resistance (time gap 
between survey and testing was 12 months).  
Interkokask and Perbio Choc have high mortality on all 4 farms. Perbio Choc, has 
both permethrin and tetramethrin as active ingredients which belong to the 
pyrethroid family, like cypermethrin. However, there are different types of 
pyrethroids, type I and type II, which differ by the addition of an α-cyano group in 
type II pyrethroids. Both permethrin and tetramethrin are type I pyrethroids and 
cypermethrin is a type II pyrethroid. Perbio Choc had a high average mortality of 
99.7 % across the six farms, showing that resistance is unlikely to be across 
pyrethroids as a whole, but rather to the different types of pyrethroids, as type II 
pyrethroid cypermethrin (active product of Milben Ex) had much lower levels of 
toxicity across the farms. Interkokask has an active ingredient of chlorocresol, 
which is a derivative of cresol. Chlorocresol is a lipid solvent which breaks through 
the chitin exoskeleton of the mites and causes death of mites by desiccation. Due 
to the mechanical nature of the mechanism of Interkokask, metabolic resistance 
cannot occur, which could explain the high efficacy of Interkokask across all 
farms. Also, Interkokask requires contact with PRM to cause desiccation, which 
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occurs in the assay testing producing consistently high levels of mortality, but is 
less likely to be achieved in a commercial setting. 
The results for Ficam are the most varied of all results, with 96.3% mortality on 
farm 51 and 1.6 % mortality on farm 35. The active compound in Ficam is 
bendiocarb which is a carbamate, to which resistance has been noted since 2004 
(Abbas et al., 2014). The high variability in the results for Ficam highlight the need 
for farm testing on an individual basis, as general assumptions of product 
effectiveness based on one farms results cannot be consistently accurate per 
region or country wide. This agreement is supported by the following: Farm 34 
had 80.1 % mortality using Ficam whereas farm 47, which is in the same county 
(Cumbria), had just 25.5 % mortality.  
CBM8 is one of the newest products to market, being registered in 2014. The 
active ingredient is Abamectin, part of the avermectin class of pesticides which is 
a glutamate-gated chloride channel allosteric modulator and causes paralysis. 
This is combined with permethrin and microencapsulated to give a slow release 
of the active ingredients (Wolstenholme and Rogers, 2005). Despite being new 
to the market, and therefore theoretically less likely to be affected by issues of 
resistance, the product is still largely ineffective across all farms surveyed. This 
is likely due to one of the main actives being permethrin, to which resistance has 
already been reported in PRM (Abbas et al., 2014), and the other being 
Abamectin to which resistance has been found in similar acari such as the two-
spotted spider mite, Tetranychus urticae (Kwon et al., 2010).  
Whilst the results from the survey largely supported the toxicity testing results, a 
few discrepancies were present which highlight the need for per farm toxicity 
testing. Farm 32 scored Interkokask 7/10 and Ficam 8/10 whilst they scored 96 
% and 58 % mortality rates on the toxicity testing respectively. However, Fendona 
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was also scored 7/10 despite only producing a 23 % mortality rate in toxicity 
testing. Farm 34 scored Perbio Choc 7/10 which is lower than the 100 % mortality 
rate in laboratory testing but farm 35 was accurate with the score of 0.5/10 for 
Ficam which scored just 2 % in toxicity tests on mites from the farm. Another 
mixed result was farm 47 which correctly scored Interkokask 8/10 in agreement 
with the 100 % mortality rate found in testing, but scored Ficam 9/10 despite only 
a 26 % mortality rate in toxicity testing. This could be due to an increased 
resistance in the mite in the time between the survey and testing, or the reduced 
mortality rate may have not yet been noticed by the farmer if the product had 
previously been effective.  
Farms 51 and 52 were chosen for further toxicity testing due to the proximity to 
the University, which allowed for the PRM collection in person. The active 
ingredients of some of the popular products (Ficam, Milben Ex and Perbio Choc), 
which are likely to be metabolised by PRM detoxification pathways, were chosen 
for further testing on both farms. Ficam, Milben Ex and Perbio Choc were used 
by 33, 17 and 4 farms respectively. The active ingredient of Milben Ex is 
cypermethrin and the active of Perbio Choc is permethrin, which both belong to 
the pyrethroid family. Ficam contains bendiocarb which belongs to the carbamate 
family. PRM have been reported to be resistant to both pyrethroids and 
carbamates across the globe and a summary of this resistance can be seen in 
Table 2.5. 
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Table 2.5: Reports of drug resistance in PRM. Both drug and class of drug are 
listed along with the country the resistance is reported in and the associated 
reference. Table adapted from Abbas et al. (2014).  
Drug Class Drug Country Reference 
Organochlorines DDT Czechoslovak (Zeman, 1987) 
Fipronil Korea (Kim et al., 
2007) 
Carbamates Carbaryl Korea, Italy (Kim et al., 
2007; Marangi 
et al., 2009) 
Furathiocarb Korea (Kim et al., 
2007) 
Organophosphates Trichlorfon Czechoslovak, 
Sweden 
(Zeman, 1987; 
Nordenfors and 
Hoglund, 2000) 
Fenitrothion Korea (Kim et al., 
2007) 
Pyrethroids Flumethrin Italy (Genchi et al., 
1984) 
Tetramethrin Czechoslovak (Zeman, 1987) 
Permethrin Czechoslovak, 
France, 
Sweden, Korea, 
Italy 
(Zeman, 1987; 
Beugnet et al., 
1997; 
Nordenfors et 
al., 2001; Kim et 
al., 2007; 
Marangi et al., 
2009) 
Deltamethrin Iran (Hadadzadeh et 
al., 2001) 
D-phenothrin Korea (Kim et al., 
2007) 
Alpha-
cypermethrin 
Korea (Kim et al., 
2007) 
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Figure 2.8: Results of the toxicity testing from 2 farms on adult female PRM. 
Active ingredients were tested on both farm 51 and farm 52. Data represents the 
mean % mortality +/- SD of N = 6 (control= ethanol for all results shown) corrected 
using the Henderson Tilton correction.  
On farm 51, Milben Ex and Fendona were found to have 18.5 % and 13.1 % 
mortality respectively (Figure 2.8). The active ingredient of both these products 
is cypermethrin which had a mortality of just 7.5 % on the same farm, suggesting 
that testing of the active ingredient supports the results from the testing of the 
commercial product containing the same active ingredient. Ficam also supports 
this trend, with a mortality of 96.3 % on farm 51 and the active ingredient is 
bendiocarb which had a mortality of 94.2 % on the same farm. However, other 
results do not support this trend, on farm 52 cypermethrin had a mortality of 8.8 
% whereas Milben Ex (active ingredient cypermethrin) had a mortality of 72 %. 
Also on farm 52 Perbio Choc (active ingredient permethrin) had a mortality of  
100 % whereas permethrin alone had a mortality of 6.9 %. These results indicate 
that whilst the active ingredient is often the critical ingredient that determines 
0
20
40
60
80
100
%
 M
o
rt
al
it
y
Substance tested 
Farm 52
0
20
40
60
80
100
%
 M
o
rt
al
it
y 
Substance tested
Farm 51
57 
 
product effectiveness, occasionally other ingredients in the product may allow the 
active ingredient to be more effective than when used by itself at the same 
concentration. For example, Milben Ex contains 200 g/L cypermethrin which is a 
type II pyrethroid but also 1 g/L tetramethrin which is a type I pyrethroid. It is 
therefore possible that the addition of the different form of pyrethroid, which is 
potentially metabolised by a different P450, could allow a commercial product to 
remain effective where the main active ingredient is no longer effective.  
Due to the low level of toxicity of some compounds when used at the 
recommended concentration, synergist testing was completed to try and improve 
the efficacy of the active ingredients and identify the mechanisms underlying 
resistance. Synergists are commonly used in combination with pesticides to 
suppress metabolism-based resistance and increase the efficacy of the agents 
(Pasay et al., 2009). Synergism studies have been completed in other arthropod 
species in order to try and increase the efficacy of current control products. For 
example, PBO has been tested in Hyalella Azteca with pyrethrins, which found 
the LC50s for pyrethrins combined with PBO to be higher than the LC50 for 
pyrethrins alone at low ratios of PBO: pyrethrin (1:1) and much higher ratios 
(100:1) were required for a synergistic effect to be observed (Giddings et al., 
2016).  
The synergists chosen for this study were diethyl maleate (DEM), piperonyl 
butoxide (PBO) and triphenyl phosphate (TPP). These synergists inhibit different 
metabolic pathways; DEM inhibits glutathione S-transferase, TPP is an esterase 
inhibitor and PBO is a general inhibitor of P450s. The mechanism by which PBO 
inhibits P450s is well documented (Philippou et al., 2013; Hodgson and Philpot, 
1974), however it is also worth noting that PBO can interact with esterases and 
inhibit their action in species such as the peach potato aphid, Myzus persicae 
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and the mosquito A. aegypti, and therefore effects seen in PBO studies are not 
conclusive of the role of P450 action (Philippou et al., 2013; Pereira et al., 2014).  
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Figure 2.9: Results of the toxicity testing from 2 farms (51 and 52) on adult 
female PRM. Figure 2.9: Results of the toxicity testing from 2 farms (51 and 
52) on adult female PRM. A= Farm 51, active ingredients tested. B= Farm 51, 
synergists were tested at 1 X concentration of active ingredients tested. C= Farm 
52, active ingredients tested. D= Farm 52, synergists were tested at 1 X 
concentration of active ingredients tested. E= Farm 52, synergists were tested at 
5 X concentration of active ingredients tested. Data represents the mean % 
mortality +/- SD of N = 3 (control= ethanol for all results shown), corrected using 
the Henderson Tilton correction. 
Using synergists on PRM from farm 51 and farm 52 (Figure 2.9) had little effect 
overall. The highest effects were seen using PBO; permethrin (6.4 mg/ml) and 
PBO (6.4 mg/ml) significantly increased mortality compared to permethrin (6.4 
mg/ml) and DEM (6.4 mg/ml) (P = 0.0461). Permethrin (6.4 mg/ml) and PBO (6.4 
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mg/ml) also significantly increased mortality when compared to permethrin (6.4 
mg/ml) and TPP (6.4 mg/ml) (P = 0.0253), leading to the assumption that P450s 
play a role in detoxification as inhibiting ESTs using TPP and inhibiting GSTs 
using DEM did not cause increased mortality, however using PBO as a general 
inhibitor of P450s did increase mortality. Permethrin (6.4 mg/ml) and PBO (6.4 
mg/ml) significantly increased mortality compared to PBO (4 mg/ml) with 
cypermethrin (4 mg/ml) (P = 0.0050). However, PBO (3.6 mg/l) when used with 
bendiocarb (3.6 mg/ml) was more effective than both permethrin and PBO (6.4 
mg/ml) and cypermethrin and PBO (4 mg/ml) (P = 0.0009 and P = 0.0006 
respectively). DEM and PBO have recently been used along with s,s,s-
tributylphosphorotrithioate (DEF), an inhibitor of esterases, to attempt to increase 
the efficacy of imidacloprid against M. domestica. All three showed significant 
synergism with imidacloprid in the resistant strain of flies and the activities of 
ESTs, GSTs and P450s were significantly higher than in the susceptible strain. 
Similar synergistic potential of DEF to imidacloprid between the susceptible and 
resistant strain suggested that GSTs and P450s played a more important role 
then ESTs in the resistant strain (Ma et al., 2017). This supports the results found 
in this study that PBO, an inhibitor of P450s, has significantly more of a 
synergistic effect than the inhibitors of GSTs and ESTs.  
Identification of the specific P450 complexes in the PRM which are responsible 
for detoxification of pesticides is essential for targeting product ineffectiveness. 
Increasing the concentration of the synergists to 5 times the concentration of the 
active ingredient did not significantly improve the results compared to using the 
synergists at 1 times the concentration of the active ingredient. Overall, the 
addition of synergists made no significant difference to the effect of the active 
product alone on either of the farms tested and therefore despite significant 
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differences in the effect of synergists when compared to one another, they are 
not an effective option when looking to increase the efficacy of pesticides 
commercially.  
The data generated is one of the first nationwide surveys carried out which is 
aimed at mapping acaricide resistance in PRM here in the UK or any European 
country. While the results are partly based on the perceived effectiveness of 
products by the egg-producing community, it is clear that this data has some 
guidance value in determining which products are potentially most effective on 
the whole, thus allowing the industry to take a more informed decision in their 
efforts to control PRM infestations and additionally facilitate efforts to limit the 
spread of resistance. However, toxicity testing data shows the survey cannot be 
solely relied upon as it often produces conflicting results. Resistance appears to 
be widespread and individual farms need to be toxicity tested in order to fully 
determine the best practice to use.  
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2.5 Conclusions and Further Research Plan 
The conclusion of the study is that infestations with PRM are widespread across 
the UK, with 98 % of farms infested compared to 60-87.5 % of farms infested in 
previous studies, suggesting prevalence of PRM is on the rise in the UK (Fiddes 
et al., 2005; Guy et al., 2004). As well as increased prevalence, resistance 
appears present on many farms, with an overall perceived product effectiveness 
score of 7/10. The dramatic differences in perceived product effectiveness on 
farms in the same county leads to the conclusion that the best practice would be 
routine testing before application of acaricides on an individual farm level to 
ensure the efficacy of products in maintained.  
Most often, farmers were aware of the issues of resistance on the farm and 
scored products being used on the farm a similar level to that found in toxicity 
testing in the laboratory. Any discrepancies found between the survey and the 
toxicity testing may be due to the 12 month time gap between them and hence 
may highlight the speed at which resistance could be developing. 
In order to carry on with this work, more farms which have been surveyed would 
be allocated for mite collection in order to do further comparison of the perceived 
effectiveness compared to the actual product toxicity. A further survey in the 
future could allow for the comparison of the overall state of product effectiveness 
and resistance in the UK over time and would be a valuable insight for use in 
product development.  
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Chapter 3: Identifying and targeting resistance mechanisms in 
the Poultry Red Mite, Dermanyssus gallinae. 
3.1 Abstract  
Very little of the genetic structure of the PRM is documented and therefore efforts 
to isolate components of the detoxification pathways are hampered. To advance 
the understanding in the area of pesticide metabolism in the PRM, enzymes 
associated with metabolism need to be identified and isolated. 127 putative 
cytochrome P450 transcriptomic sequences were analysed to assign them a 
cytochrome P450 clade based on homology. Of the 127 sequences, 49 were 
potentially xenobiotic metabolising based on homology to Anopheles gambiae. 
These 49 sequences were then used in further analyses and 35 potential 
xenobiotic metabolising genes were identified based on homology to genetically 
similar species (Musca domestica, Aedes aegypti and Drosophila melanogaster). 
However, this will only allow the prediction of their potential metabolic substrates. 
A more targeted approach to identifying and isolating specific enzymes involved 
in the metabolism of acaricides is to use Activity Based Probes which require a 
preparation of microsomes from PRM which contain active cytochrome P450s. In 
this chapter, work has been carried out to generate viable microsomes for use in 
probe assays. However, the inactive P420 form of the cytochrome was detected 
and the assay requires further development in order to be used to identify the 
cytochromes responsible for acaricide detoxification. As well as identifying 
P450s, 2 potential P450 oxidoreductase gene fragments were found at the 5’ and 
3’ end of the gene and attempts were made to isolate this sequence. A potential 
cytochrome b5 sequence was identified which will be isolated and purified.  
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3.2 Introduction 
One of the biggest issues that farmers face when trying to combat the problem of 
the poultry red mite (PRM) is the growing incidence of pesticide resistance. It has 
been estimated that €0.14 per hen is a direct cost spent on acaricides to target 
PRM (Van Emous, 2005), and from the survey completed in chapter 2 of this 
study, 98 % of farms reported infestations with PRM in the UK. Resistance to 
widely used products has been reported since 1984 in both of the major pesticide 
groups; organophosphates and pyrethroids (Abbas et al., 2014), and legislation 
means fewer new products are entering the market. Two products have been 
registered for use on PRM in the last 10 years (Byemite, Bayer and Exzolt, MSD 
Animal Health) and only Exzolt has been registered for use in the UK (HPRA, 
2009). Exzolt, registered in 2017, has an active ingredient of fluralaner which is 
a systemic acaricide which is administered orally. Fluralaner selectively targets 
binding sites on nerve ligand-gated sodium channels which leads to paralysis and 
death (Thomas et al., 2018). This differs from the mode of action of other 
pesticides such as carbamates and pyrethroids but resistance could be forming 
to such a mechanism already, which requires a more in depth understanding in 
order to overcome it, a point which MSD Animal Health are unwilling to discuss 
(Gassel et al., 2014).  
In the survey completed in Chapter 2 of this study, 53 % of the products reviewed 
were scored 7/10 or lower for product effectiveness, representing the low 
satisfaction in the products efficacy by the users. In the toxicity testing completed 
in Chapter 2, the great difference in product efficacy was demonstrated on an 
individual farm level. An example of this was Ficam which had a mortality of 96.3 
% on Farm 51 and a mortality of 1.62 % on Farm 35, despite the farms being only 
47 miles apart. This dramatic difference in efficacy, on farms which are so 
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geographically close together, illustrates the need to investigate resistance on an 
individual farm level. Identification of the cause of resistance in each individual 
case requires greater understanding of resistance mechanisms, and thus the 
enzymes involved, in order to explain this difference in mortality results from 
nearby farms.  
Mosquitoes have been treated as a vector using pyrethrum from flower extract 
since the 1930s and resistance to pyrethroids and other insecticides such as 
Dichdichlorodiphenyltrichloroethane (DDT) and dieldrin has been reported since 
1956 (Davidson, 1956; Ginsburg, 1937) . This resistance occurs through bio-
degradation of the insecticide. In mosquitoes resistance is mainly associated with 
target site modification and metabolic resistance (David et al., 2013). 
Target site resistance to both carbamates and organophosphates is conferred by 
a single point mutation which causes insensitivity of AChE and allows it to resist 
phosphorylation (Weill et al., 2004; Antonio-Nkondjio et al., 2016). This mutation, 
which is coded for by the Ace-1R gene, involves a substitution from glycine to 
serine at position 119 (G119S) in certain species of mosquito; Culex 
quinquefasciatus, Anopheles gambiae and Anopheles albimanus (Scott and 
McAllister, 2012; Penilla et al., 1998; Djogbenou et al., 2008; Antonio-Nkondjio et 
al., 2016). Rhipicephalus microplus has been shown to have a 30 % insensitivity 
of AChE to propoxur (a pesticide of the carbamate family) which indicates that 
AChE also plays a role in resistant tick populations (Janadaree Bandara and 
Parakrama Karunaratne, 2017).  
Pyrethroids target voltage sensitive sodium channels, and substitutions in this 
target site inhibit binding of the pyrethroid and hence inferring resistance. So far 
more than 50 sodium channel mutations have been identified in pyrethroid 
resistance insect pests and human disease vectors, many of which have been 
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functionally confirmed to be responsible for pyrethroid resistance (Dong et al., 
2014; Rinkevich et al., 2013). 
In R. microplus, a mutation in the domain II S4-5 linker region of the para sodium 
channel has been linked to synthetic pyrethroid resistance. The mutation causes 
a change from cytosine to adenine at position 190 in the tick sequence which 
causes a substitution from leucine to isoleucine (L64I). Homozygote allelic 
frequencies correlated highly with the percentage survival at the discriminating 
concentration of cypermethrin (0.3 % w/v) (Morgan et al., 2009).  
However, a 2010 study found that the L64I mutation was not found in tick 
populations that were resistant to flumethrin. The domain II S4-5 linker region 
sequence identified a G-T non-synonymous mutation at position 214 that results 
in a glycine to valine substitution (G72V). The frequency of the G72V 
homozygous genotype was moderately related to the percentage survival at the 
discriminating level of flumethrin (0.02 % w/v) (r = 0.74). Though when both G72V 
and L64I mutations were present, there was a much stronger relationship 
between genotype and resistance to flumethrin (r = 0.93), suggesting a 
connection between the two mutations of the same gene (Jonsson et al., 2010).  
The mutation V1014 of the voltage-gated sodium channel (VGSC) has been 
linked to knockdown resistance (kdr) in numerous insects (Soderlund and 
Knipple, 2003). It has been shown that the kdr phenotype is a key predictor of the 
resistance phenotype (Brooke, 2008; Donnelly et al., 2009; Silva et al., 2014). 
The V1014 mutation was first reported in M. domestica and conferred pyrethroid 
resistance and the mutation has subsequently been identified in several species 
(Williamson et al., 1996; Silva et al., 2014; Dong et al., 2014; Fang et al., 2019).  
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The V1016G point mutation in A. aegypti, the primary vector of dengue virus, has 
been found to significantly correlate with the survivability rates and resistant ratios 
in pyrethroid bioassays (Amelia-Yap et al., 2019). As well as a valine to glycine 
substitution (V1016G), a pheylalanine to cysteine substitution (F1534C) is also 
common in A. aegypti populations in Asia and is associated with resistance to 
type I pyrethroids (Saingamsook et al., 2017; Yanola et al., 2010).  
Parasitic mites have also had VGSC mapped. Varroa destructor has had a 
significant worldwide impact on bee colony health and reports of pyrethroid 
resistance are widely reported (Rosenkranz et al., 2010; Gracia-Salinas et al., 
2006; Bak et al., 2012; Elzen et al., 1998). A modification of leucine to valine at 
position 925 (L925V) of the VGSC has been correlated with resistance, with high 
mutation frequencies exclusively in hives with recent history of pyrethroid 
treatment (Gonzalez-Cabrera et al., 2013; Gonzalez-Cabrera et al., 2016; Hubert 
et al., 2014).  
However, studies have shown that resistance to pesticides in arthropods is most 
commonly through the increased expression of enzymes which are capable of 
pesticide metabolism. Metabolism of a drug is divided into two main phases, 
phase I and phase II; phase I involves modification of the drug which prepares it 
for the phase II reactions by the addition or exposure of functional groups, phase 
II involves conjugation of these functional groups which allows the drug to be 
excreted (Gibson and Skett, 2001). These detoxification enzymes are namely 
enzymes such as glutathione-S-transferases (GST) (phase II detoxification), 
cytochrome P450 (CYP) (phase I detoxification) and esterases (EST) (phase I 
detoxification) (Wan et al., 2014; Istvan et al., 2017; Janadaree Bandara and 
Parakrama Karunaratne, 2017). P450s, as well as GSTs, have been highlighted 
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as principle agents in xenobiotic metabolism (Sun et al., 2018; Clements et al., 
2017; Feyereisen, 2011).  
GSTs are involved in phase II (conjugation) of the detoxification process. GSTs 
catalyse the conjugation of reduced glutathione (GSH) to the electrophilic 
xenobiotic (Bartley et al., 2015; Sheehan et al., 2001). The glutathione conjugate 
targets the xenobiotic to membrane transporters which allow it to be excreted 
form the cell during the final phase of the detoxification process (Bartley et al., 
2015; Cole and Deeley, 2006). GSTs have been proven to be overexpressed in 
resistant species, with one study finding a ten-fold increase in GST activity in 
organophosphate resistant Tetranychus urticae (red spider mite) (Nauen and 
Stumpf, 2002). A five-fold increase in the expression of a GST transcript was 
found in R. microplus after exposure to the organophosphate coumaphos and in 
Anopheles funestus GSTe2 was the most upregulated detoxification gene in both 
DDT and permethrin resistant strains (Saldivar et al., 2008; Guerrero et al., 2012; 
Tchigossou et al., 2018). As well as the overexpression of GST genes, 
cytochrome P450 genes CYP6P9a and CYP6P9b were also overexpressed in 
resistant strains of the mosquito, with GSTd1-5 and GSTd3 more upregulated in 
strains resistant to DDT than in permethrin resistant strains (Tchigossou et al., 
2018). 
Metabolic resistance occurs most often via the over expression of detoxification 
enzymes such as P450s, GST’s and Carboxy/cholinesterases (Hemingway and 
Ranson, 2000; Bartley et al., 2015; Tchigossou et al., 2018; Antonio-Nkondjio et 
al., 2017). P450s are the main detoxification enzyme family associated with the 
increased resistance to insecticides such as pyrethroids in mosquitoes, which is 
the most commonly used insecticide in vector control (David et al., 2013; Antonio-
Nkondjio et al., 2017). 
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The P450 monooxygenase arrangement is an electron transport chain cycle 
which involves both hydroxylation and oxidation pathways in order to degrade 
and detoxify compounds (Deng et al., 2007). The P450 protein itself is the 
terminal oxidase of the cycle and is a super family of proteins with many clades. 
Arthropod P450s fall into four different clades; CYP2, CYP3, CYP4 and 
mitochondrial clade, based on evolutionary relationships (Feyereisen, 2006). The 
mitochondrial P450s and the CYP2 clades have been associated with vital roles 
in hormone biosynthesis, for instance CYP18A1, CYP307A1 and CYP306A1 in 
Helicoverpa armigera and CYP301A1 in Drosophila melanogaster (Gilbert, 2004; 
Zhang et al., 2016; Sztal et al., 2012; Zhang et al., 2018). However, the CYP3 
and CYP4 clades have been associated with abiotic stresses including pesticide 
metabolism and detoxification roles, making them clades of interest in this project 
(Yu et al., 1984; Claudianos et al., 2006). Pyrethroid resistant mosquitoes have 
been observed to have higher levels of P450 activity than non-resistant 
mosquitoes (Amenya et al., 2008; Vulule et al., 1999). Commonly, the elevated 
P450 is linked to the CYP6 family (Hemingway et al., 2004; Fossog Tene et al., 
2013; Antonio-Nkondjio et al., 2016). Resistance needs to be managed as soon 
as possible, removing the insecticide facing resistance to allow the susceptible 
phenotype to flourish again. To find the range of genes involved in resistance, a 
microarray was made from fragments of 230 Anopheles gambiae genes 
putatively involved in pesticide metabolism. This was then used to track the 
expression of detoxifying genes in resistant and susceptible strains leading to the 
identification of several P450s, as well as GSTs, associated with pyrethroid 
resistance in A. gambiae (David et al., 2005). In 2016, Antonio et al. (2016) 
proved both A. gambiae and A. coluzzii were resistant to bendiocarb and no 
AChE G119S mutation was detected, suggesting the resistance mechanism was 
metabolic rather than target site based. Microarray analysis showed over 
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expression of several cytochrome P450s including CYP6Z3, CYP6Z1, CYP12F2, 
CYP6M3 AND CYP6P4 (Antonio-Nkondjio et al., 2016). This principle has been 
expanded for use in other mosquito strains and now new initiatives are under 
development to provide monitoring tools for resistance. The Innovative Vector 
Control Consortium has developed a Vector Population Monitoring Tool which 
can collect deceased mosquitoes and measure their insecticide resistance status 
and malaria sporozoite infection rates (Hemingway et al., 2006). This major 
development has only been possible through the availability of the vector’s 
genome sequence (David et al., 2013). Recommendations can now be made on 
an individual case level on the best practice for insecticide use in mosquitoes 
which manages the spread of resistance.  
Genes found in the clade CYP3 are most numerous in insect P450s and this is 
the clade of interest in terms of pesticide metabolism as it contains the 
subfamilies CYP6 and CYP9 (Feyereisen, 2006). CYP6 and CYP9 subfamilies 
have been extensively linked to xenobiotic metabolism and therefore, pesticide 
resistance in many insect species including Triatoma infestans, Aedes aegypti, 
Locust migratoria and Drosophilia melanogaster and members of this subfamily 
are inducible by both pesticides and natural compounds, making them the 
families of interest in PRM (Grosso et al., 2016; Ishak et al., 2017; Huang et al., 
2012; Chandor-Proust et al., 2013; Wan et al., 2014; Guo et al., 2016; Sun et al., 
2018).    
Data available for resistance mechanisms in PRM is mostly observational data 
that has been taken from studies of mite behaviour as well as toxicity testing 
experiments (Nechita et al., 2015; George et al., 2010b; George et al., 2010a; 
Brauneis et al., 2017). Very little of the PRM’s genomic structure is documented 
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and therefore efforts to isolate components of the detoxification pathways are 
hampered.  
The mechanism of P450 action in eukaryotes is localised to the smooth 
endoplasmic reticulum and is a process of an electron transport cycle. The 
substrate (pesticide) binds to the heme group of the P450 which induces an 
electron transfer from NADPH via POR. O2 binds to the resulting ferrous heme 
which forms a highly reactive intermediate. A second electron is then transferred 
from a redox partner, this could be a second electron from POR or could be an 
electron provided by cytochrome b5. Hydrogen atoms bind to the split O2 to form 
H2O and the remaining oxygen is temporarily bound to the iron before it is inserted 
into the substrate, to complete the monooxygenase reaction (Figure 3.1).  
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Figure 3.1: The catalytic cycle of Cytochrome P450. RH represents substrate 
and is shown in yellow; POR represents cytochrome P450 oxidoreductase; b5 
represents cytochrome b5.   
The ability to provide recommendations for treatment on a per case basis needs 
to be achieved in PRM as resistance is widespread and cannot be tracked to a 
geographical location, with resistance varying on an individual farm level 
(Chapter 2). PRM is also a haematophagous arthropod which may share similarly 
high levels of P450 activity in resistant strains to other insect species, such as 
the mosquito and the cattle tick. Transcriptomic sequence data has been 
provided, by Prof. Dr. Christina Strube, and will be analysed in this project to allow 
the identification of CYPs and assignment to families based on sequence 
74 
 
homologies. The same process will be carried out for the accessory proteins 
which are associated with P450 complexes, POR and cytochrome b5, to allow for 
expression and characterisation of these proteins which is discussed in Chapter 
4. Bioinformatics analysis of the P450s will only allow the prediction of their 
potential metabolic substrates. A more targeted approach to identifying and 
isolating specific enzymes involved in the metabolism of the acaricide of interest 
is to use Activity Based Probes (ABPs). In this approach the probe is a chemically 
modified form of the acaricide of interest such that it can bind to the enzyme, but 
not be metabolised by it. The probe is tagged to allow purification of the enzymes 
it is bound to, as well as allowing for visualisation on protein gels (Ismail et al., 
2016). The use of probes requires a microsomal prep to be made from the PRM, 
which will be developed as part of this project, and for that prep to contain active 
P450s.  
In this chapter, work will be completed to analyse the transcriptomic data from 
the PRM and assign sequences a putative xenobiotic metabolising role based on 
homology to sequences in similar species with known xenobiotic metabolising 
functions. This is based on a similar approach used by a previous PhD student, 
Kirsty Graham, who used it to successfully isolate a novel CYP, (CYP3006G8), 
cytochrome P450 oxidoreductase (POR) and cytochrome b5 from R. microplus 
and cytochrome b5 from I. scapularis. Based on this work, the PRM sequences 
will then be used to isolate POR and b5 sequences in order for the accessory 
proteins to be expressed and characterised. Finally, microsomes will be prepared 
and an assay developed to determine the level of active P450s in the sample for 
use with APBs (Ismail et al., 2016).  
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3.3 Methods 
3.3.1 Analysis of Transcriptome Using Bioinformatics 
PRM transcriptomic data that has been acquired from collaborators in Germany 
(Prof. Christina Strube, Institute for Parasitology, University of Veterinary 
Medicine Hannover) was used to identify potential PRM acaricide metabolising 
P450s. The bioinformatics database used for this project was the National Center 
for Biotechnology Information (NCBI).  
The 127 sequences sent were all putatively P450 sequences which had been 
pre-screened by Prof. Strube. These were entered into a Basic Local Alignment 
Search Tool via the National Centre for Biotechnology Information (NCBI) using 
a BLASTn search in the nucleotide collection (nr/nt) database to get a description 
of any similar sequences found and what clade the sequences belonged to 
(Figure 3.2). Any sequences presumed to be xenobiotic metabolising (49 
sequences) were then taken and further researched with the aim of finding 
homology to cytochrome P450 clade 3 family (subfamilies monooxygenase 6 and 
cytochrome P450 monooxygenase 9) in Anopheles gambiae. All 49 sequences 
were also searched against each other in NCBI using a BLASTn multiple 
alignment search and sequences with a high homology were aligned using 
Clustal Omega Multiple Alignment Tool (ClustalW with character counts output 
with default settings). Of the 127 initial partial sequences, 37 were putatively 
found to metabolise xenobiotics based on P450 homology in Anopheles gambiae 
(sequences were only considered if the query cover was over 20 %). This process 
was also completed in reverse, with known pyrethroid metabolising enzymes from 
the mosquito (CYP6Z2; Accession number AF487780.1, CYP6P3; Accession 
number AF487534.1) being searched in the PRM database (tax id: 34641) to 
confirm homology. These PRM sequences were then searched against other 
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insect databases which contained known pyrethroid metabolising sequences 
(Musca domestica; tax id 7370, Drosophila melanogaster; tax id 7227 and Aedes 
aegypti; tax id 7159). This was to further verify the pyrethroid metabolising 
sequences found from the original homology to A. gambiae. Of the 37 matches 
to CYP6 and CYP9 in Anopheles gambiae, 35 sequences have homology across 
the three additional species searched.  
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Figure 3.2: Flowchart of P450 sequences isolation process. The chart begins 
with the 127 sequences that were sent as potentially PRM P450s (beige) and 
ends with the 35 sequences which are most likely to be drug metabolising 
sequences from the PRM (green). XME; xenobiotic metabolising enzyme.  
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3.3.2 The Use of Bioinformatics to Identify Potential b5 and POR Sequences  
PRM transcriptomic data that has been acquired from collaborators in Germany 
(Prof. Prof. Christina Strube, Institute for Parasitology, University of Veterinary 
Medicine Hannover) was also used to identify potential PRM accessory proteins.  
The known nucleotide sequence for cytochrome b5 in Rhipicephalus (Boophilus) 
microplus (southern cattle tick) was used to complete a tBLASTx search, using 
NCBI, against the Transcriptome Shotgun Assembly (TSA) database of the 
Dermanyssus gallinae (tax id: 34641). This corresponded to a gene in the PRM 
transcriptome database with 72 % identity to the cattle tick b5 (accession number 
GAIF01005602.1).  
The cattle tick POR gene was also used to identify a homologous gene in PRM. 
The known POR gene from the cattle tick was searched in NCBI using tBLASTx 
search against the Transcriptome Shotgun Assembly (TSA) database of the 
Dermanyssus gallinae. This corresponded to two partial genes from the PRM. 
One gene section was at the 5’ end of the POR gene (GAIF01009008.1) and the 
other was at the 3’ end of the POR gene (GAIF01021004.1).  
3.3.3 Production of a Phylogenetic Tree for Cytochrome b5 
A phylogenetic tree was created in order to view the relationship between the b5 
gene in acari as well as other insect and host species. This was created using 
the FASTA sequences from each species which were obtained from NCBI’s 
nucleotide database. The FASTA were aligned using Clustal Omega (DNA input). 
The alignments were arranged into a phylogenetic tree using the R project for 
statistical computing by a fellow PhD student, Gregory Young.  
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3.3.4 RNA Extraction and the Isolation and Amplification of P450 
oxidoreductase (RACE ready cDNA Synthesis) 
RNA was extracted from 0.5 g of PRM and stored in RNAlater (Thermo Fisher, 
Paisley, UK). Mites were homogenised manually, using a pestle and mortar, 
before adding 1 ml of TRIzol® reagent (Thermo Fisher, Paisley, UK). The lysate 
was incubated for 5 minutes at room temperature, 0.2 ml of chloroform was added 
and the lysate was shaken vigorously. This was centrifuged for 15 minutes at 604 
xg, 40 °C, in a benchtop centrifuge. The aqueous phase was then put through 
the PureLink RNA Mini Kit (Life Technologies, New York, USA) following 
manufacturer’s instructions before being eluted in 30 μl of nuclease free water. 
The RNA quantity (ng/μl) and purity (260/ 280 value) was measured using the 
ND-100 (Nanodrop Technologies, Wilmington, USA) and integrity was checked 
using agarose gel electrophoresis. 2 μl of 2 X RNA loading buffer (20 % (v/v) 
Glycerol, 0.025 % (w/v) Bromophenol Blue, 1 X TAE) was added to 4 μl of RNA 
and the sample heated at 70 °C, then cooled instantly on ice. The samples were 
analysed by electrophoresis on a 1 % (w/v) agarose gel and were considered of 
good quality if no smearing was visible. 
This RNA was used in a RACE (Rapid Amplification of cDNA Ends) reaction to 
provide a full-length POR sequence via a GeneRacer kit (Life Technologies, 
Paisley, UK). The protocol was followed according to manufacturer’s instructions.  
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Figure 3.3: GeneRacer protocol overview. Flow chart of the stages of the 
GeneRacer kit which begins with total RNA extracted from PRM and leads to 
RACE ready cDNA. Diagram adapted from manufacturer’s protocol.  
cDNA prepared from the GeneRacer kit was then used to amplify fragments 
which corresponded to the 5’ and 3’ end of the putative POR gene. This was done 
using the gene specific primers (GSPs) which were designed as shown in Table 
3.1. 5’ and 3’ race PCRs were carried out and the reactions were set up as follows 
for 5’ RACE; 0.5 μl GeneRacer 5’ primer (10 μM) (5’ GGA CAC TGA CAT GGA 
CTG AAG GAG TA 3’), 0.5 μl GSP PRM POR 4 rev or GSP PRM POR 8 rev (10 
μM), 0.5 μl RACE Ready cDNA template, 2.5 μl amplification buffer,  
0.5 μl dNTPs (10 mM), 0.25 μl VELOCITY DNA polymerase, 7.75 μl sterile 
distilled water with a final volume of 12.5 μl. 
For 3’ RACE; 0.5 μl GeneRacer 3’ primer (10 μM) (5’ GCT GTC AAC GAT ACG 
CTA CGT AAC G 3’), 0.5 μl GSP PRM POR 4 fwd 1/2 or GSP PRM POR 8 fwd 
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1/2 (10 μM), 0.5 μl RACE Ready cDNA template, 2.5 μl amplification buffer,  
0.5 μl dNTPs (10 mM), 0.25 μl VELOCITY DNA polymerase, 7.75 μl sterile 
distilled water with a final volume of 12.5 μl.  
Table 3.1: Gene specific primers designed for use in RACE-PCR. A set of 
primers was designed for each end of the POR gene. Two forward primers were 
designed for each pair of primers to increase chances of isolating the putative 
accessory protein. 
 
5’ and 3’ RACE fragments were generated using the following PCR cycling 
conditions: 1 cycle of 98 °C for 2 minutes, followed by 40 cycles of 98 °C for 30 
seconds, 61 °C (5’ RACE) or 58 °C (3’ RACE) for 30 seconds, 72 °C for 20 
seconds, followed by 1 cycle of 72 °C for 10 minutes. These cycling parameters 
are the same as the parameters used in the positive GeneRacer control, the 
primers for which can be viewed in Table 3.2.  
 
 
 
 
Primer I.D Forward primer 
1 5’-3’ 
Forward primer 
2 5’-3’ 
Reverse Primer  
5’-3’ 
PRM POR 4  GGA AGA TGA GGA 
TTC TTT GGC CGT G 
ACT GAT CGA GAT 
GGC GGA AGA TGA G 
CTC CGA CCA TAC 
GAG CGG CAT TG 
PRM POR 8 TTA GCC ACT TGG 
AGT TTG CAG TGT G 
CGT TTA GCC ACT 
TGG AGT TTG CAG T 
GAT CGT GTT GTT 
CGT CCG CCC AC 
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Table 3.2: Primers provided in the GeneRacer kit for use in RACE-PCR. Two 
GeneRacer primers are provided, one 5’ and one 3’, as well as two control 
primers A and B.1.  
 
Both 5’ and 3’ RACE reactions were analysed by agarose gel electrophoresis 
using a 1 % agarose gel.  
3.3.5 PRM Microsome Preparation  
Microsomes were prepared using protocols recommended by Dr Hanafy Ismail 
(Ismail et al., 2016). Briefly, PRM were sourced from a farm in the North East of 
England and were stored at -80 °C after being snap frozen in liquid nitrogen.  
1.25 g of thawed PRM were added to 10 ml of ice-cold PBS (2.7 mM potassium 
chloride, 137 mM sodium chloride, 10 mM potassium phosphate. pH 7.4 ± 0.2 
(25 °C)). The PRM were homogenised using a handheld electric homogeniser 
(IKA T10 basic homogeniser workcenter) on ice. A cOmplete Protease Inhibitor 
Primer I.D Sequences Bases Tm 
GeneRacer 5′ 
Primer 
5′-CGACTGGAGCACGAGGACACTGA-3′ 23 74 °C 
GeneRacer 3′ 
Primer 
5′-GCTGTCAACGATACGCTACGTAACG-3′ 25 76 °C 
Control 
Primer A 
5′-GCTCACCATGGATGATGATATCGC-3′ 24 72 °C 
Control 
Primer B.1 
5′-GACCTGGCCGTCAGGCAGCTCG -3′ 22 76 °C 
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Cocktail Tablet (Roche) was added to the 10 ml solution. Insoluble material and 
debris was removed by centrifugation (Sorvall RC-5B Plus, SLA 1500 rotor) at 
10,000 g, 4 °C for 10 minutes.  
The clarified lysate was decanted and centrifuged in an ultracentrifuge (Beckman 
Coulter Optima L-100XP, rotor SW41 Ti) at 100,000 g for 45 minutes. Tubes used 
were thin walled ultra-clear tubes (Beckman Coulter). The microsomal pellet was 
resuspended in 1 ml of potassium phosphate buffer (50 mM potassium 
phosphate. pH 7.4 ± 0.2 (25 °C) containing 20 % glycerol), snap frozen in liquid 
nitrogen and stored at -80 °C until use.  
3.3.6 Microsomal P450 Activity Testing  
The total protein concentration of the microsomal preparation was determined 
using a Bicinchoninic acid (BCA) Protein Assay Kit (Thermo Fisher, Paisley, UK) 
using manufacturer’s instructions to ensure a high level of protein was present in 
the sample. 
In order to test the metabolic activity of the microsomal preparation, a protocol 
was adapted from McLaughlin et al. (2008). Briefly, microsomes were thawed on 
ice. 188 µL of potassium phosphate buffer (50 mM potassium phosphate. pH 7.4 
± 0.2 (25 °C) containing 20 % glycerol), was added to 15 wells of a Greiner flat-
bottomed white 96 well plate. 10 µL of microsomes were added to each well, 
three were left clear of microsomes to be used as a control (10 µL of extra buffer 
was added to control wells). To examine metabolism, 2 µL of ethoxy-, methoxy-, 
benzyloxy- and pentoxy- resorufin (ER, MR, BR AND PR)  
(0.5 mM stock soluble in DMSO) were added to each well in triplicate. The plate 
was incubated for 10 minutes at 30 °C before being read on a plate reader (Biotek 
Synergy HT) for fluorescence (Excitation 530 nm; Emission 585 nm). 10 µL of  
10 mM NADPH was added and the fluorescence readings were taken again. 
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To determine P450 content a method was adapted from Omura and Sato 
(1964a). Briefly, 7 µL of microsomes were added to 2 ml of spec buffer (200 mM 
Tris (pH 7.4), 20 mM CHAPS, 40 % glycerol, 2 mM EDTA). A small quantity of 
sodium hydrosulphite was added and gently mixed before dividing between 2 
matched UV cuvettes. Absorbance was measured between 400-500 nm and a 
baseline was run on the spectrophotometer. One cuvette was taken as the 
sample cuvette and was flushed with CO for 30 seconds before reading on the 
spectrophotometer.  
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3.4 Results and Discussion  
3.4.1 Gene Database and Cytochrome P450 Analysis 
As well as resistance mapping, this project aims to characterise the mechanisms 
responsible for inferring resistance and to investigate novel ways of targeting 
such mechanisms. The value of such a task to the farming community cannot be 
understated. Farmers are facing low product efficacy and a lack of novel products 
on to the market (Gassel et al., 2014). An understanding of xenobiotic metabolism 
in PRM could allow for products to be produced which bypass the established 
route of xenobiotic metabolism and resistance in the PRM and hence improve 
product efficacy.  
Many of the pesticides currently on the market which target PRM have an active 
ingredient from the pyrethroid family such as; Milben Ex (Schopf, Krölpa, 
Germany), Perbio Choc (Lodi, Kingswinford, UK) and Fendona (BASF, Cheadle 
Hulme, UK). Milben Ex was used by a third of the farms surveyed in Chapter 2 of 
the project and Perbio Choc and Fendona were used by 4 farms and 1 farm 
respectively. Resistance to pyrethroids is rising in PRM as well as resistance to 
other commonly used pesticides such as organophosphates and carbamates 
(Abbas et al., 2014). Due to the well-established role of cytochrome P450s in 
pyrethroid metabolism in other species, it was decided that focus would be on the 
isolation of the CYPs in PRM (Cossio-Bayugar et al., 2018; Smith et al., 2018; 
Walsh et al., 2018).  
To begin this process, PRM transcriptomic data was provided by Prof. Christina 
Strube who had pre-screened the sequences and sent 127 which were potential 
cytochrome P450 sequences. The 127 provided sequences were individually 
entered into a Basic Local Alignment Search Tool via the National Centre for 
Biotechnology Information using the parameters outlined in section 3.3.1. This 
86 
 
was completed to get a description of the gene function of any similar sequences 
found in other species, so they could then be separated into whether or not the 
gene is capable of xenobiotic metabolism based on homology. Of the 127 
sequences, 49 had high homology (over 50% identity) to known xenobiotic 
metabolising genes in other species. The 49 transcripts predicted to have a role 
in xenobiotic metabolism were assigned potential functions/P450 clades and 
were used for the next stage of analysis.  
The 49 sequences were also run through a multiple alignment search using NCBI 
BLASTn to find homology to one another, in order to identify if any sequences 
could overlap and belong to the same P450 gene. Out of the 49 sequences, 7 
different groups of sequences were found with high homology to one another 
(Table 3.3).  
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Table 3.3. Sequence alignments between sequences predicted to have a 
role in xenobiotic metabolism. Sequences searched in NCBI BLASTn search 
against one another and matches with higher than 20% query cover and 50% 
percentage identity have been listed.  
Query Sequence Percentage 
Identity (%) 
Query 
Cover (%) 
Matched Sequences 
G9NSEKQ01BJ0HY 99 100 G9NSEKQ02HCZIP 
99 71 G9NSEKQ02J2W0U 
99 59 G9NSEKQ01C888X 
G9NSEKQ02IHTVF 100 71 G9NSEKQ02IIAQI 
99 59 G9NSEKQ02GCXMA 
100 36 G9NSEKQ02GO1J4 
isotig07728 99 100 isotig07729 
92 85 isotig03762 
92 85 isotig03761 
96 51 isotig07730 
92 55 isotig03766 
94 51 isotig07731 
89 38 isotig03765 
95 10 G9NSEKQ02IHP0I 
G9NSEKQ02HLDP6 100 100 G9NSEKQ02JCWD2 
97 62 G9NSEKQ01BSUN6 
G9NSEKQ02H37HD 89 100 isotig03762 
88 98 isotig03761 
G9NSEKQ02GWOVH 99 54 G9NSEKQ02F57XU 
G9NSEKQ02I4V33 99 85 G9NSEKQ02GMHEH 
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This could mean that these are sequences from different parts of the same P450 
gene. Following isolation of a specific pyrethroid metabolising P450s using ABPs 
and identification of the corresponding nucleotide sequences from the database, 
these overlapping sequences would allow extension to potential obtain a full 
coding sequences for the individual P450s.Sequences which were presumed to 
be xenobiotic metabolising were then searched in a tBLASTx search (see section 
3.3.1) in the A. gambiae database to find homology to XMEs.  
 
Figure 3.4: Insect P450 genes. Insect P450 genes fall into four major clades 
which, as shown here, are CYP3, CYP4, mitochrondrial CYP and CYP2. Within 
each clade are the CYP family numbers attributed to insect P450 genes. Adapted 
from Feyereisen (2006).  
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Insect P450s can be separated into 4 clades (Figure 3.4) which contain different 
subfamilies or clans. Of the 127 initial partial sequences, 37 were putatively found 
to metabolise xenobiotics based on P450 homology in Anopheles gambiae. All of 
the sequences searched in the Anopheles gambiae database had homology to 
the CYP3 or CYP4 clade (Table 3.4). Of the 37 sequences searched in the 
database 27 had homology to the CYP3 clade and 10 had homology to the CYP4 
clade. Both of these clades are the clades to which xenobiotic metabolising 
P450s map to in nearly all insect species and have been frequently associated 
with resistance in mosquitoes (Feyereisen, 2006). CYP6Z1 and CYP6P3 in A. 
gambiae and CYP4G16 in A. arabiensis have all been identified as metabolising 
DDT, permethrin as well as deltamethrin respectively (Chandor-Proust et al., 
2013; David et al., 2013). The 29 sequences with homology to the CYP3 clade 
were all of the clan Cytochrome P450 monooxygenase 6. This is responsible for 
pesticide metabolism in genetically similar species to the PRM such as CYP6 
enzymes which cause resistance to pyrethroids in the fruit fly (Bactrocera oleae) 
and reduce mortality in response to deltamethrin in migratory locust (Locusta 
migratoria) (Pavlidi et al., 2018; Guo et al., 2016).  
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Table 3.4: PRM sequences with corresponding A. gambiae homology. 
Column 1= PRM sequence name from the transcriptome data, Column 2= Max 
Score with A. gambiae sequence (NCBI tBLASTx), Column 3= Description of A. 
gambiae sequence that PRM sequence has homology to. Max Score of over 50 
to mosquito XMEs have been shaded.  
 
PRM Sequence Name Max Score (NCBI 
tBLASTx) 
Anopheles Gambiae 
Sequence match 
Associated 
P450 Clade 
G9NSEKQ01BEANL 33.6 CYP6M1 CYP3 
G9NSEKQ01BJ0HY 46.4 CYP6Y1 CYP3 
G9NSEKQ02IHTVF 36.3 CYP6S2 CYP3 
G9NSEKQ02IIAQI 36.8 CYP6S2 CYP3 
G9NSEKQ02JXVSF 43.7 CYP6AA1 CYP3 
isotig07728 56.1 CYP6P4 CYP3 
isotig07729 56.1 CYP6P4 CYP3 
isotig07730 58.8 CYP6P3 CYP3 
isotig07731 60.6 CYP6P3 CYP3 
isotig21871 42.3 CYP6P3 CYP3 
isotig22816 98.7 CYP6AA1 CYP3 
isotig23857 40.0 CYP6Z1 CYP3 
isotig24478 67.5 CYP4AA1 CYP4 
isotig30646 26.3 CYP6M1 CYP3 
G9NSEKQ02IVX7L 50.1 CYP4C35 CYP4 
isotig29635 63.8 CYP4G16 CYP4 
G9NSEKQ02HLDP6 51.0 CYP4J9 CYP4 
G9NSEKQ02JCWD2 51.5 CYP4J9 CYP4 
G9NSEKQ01BSUN6 38.9 CYP4J9 CYP4 
isotig12928 122 CYP4C26 CYP4 
isotig12504 92.7 CYP6M4 CYP3 
G9NSEKQ02H37HD 58.3 CYP325G1 CYP4 
isotig03761 49.2 CYP6Y1 CYP3 
isotig03762 49.2 CYP6Y1 CYP3 
isotig03766 42.3 CYP6M1 CYP3 
G9NSEKQ01CMVYR 39.6 CYP6Y1 CYP3 
G9NSEKQ02J2W0U 31.3 CYP6N1 CYP3 
G9NSEKQ02GWOVH 63.4 CYP6AA1 CYP3 
G9NSEKQ02HCZIP 42.8 CYP6M4 CYP3 
isotig20277 53.8 CYP6P4 CYP3 
G9NSEKQ01DNWU8 30.9 CYP6S1 CYP3 
G9NSEKQ02G7EKB 94.1 CYP4H16 CYP4 
G9NSEKQ02GCXMA 28.6 CYP6S2 CYP3 
G9NSEKQ02I4V33 50.1 CYP6P2 CYP3 
isotig25683 55.1 CYP6Y1 CYP3 
G9NSEKQ02IHP0I 30.9 CYP6R1 CYP3 
G9NSEKQ01EFBC3 38.2 CYP314A1 CYP4 
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With a list compiled of sequences with a high homology to sequences in 
Anopheles gambiae, in clades and subfamilies which are capable of metabolising 
xenobiotics, the process could be completed in the reverse. Known pyrethroid 
metabolising enzymes from the mosquito were searched in the database to 
confirm homology within the PRM transcriptome. These sequences were; 
CYP6P3, confirmed to metabolise permethrin and deltamethrin in A. gambiae 
and CYP6Z2, confirmed to metabolise permethrin in A. gambiae (Muller et al., 
2007; David et al., 2013). A. gambiae CYP6Z2 (AF487780.1) had 59 %, 41 % 
and 42 % identity to 3 reading frames of the PRM isotig25683 which had already 
been isolated as a potential pyrethroid metabolising enzyme. A gambiae CYP6P3 
(AF487534.1) had 47 %, 47 %, 41 % and 38 % identity to PRM isotig20277 over 
4 reading frames (with 30 % query cover) which had also been identified as 
pyrethroid metabolising in the mosquito. With the sequences having homology to 
known pyrethroid metabolising sequences in A. gambiae, the 37 sequences 
could be searched against other insect databases. This was to further verify the 
pyrethroid metabolising sequences found from the original homology to A. 
gambiae. Musca domestica, Drosophila melanogaster and Aedes aegypti were 
chosen to further search the genome database. M. domestica was chosen due 
to vast amount of research available and the huge genome research which has 
been completed as well as there being known pesticide metabolising gene 
sequences. A second mosquito species was chosen, A. aegypti, as an important 
pest species with high clinical significance and the ability to confirm results from 
A. gambiae. Finally, D. melonagaster, chosen due to it being extensively used in 
research and having a large genomic database. The results of this extensive 
search can be viewed in Table 3.5. Of the 37 PRM sequences found in A. 
gambiae to be potentially pyrethroid metabolising, 35 have P450 sequence 
homology across all three species (when only those with over 20 % query cover 
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in all species are considered). Of those sequences, 11 have a max score of over 
50 in all three species. Many of the sequences have a high homology to CYP6A 
subfamily which are overexpressed in pesticide resistant M. domestica and have 
roles in detoxification in Bactrocera dorsalis (Hojland et al., 2014; Huang et al., 
2012).  
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Table 3.5: PRM sequence identities with 3 other species. PRM sequence 
names are shown with hits from 3 species as well as the corresponding Max 
Scores from NCBI as a measure of identity. Max scores of over 50 have been 
shaded. Results with less than 20 % query cover across all species have been 
removed.  
PRM Sequence Name Musca 
domestica 
Sequence 
Max Score Aedes 
aegypti 
Sequence 
Max Score Drosophila 
melanogaster 
Sequence 
Max Score 
G9NSEKQ01BEANL CYP6C2 35.9 CYP6Z8 33.1 CYP6A20 34.1 
G9NSEKQ01BJ0HY CYP6A37 69.3 CYP9M6v5 54.7 CYP6A19 56.5 
G9NSEKQ02IHTVF CYP6A37 34.5 CYP6AL1 32.7 CYP6A14 37.3 
G9NSEKQ02IIAQI CYP6A37 30.9 CYP6AL1 31.8 CYP28A5 31.8 
G9NSEKQ02JXVSF CYP6A4 45.5 CYP9J32 46.9 CYP6A14 44.6 
isotig07728 CYP6A37 50.1 CYP9J32 50.6 CYP6A16 47.3 
isotig07729 CYP6A37 50.1 CYP9J32 52.4 CYP6A16 49.6 
isotig07730 (CYP6C1 52.4 CYP4 35.9 CYP6G1 54.2 
isotig07731 CYP6C1 52.4 CYP4 35.4 CYP6G1 55.1 
isotig21871 6A38v1 44.5 CYP9M6v2 43.2 CYP6A16 37.7 
isotig22816 CYP6A5v2 96.8 CYP4H28v3 90.0 CYP6A16 105.0 
isotig23857 CYP6G4 46.0 CYP9M6v4 46.4 CYP6D5 40.5 
isotig30646 CYP6A37 28.1 CYP6Z8 24.9 CYP6A16 41.8 
G9NSEKQ02IVX7L CYP4D35 48.3 CYP4H44P 43.7 CYP311A1 38.2 
isotig29635 CYP4D36 79.4 CYP4H31v2 79.4 CYP4C3 77.1 
G9NSEKQ02HLDP6 CYP4G13v2 57.4 CYP4H44P 34.1 CYP4AC1 80.8 
G9NSEKQ02JCWD2 CYP4G13v2 40.5 CYP4H44P 34.1 CYP312A1 41.4 
G9NSEKQ01BSUN6 CYP4G13v2 42.1 CYP4H44P 34.4 CYP312A1 40.3 
isotig12928 CYP4D4v2 80.3 CYP4H31v2 200.0 CYP4C3 179 
isotig12504 CYP6A36 86.8 CYP9J28 101.0 CYP5A16 84.9 
G9NSEKQ02H37HD CYP6A4 54.6 CYP6CB1 62.9 CYP6A16 58.3 
isotig03761 CYP6A4 55.6 CYP9J32 53.8 CYP6A16 57.9 
isotig03762 CYP6A4 55.6 CYP9J32 53.8 CYP6A16 57.9 
isotig03766 CYP6A37 42.8 CYP9J1 35.0 CYP6A16 42.8 
G9NSEKQ01CMVYR CYP6A25 41.8 CYP3A31 40.5 CYP6A16 44.1 
G9NSEKQ02J2W0U CYP6A37 48.7 CYP3A31 33.2 CYP9C1 40.5 
G9NSEKQ02GWOVH CYP6A5 50.1 CYP6AL1 50.6 CYP6A19 50.6 
G9NSEKQ02HCZIP CYP6A37 51.0 CYP9J 47.8 CYP6A2 49.6 
isotig20277 CYP6A5v2 62.5 CYP9J24 54.2 CYP6A16 52.8 
G9NSEKQ02G7EKB CYP4D4v2 71.2 CYP9J26 75.8 CYP6A22 79.4 
G9NSEKQ02GCXMA CYP6A7 35.0 CYP6CB1 33.1 CYP6A14 37.3 
G9NSEKQ02GMHEH CYP6D3 27.2 CYP3A21 29.0 CYP9F3 25.4 
G9NSEKQ02I4V33 CYP6C1 54.2 CYP3A21 59.7 CYP6D4 41.8 
isotig25683 CYP6A40 47.8 CYP9J26 55.1 CYP6D5 49.2 
G9NSEKQ01EFBC3 CYP6C1 27.2 CYP2j6 33.6 CYP305A1 39.1 
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As well as comparing the PRM sequence data to insect databases, the 
sequences were searched in an open database in order to analyse the top hits 
from the open search (Table 3.6). The majority of the cytochrome matches were 
from Tropilaelaps mercedesae, the Asian bee mite as well as Galendromus 
occidentalis, the western predatory mite. All cytochromes to which the PRM 
shows homology are from the CYP3 clade of cytochromes which gave further 
evidence of the pesticide metabolising properties of the PRM sequences isolated 
(Pavlidi et al., 2018; Guo et al., 2016). 
Table 3.6: P450 homology to PRM sequences from NCBI database. Results 
of BLASTx search in open database (non-redundant protein sequences nr) with 
no organism selected. Top cytochrome hits to which the PRM sequences have 
homology to are listed, as well as the species the cytochrome is from and the 
percentage identity (as taken from NCBI). 
PRM Sequence Name Key NCBI Hits Species Percentage 
identity (%) 
G9NSEKQ01BEANL CYP  P450 3A11 Tropilaelaps mercedesae 
(Asian bee mite) 
53 
G9NSEKQ01BJ0HY CYP  P450 3A31 Tropilaelaps mercedesae 
(Asian bee mite) 
65 
G9NSEKQ02IHTVF CYP  P450 3A21 Galendromus occidentalis 
(Western predatory mite) 
65 
G9NSEKQ02JXVSF CYP  P450 3A11 Tropilaelaps mercedesae 
(Asian bee mite) 
53 
Isotig07728 CYP  P450 3A16 Tropilaelaps mercedesae 
(Asian bee mite) 
63 
Isotig07729 CYP  P450 3A16 Tropilaelaps mercedesae 
(Asian bee mite) 
62 
Isotig07730 CYP  P450 3A16 Tropilaelaps mercedesae 
(Asian bee mite) 
56 
Isotig07731 CYP  P450 3A16 Tropilaelaps mercedesae 
(Asian bee mite) 
56 
Isotig21871 CYP  P450 3A14 Galendromus occidentalis 
(Western predatory mite) 
42 
Isotig23857 CYP  P450 3A14 Galendromus occidentalis 
(Western predatory mite) 
48 
Isotig30646 CYP  P450 3A16 Tropilaelaps mercedesae 
(Asian bee mite) 
54 
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Table 3.6: Continued.  
 
Of the sequences searched in the open database, one of the highest homologies 
(65 %) was between the PRM sequence G9NSEKQ01BJ0HY and CYP P450 
3A31 in the Asian bee mite (Figure 3.5). The alignment shows high homology 
across the length of the coding sequence.  
 
 
Isotig12504 CYP  P450 3A21 Varroa destructor 
(Varroa mite) 
64 
G9NSEKQ02H37HD CYP  P450 3A6 Tropilaelaps mercedesae 
(Asian bee mite) 
51 
Isotig03761 CYP  P450 3A16 Tropilaelaps mercedesae 
(Asian bee mite) 
60 
Isotig03762 CYP  P450 3A16 Tropilaelaps mercedesae 
(Asian bee mite) 
60 
Isotig03765 CYP  P450 3A16 Tropilaelaps mercedesae 
(Asian bee mite) 
56 
Isotig03766 CYP  P450 3A16 Tropilaelaps mercedesae 
(Asian bee mite) 
65 
G9NSEKQ01CMVYR CYP  P450 3A31 Galendromus occidentalis 
(Western predatory mite) 
38 
G9NSEKQ02J2W0U CYP  P450 3A24 Varroa jacobsoni 
(Varroa mite) 
62 
G9NSEKQ02GWOVH CYP  P450 6D5 Galendromus occidentalis 
(Western predatory mite) 
44 
G9NSEKQ02HCZIP CYP  P450 3A24 Varroa jacobsoni 
(Varroa mite) 
48 
Isotig20277 CYP  P450 3A19 Centruroides sculpturatus 
(Arizona bark scorpion) 
38 
G9NSEKQ02GCXMA CYP  P450 3A21 Galendromus occidentalis 
(Western predatory mite) 
48 
G9NSEKQ02GMHEH CYP  P450 3A56 Varroa destructor 
(Varroa mite) 
49 
G9NSEKQ02I4V33 CYP  P450 3A56 Varroa destructor 
(Varroa mite) 
57 
Isotig25683 CYP  P450 3A56 Varroa jacobsoni 
(Varroa mite) 
54 
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Figure 3.5: Alignment of PRM G9NSEKQ01BJ0HY and CYP P450 3A31 from 
the Asian bee mite. Alignment created in NCBI. Query= PRM sequence, 
Subject= Asian bee mite sequence.  
From this analysis, a database has been created of potential pesticide 
metabolising P450 sequences which can be compared to future peptide data 
obtained from the ABPs. Any peptides isolated using the ABPs can be compared 
to the database and provide confirmation of gene function. This production of a 
library of sequences with probable pesticide metabolising functions is novel in the 
PRM and allows a wealth of future work to be done which could allow greater 
understanding of pesticide metabolism in PRM.  
3.4.2 Bioinformatics Analysis of b5 and POR from PRM 
The importance of understanding the role of accessory proteins in the function of 
metabolising enzymes is vital to developing control methods for the pest species 
PRM. Firstly b5 and POR sequences needed isolating using the transcriptomic 
data provided. Using the b5 sequence from R. microplus as bait (see section 
3.3.2), a highly similar sequence was identified from the PRM transcriptomic 
database (Figure 3.6).  
97 
 
 
Figure 3.6: Alignment of b5 in cattle tick and PRM. Comparison of the 
predicted PRM b5 protein sequence against the known Cattle tick cytb5 sequence, 
showing high similarities (72 % identity using NCBI) (GAIF01005602.1). Key 
heme associated residues have been coloured blue.  
The gene appeared highly conserved, missing just 4 amino acids from the start 
of the gene and 20 from the end of the sequence. To obtain the full sequence, 
the transcript sequence was taken from the PRM database and searched for a 
start and stop codon, to facilitate the incorporation of predicted start and stop 
codons and part of the untranslated 3’ and 5’ regions, which allowed the 
extension of the gene by 123 nucleotides at the 5’ and 120 at the 3’ end of the 
gene. Confidence in the correct identification of the b5 gene was increased due 
to the presence of key heme associated residues, shaded blue in the alignment, 
which are conserved across all cytochrome b5 sequences including mammalian 
(Schenkman and Jansson, 2003). These histidine residues co-ordinate with the 
pocket of the b5 which contains the heme iron. This putative b5 sequence could 
then be used for expression and characterising of the gene which is vital for the 
increased understanding xenobiotic metabolism in PRM (see Chapter 4).  
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Figure 3.7: An alignment between the cytochrome b5 gene in Dermanyssus 
gallinae, Rhipicephalus microplus and Ixodes scapularis and their host 
species. Alignment created between PRM b5 as well as mosquito (A. gambiae), 
domestic fowl (G. gallus), human (H. sapien), cattle (B. Taurus), southern cattle 
tick (R. microplus) and deer tick (I. scapularis). Key heme associated histidine 
residues have been highlighted in black. The high sequence homology between 
host species and how this differs from acari is highlighted in green. Conserved 
region in tick species highlighted with dashed line.  
The cytochrome b5 gene has been isolated from two veterinary important acari, 
Rhipicephalus (Boophilus) microplus (southern cattle tick), Ixodes scapularis (the 
black-legged tick or deer tick) as well as from Dermanyssus gallinae (poultry red 
mite). This allows comparison at the sequence level with other arthropods and 
their host species (Figure 3.7). Comparison of the tick and mite b5 sequences to 
determine the degree of homology among haematophagous arthropods 
confirmed the conservation of key haem binding residues and highlights the high 
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homology around these residues. The green highlighted sequence shows the 
high sequence homology of host species and how this differs from acari. The 
presence of a histidine and proline residue in this position in the host but not in 
the acari could cause a slight change in structure which could become evident 
during 3D modelling. Also, the tick species have a conserved region of 
GVAAAAS, found near the C-terminus (highlighted with a dashed line in Figure 
3.7) which is specific to the tick and is not found in host species.  
 
 
 
Figure 3.8: Phylogenetic tree of cytochrome b5 sequences. Sequences were 
aligned using Clustal Omega using FASTAs for each sequence from NCBI before 
being used to create a phylogenetic tree using ‘R’ statistical computing program.  
A phylogenetic tree was created to identify potential differences in cytochrome b5 
that could be exploited in order to design new targeted b5 acaricides (Figure 3.8). 
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High homology was seen between the acari species as expected, with clustering 
to a distinct branch among the arthropods. The acari have clustered separately 
from haematophagous insects, who are also clustered distinctly from the other 
insects. Interestingly Gallus gallus, host of D. gallinae, has clustered to the right 
hand side of the tree whilst other mammalian species have clustered on the far 
left of the tree on a branch that splits early in the tree, implying greater sequence 
divergence. This suggests that there are differences enough in the Cytb5 
sequence to allow separation despite the high sequence homology. Accession 
numbers can be found in Table 3.7.  
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Table 3.7: Species included in phylogenetic tree. The species are listed with 
both latin and common names as well the accession number for the cytochrome 
b5 sequence. FASTA sequences for R. microplus and I. Scapularis were provided 
by a previous PhD student, Kirsty Graham.  
Accession Number  Latin name  Common name  
XP_003748384 Metaseiulus occidentalis Western orchard predatory mite 
AHZ12900 Panonychus citri Citrus red mite  
XP_308640 Anopheles gambiae African malaria mosquito  
XP_001867082 Culex quinquefasciatus Southern house mosquito  
XP_001660580 Aedes aegypti Yellow fever mosquito  
NP_001274474 Musca domestica House fly  
ABW37749 Drosophila melanogaster Fruit fly  
XP_002032763 Drosophila sechellia Fruit fly  
NP_001025752 Gallus Gallus Red jungle fowl  
NP_001232778 Taeniopygia guttata  Zebra finch  
XP_003204966 Meleagris gallopavo  Domestic Turkey  
XP_012960808 Anas platyrhynchos  Mallard  
XP_013036578 Anser cygnoides domesticus  Domestic goose  
NP_776458 Bos Taurus Cattle  
P00167 Homo Sapien  Human  
NP_080073 Mus musculus House mouse  
NP_071581 Rattus norvegicus Brown rat  
NP_001001770 Sus scrofa Wild boar  
 
Finally, the aim is to express the b5 gene from D. gallinae, R. microplus and I. 
scapularis (Chapter 4). This will be done by using a recombinant baculovirus to 
express the cytochrome b5 gene in cultured insect cells. By doing this, the effect 
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of changes in the expression of b5 within cells can be determined and their 
susceptibility to pesticides can be monitored, thus assessing the possible role of 
b5 in resistance. The information obtained from sequence comparisons and future 
3D modelling will provide a molecular basis for the design of new acaricides or 
synergists targeting b5 and thus provide a means of controlling populations of 
acari that have become resistant to the acaricides currently in use. 
As well as isolating b5 from the PRM transcriptome, POR needed to be identified 
as a key accessory protein for P450 complexes. POR was also found using the 
R. microplus sequence as a bait to search the PRM database (section 3.3.2). 
Unlike with b5, no clear sequence was identified using this method, however two 
separate sequences which potentially represented both the 3’ and 5’ end of the 
POR sequence were identified.  
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Figure 3.9: POR alignment of 3’ and 5’ end of the gene. A= Comparison of 
predicted section of PRM POR sequence against the known cattle tick sequence 
at the 3’ end of the gene (GAIF01021004.1). FAD domain boxed with a dashed 
line and NADP(H) domain boxed with a solid line. B= Comparison of predicted 
section of PRM POR sequence against the known cattle tick sequence at the 5’ 
end of the gene (GAIF01009008.1). Key co-factor binding regions are shaded 
blue. Gene specific primer sequences for both forward and reverse primers used 
in GeneRacer reactions are represented by purple arrows for both sequences.  
These PRM sequences showed high homology to R. microplus POR at both the 
3’ and the 5’ end of the gene. FAD and NADP(H) domains were highly conserved 
between the species (Figure 3.9) but the conservation of key co-factor binding 
regions, which vary little between acari species, was less conserved than 
expected (Wang et al., 1997) . This could result in a sequence being amplified 
 
A 
B 
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from PRM which was genetically similar to, but not, POR. Any new sequences 
which could be amplified from PRM and have homology to P450s or P450 
accessory proteins would be of value to future PRM research and so the partial 
sequences were used for downstream applications. These sequences were used 
to create RACE ready cDNA which was required to amplify a full length PRM 
POR gene.   
3.4.3 Amplification of P450 Oxidoreductase from Dermanyssus gallinae 
The sequence that was isolated as potentially being PRM POR was found in two 
sections, the 3’ end and the 5’ end, as described in section 3.3.2. In order to find 
the full-length sequence, RACE (Rapid Amplification of cDNA Ends) ready cDNA 
was prepared using the GeneRacer Kit. This was to generate full length, RNA 
ligase-mediated rapid amplification of 5’ and 3’ ends of the POR sequence. 
Primers were designed to both ends of the putative POR fragment, with 2 forward 
primers being designed for each set to maximise chances of successful 
amplification, see Table 3.1. The protocol was completed, as described in section 
3.3.4, using the second RNA extracted from the PRM which can be viewed in 
Figure 4.7 of section 4.4.1 after being run on an agarose gel.  
As well as using the GeneRacer kit on the PRM RNA, HeLa total RNA, provided 
with the GeneRacer kit, was used as a positive control to confirm the kit’s viability. 
Control PCRs were then performed on the HeLa cDNA before the PCRs were 
carried out on the PRM cDNA. Control primers to the β-actin gene are included 
for use in the positive control PCRs (Table 3.2) and when the control primers are 
used with the 5’ or 3’ GeneRacer primers, the 5’ or 3’ end of the β-actin gene is 
amplified. When the GeneRacer 5’ primer and Control Primer B are used with the 
HeLa template, a band of around 850 bp is amplified, when the 3’ GeneRacer 
and the control Primer A are used with the HeLa template, a region of around 
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1750 bp is amplified and, finally, when Control Primer A and Control Primer B are 
used a region of around 750 bp is amplified (Figure 3.10). 
 
 
 
 
 
Figure 3.10: GeneRacer positive control. M= molecular markers, Lane 1= 
GeneRacer 5’ primer + Control Primer B.1 + HeLa template, Lane 2= Control 
Primer A + Control Primer B.1 + HeLa template, Lane 3= GeneRacer 3’ primer + 
Control Primer A + HeLa template. 
PRM POR was expected to be around 2200 bp long in total, based on the length 
of the RM POR sequence. Initial PCR using VELOCITY DNA Polymerase 
(Bioline, London, UK) was unsuccessful, but optimisation of the PCR using 
cycling parameters of: 1 cycle of 98 °C for 2 minutes, followed by 30 cycles of 98 
°C for 30 seconds, 60 °C for 30 seconds and 72 °C for 60 seconds, with a final 
step of 72 °C for 10 minutes produced a more promising result, as seen in Figure 
3.11. 
 
 
 
 
1500bp 
1000bp 
 M    1                M           2  M     3 
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Figure 3.11: Agarose gel of the RACE PCR. M= molecular markers, Lane 1= 
3’ RACE with PRM POR 4 (forward 1), Lane 2= 3’ RACE with PRM POR 8 
(forward 1), Lane 3= 5’ RACE with PRM POR 4 (reverse), Lane 4= 5’ RACE with 
PRM POR 8 (reverse).  
The sequence produced from the 3’ RACE primers and the 5’ GSP was expected 
to be around 500bp and the sequence produced from the 5’ RACE and 3’ GSP 
was expected to be approximately 1700bp long based on the position of the 
aligned sequences. This 5’ RACE PCR produced a band of ~1700 bp long which 
was the expected size for the gene of interest. POR in total is expected to be 
around 2.2 kb based on POR in similar species such as R. microplus and the aim 
is to produce two overlapping RACE products which can be joined to produce a 
full-length POR sequence.  
The PCR was scaled up from a 12.5 µl reaction to a 50 µl reaction to allow the 
excising of the band from the agarose gel. This scaling up failed to produce a 
band and after several attempts it was decided to do four 12.5 µl replicas of the 
 M                1         2        3         4 
1500bp 
1000bp 
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PCR and pool them together. This was unsuccessful, and several PCR 
optimisation steps were undertaken which also failed. This approach was used 
by a previous PhD student, Kirsty Graham, who also failed to scale up a 
previously successful small scale PCR in tick species R. microplus and I. 
scapularis. This could be an issue which is common to acari and leads to 
difficulties with amplification. 
A new PRM RNA extraction was carried out using the methods described in 
section 3.3.4. This RNA quantity was 1208 ng/μl and had a 260/280 reading of 
2.2 on the nanodrop and was considered pure enough to continue. This RNA was 
put through the GeneRacer kit and was used in RACE PCR reactions. 
The first RACE PCR with the latest PRM RNA extraction was completed using 
the same conditions and parameters that were used when the 5’ RACE product 
was previously produced. After this was unsuccessful, PCR optimisation was 
carried out, including using a high-fidelity polymerase (Q5, NEB) in order to 
increase the chances of accurate replication of the template, using higher 
concentrations of primer stocks (100 mM stock rather than 10 mM) to ensure 
primer concentration was not a limiting factor, using 3 varying concentrations of 
MgCl2 (0.125 µl, 0.250 µl and 0.500 µl in a 12.5 µl reaction) as a cofactor for the 
polymerase as well as 3 varying concentrations of DMSO (0.062 µl, 0.125 µl and 
0.250 µl in a 12.5 µl reaction) to lower the Tm of the PCR to improve amplification 
of GC regions. The cycling parameters were adapted numerous times, with both 
a two-step and three-step PCR being trialled as well as cycle numbers ranging 
from 30-40 cycles. Different annealing temperatures were also attempted for both 
sets of primers ranging from 58-70 ºC. After this optimisation was unsuccessful, 
a final RNA prep was extracted from the PRM. This prep contained 278.6 ng/μl 
of RNA and had a 260.280 value of 1.95 and was put through the GeneRacer kit. 
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This RACE ready cDNA was used to carry out the optimisation steps as described 
above in RACE PCR (example gel in Figure 3.12, conditions: 1 cycle of 98 °C for 
2 minutes, followed by 40 cycles of 98 °C for 30 seconds, 60 °C for 30 seconds 
and 72 °C for 60 seconds, with a final step of 72 °C for 10 minutes), including 
using the secondary set of forward primers which had been designed.  
 
 
Figure 3.12: Example agarose gel of RACE PCR. M= molecular markers, Lane 
1= 3’ RACE with PRM POR 4 (forward 1), Lane 2= 3’ RACE with PRM POR 8 
(forward 1), Lane 3= 5’ RACE with PRM POR 4 (reverse), Lane 4= 5’ RACE with 
PRM POR 8 (reverse).  
Final amplification resulted in no bands of the appropriate size, as seen from the 
example gel in Figure 3.12, and the amplification of POR remains to be achieved.  
The next step would be to redesign the primers in order to try maximise success 
with POR, and to return to the initial polymerase which obtained a 5’ RACE 
product. Since this project has been undertaken, a draft genome assembly of D. 
gallinae has been completed which would allow further analysis of sequences 
 M    1     2     3     4 
1500bp 
1000bp 
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from PRM which correspond to the POR gene in similar insect species (Burgess 
et al., 2018). The work completed in this project will be of great value in the future 
when isolating the POR from PRM as it provides a wealth of background detail 
on PCR optimisation. 3 RACE ready preps of cDNA from the PRM are now stored 
in -80 °C and allows future researchers to have a quick start on the process of 
PCR optimisation.  
3.4.4 Microsome Preparation and Assay Development  
PRM P450 sequences can be assigned a predicted function based on homology, 
but to identify and obtain the specific sequences of P450s involved in the 
metabolism of acaricides in PRM, Activity Based Probes were required. ABPs 
allow a targeted approach to amplifying P450s. In the approach used by Kirsty 
Graham, P450 sequences from the relevant species (R. microplus) were 
provided. Sequences were chosen to be cloned based on predicted xenobiotic 
metabolising functions, as determined by homology to known pyrethroid 
metabolising P450s from A. gambiae. Therefore this was not a targeted process 
as it was not certain if a cloned P450 would indeed have this functionality. In the 
targeted approach undertaken in this project, an ABP could isolate a P450 based 
on specific acaricide binding activity and thus clone a P450 certain to have a role 
in the metabolism of an acaricide. 
In order to use ABPs, and to make use of the library of putative pesticide 
metabolising sequences, a preparation of microsomes is required which contains 
active P450s for the ABPs to bind to. The process of extracting the microsomes 
from the PRM was challenging and many stages of assay development were 
completed.  ABPs work in a mechanism dependant manner to covalently label 
the P450s (Figure 3.13). This label is able to be detected by adding a fluorescent 
reporter group, using copper-catalyzed azide-alkyne cycloaddition (“click 
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chemistry”), on to the probe. This can then be used to detect the P450 once the 
probe has bound to them (Wright and Cravatt, 2007). ABPs have previously been 
used to gain greater insight into the potential mechanisms of artemisinin (ART)-
based antimalarial action. It is essential to maintain the efficacy of ART as it has 
significantly reduced the number of malaria deaths in the last decade (Ismail et 
al., 2016). ART Activity Based Probes were used to identify proteins within the 
malaria parasite that are alkylated by ART, hence offering a strategy for 
investigating resistance mechanisms to ART-based drugs (Ismail et al., 2016). If 
used in PRM, these probes could assist in the isolation of acaricide metabolising 
P450s and pave the way to combatting resistance to commonly used pesticides, 
by creating a fuller picture of the relevant metabolic pathway within the PRM.  
Figure 3.13: Activity Based Probes (ABPs). ABPs consist of a chemically 
reactive warhead, a recognition element and the reporter tag. The recognition 
element is optimised for the P450 enzyme family and delivers the probe to the 
catalytic site of the enzyme. In the case of PRM ABPs, deltamethrin would be 
used as the recognition element. The reporter group allows visualisation by SDS-
PAGE or identification using mass spectrometry. Diagram adapted from MRC 
Protein Phosphorylation and Ubiquitylation Unit (2016) and Brauneis et al. 
(2017).  
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ABPs function by being a similar structure to the acaricide in question, hence 
being metabolised by the same pathways in the host species. ABPs based on 
the deltamethrin scaffold have been used to identify pyrethroid-reactive P450s 
and related detoxification enzymes in rat liver microsomes. This highlights the 
probes potential for directly assessing pyrethroid-metabolizing enzyme activity in 
the PRM (Ismail et al., 2013). 
The use of ABPs requires active P450s found in microsomal preparations. The 
term ‘microsomes’ describes the high speed centrifugation of the post-
mitochondrial supernatant of the insect tissue (Figure 3.14). The PRM 
homogenate can be spun at increasingly higher speeds which will separate the 
homogenate into its components based on their size and density. Whole cells, 
nuclei and components of the cytoskeleton pellet first, followed by mitochondria 
at around 10000 xg. Once these larger and denser cell components have formed 
a pellet; the supernatant, containing soluble enzymes, can be spun at 100000 xg. 
This produces a sediment which is mainly comprised of material from the 
endoplasmic reticulum of the insect cells (Siekevitz, 1963). This pellet contains 
an isolated and concentrated stock of cytochrome P450s, which are located on 
the endoplasmic reticulum, known as microsomes. The family of cytochrome 
P450s which are present in microsomes are responsible for Phase I 
biotransformation of xenobiotics. Incubation of test material with microsomal 
preparations in various species is the usual method by which the Phase I 
biotransformation of xenobiotics are determined.  
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Figure 3.14: Diagram showing differential centrifugation. Repeated 
centrifugation at increased speeds separates the PRM homogenate into its 
components based on size and density (larger and denser compounds centrifuge 
into a pellet quickest as they experience the largest centrifugal force). Smaller 
components stay in the supernatant until the centrifugal force increases enough 
to form a pellet. This allows the small microsomes to be separated into a 
concentrated microsomal prep. 
In order to determine the amount of protein in the microsome prep, a BCA assay 
was completed (as described in section 3.3.6). 12.80 µg/µl of protein was present 
in the microsome sample and this preparation was then used in a resorufin assay 
in order to determine whether active P450s were present. The resorufin assay 
was adapted from research by Mclaughlin in 2008 and examines the metabolism 
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of ethoxy-, methoxy-, benzyloxy- and pentoxyresorufin (ER, MR, BR AND PR) in 
order to identify fluorogenic substrate probes for the P450 genes. Whichever 
resorufin showed the highest specific activity would be further examined with 
respect to the kinetic parameters of that particular resorufin (McLaughlin et al., 
2008). Resorufin assays were measured as described in section 3.3.6, at 
Excitation 530 nm and Emission 585 nm and the results can be viewed in Figure 
3.15.  
 
Figure 3.15: Results of resorufin assay in graphical form. Ethoxy-,  
methoxy-, benzyloxy- and pentoxyresorufin are represented by different colours. 
Readings were taken once a minute for 9 minutes and florescence at Excitation 
530 nm and Emission 585 nm is recorded. Results corrected for control (no 
microsomal preparation present).  
With results from the plate reader showing no difference in metabolism of ER, 
MR, BR and PR, a new microsomal prep was made. This time, a handheld electric 
homogeniser (IKA T10 basic homogenizer workcenter) and a manual dounce 
homogeniser were used to create two separate preparations for comparison, to 
ensure that the electric homogeniser was lysing the mites to a high enough 
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degree that active microsomes were prepared. A BCA was carried out to ensure 
there was a high level of protein present. The sample prepared using an electric 
homogeniser contained 34.31 µg/µl and the sample prepared using a manual 
homogeniser contained 38.83 µg/µl of protein. The small difference in protein 
content between the methods of extraction was promising, as electric 
homogenisation is quicker and therefore a preferred method, and both 
preparations were tested using a P450 spectrophotometer assay to view the peak 
in absorbance at 450 nm as a quantifier of P450 content (Figure 3.16).  
 
Figure 3.16: P450 spectrophotometer assay homogenised microsome prep 
from PRM. A= manually homogenised sample. B= Machine homogenised 
sample. Wavelength was measured from 400-500 nm.  
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Ferrous P450 reacts with carbon monoxide to form a complex which produces a 
spectrum that peaks at 450 nm when the P450 is active. The peak at 420 nm 
implies the presence of P450 in the sample but that which is enzymatically 
inactive (Omura and Sato, 1964b; Omura and Sato, 1964a). This conversion of 
P450 to the P420 form is common in cytochrome P450s but usually occurs after 
being exposed to high temperatures (of up to 60 ºC) or high pressure (2 X 108 to 
2.4 X 108 Pa) (Hui Bon Hoa et al., 1989; Martinis et al., 1996). P450s can also 
convert to this form if exposed to proteases, detergents, acetone, neutral salts or 
denaturants (Imai and Sato, 1967; Yu and Gunsalus, 1974; Sasaki et al., 2005). 
The result of this microsome preparation was a high protein sample containing 
P450s, but those which were not in the active form. Due to this, they could not be 
used with APBs as they would not bind to the probe which was mimicking the 
xenobiotic. The cause of this could be the difficulties in producing a homogenised 
preparation of microsomes without the preparation being exposed to heat. 
Electrically homogenised samples are kept on ice throughout the protocol but the 
friction from the homogeniser generates heat. Manual homogenising produces a 
higher protein content (38.83 µg/µl) than electrically homogenising and also 
generates less friction and heat, although manual homogenisation is difficult to 
complete entirely on ice. Alternatively, the issue could be due to the amount of 
protease inhibitor (A cOmplete Protease Inhibitor Cocktail Tablet (Roche)) added 
to the microsome sample. A higher concentration of protease inhibitor may stop 
the conversion of P450 into the inactive P420 form. 
Progress has been made in developing the protocol for microsome preparation, 
originally developed for use in the mosquito, and the sample now contains P450 
protein. Work to ensure active P450 is included in the microsomal preparation 
would be the next step in the protocol development and would allow for the 
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interesting stage of using Activity Based Probes with PRM samples for the first 
time.  
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3.5 Conclusions and Further Research Plan 
The pesticides used today to target PRM are being metabolised by the same 
mechanisms in many arthropod species. Once this pathway is discovered in the 
PRM, products on the market can be adapted to ensure efficacy is maintained 
and new products can be brought to market which are metabolised by different 
pathways entirely. An argument has been presented that alternative compounds 
should be developed/used, leading to increased research into the use of bio-
control products such as essential oils, with the view that these compounds will 
be less toxic to the environment (George et al., 2010a). This research however 
has had limited success regarding the killing efficiency of these compounds and 
in some cases generated conflicting results. It also must be borne in mind that 
“natural” compounds are metabolised in the same way as synthetic compounds 
and are thus prone to the same issues e.g. development of resistance. The 
preservation of product efficacy against PRM is crucial to maintain the viability of 
egg farming within the UK.  
In order to maintain product efficacy, in depth knowledge of the mechanisms of 
resistance in PRM, such as cytochrome P450s and their accessory proteins, is 
required for this mechanism to be bypassed in future products. In this chapter, 
the PRM transcriptomic database has been analysed and potential xenobiotic 
metabolising P450s have been identified. In addition to this, the transcriptomic 
data has also been used to identify PRM cytochrome b5 which can now be used 
in a baculovirus expression system in order to characterise its role in xenobiotic 
metabolism (Chapter 4). POR requires further research in order to purify the 
accessory protein and characterise it using the baculovirus expression system 
and the recent draft genome assembly of PRM may aid future efforts to isolate 
POR (Burgess et al., 2018). 
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Finally, using ABPs to identify the pathways of pesticide metabolism is essential 
for this preservation of efficacy. This project has attempted to develop/adapt a 
protocol for microsomal preparation containing active P450 proteins similar to 
that used for several insect species. Further work needs to be completed for 
those P450s to remain active in the sample, which will be aided by the knowledge 
of techniques developed in this project. Temperature is likely to be a factor in the 
degradation of the P450 sample and repeat preparations should be made with a 
concerted effort of the sample remaining at 4 ºC, potentially with the protocol 
being completed in a cold room.  
When an active P450 microsomal preparation has been achieved, any peptide 
data from the use of probes can be compared with the database that has been 
created of potential pesticide metabolising P450 sequences and is able to provide 
confirmation of gene function, a novel step within the PRM. P450s isolated can 
be expressed using a recombinant expression system to allow for 
characterisation of the gene. As well as this, further optimisation of the POR gene 
PCRs could allow for further expression of the accessory protein, which, when 
combined with the expression of cytochrome b5 in chapter 4 of this project, allows 
for a new understanding of the P450 complex as a whole in PRM.  
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Chapter 4: The Isolation and Expression of P450 Accessory 
Proteins in the Poultry Red Mite, Dermanyssus gallinae.  
4.1 Abstract  
Drug detoxifying mechanisms in Dermanyssus gallinae are yet undocumented, 
unlike detoxifying mechanisms in other insect species of clinical significance. An 
important step, in order to advance understanding of poultry red mite (PRM) 
resistance, is to isolate cytochrome P450s from D. gallinae which are putatively 
involved in the metabolism of pesticides and additionally to isolate the accessory 
proteins which have a role in the functioning of the P450 complexes themselves. 
In this project, RNA was isolated from PRM and, using sequence data previously 
analysed, gene specific primers have been developed to both cytochrome b5 and 
P450 oxidoreductase to allow isolation of these accessory proteins. The 
successful isolation and expression of cytochrome b5 from PRM allowed the 
testing the cross-reactivity of mosquito b5 antibody which could detect 5 ng of b5 
protein. This led to the in vitro expression of b5 in Spodoptera frugiperda insect 
cells. As well as the in vitro expression of cytochrome b5, Glutathione S-
transferase (GST) from PRM was amplified and expressed in vitro as comparison 
of detoxification enzyme functions. The ability of cells expressing GST to catalyse 
the conjugation of reduced glutathione to 1-chloro-2,4-dinitrobenzene was 
assessed by measured absorbance at 340 nm at 1 minute and after 20 minutes. 
The results of the assay show a clear increase in absorbance in the samples 
transfected with the GST baculovirus versus control at both 1 minute (P = 0.0225) 
and 20 minutes (P = 0.0083) and indicates the increased metabolic functioning 
of those cells. From the in vitro testing, Glutathione S-transferases appear to have 
the ability to increase cell viability when exposed to common pesticides 
(deltamethrin, permethrin and bendiocarb). The role of b5 is still unidentified but 
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purified b5 is now ready to be used in P450 assays, once P450s have been 
isolated, to determine the effect of b5 on specific pesticide metabolism. Purified 
GST is also ready for co-expression assays with P450s, which is one step closer 
to a greater understanding of pesticide metabolism and resistance in D. gallinae.  
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4.2 Introduction  
Drug detoxifying mechanisms in the poultry red mite (PRM) Dermanyssus 
gallinae, are yet undocumented, unlike detoxifying mechanisms in other insect 
species of clinical significance, such as the common house fly, Musca domestica. 
House flies can transmit a number of infections to humans due to their repeated 
visiting of both faeces and human food. Of the 100 different pathogens 
transmitted by house flies, 65 can be transmitted to humans including anthrax, 
cholera and salmonella (Service, 2012). Due to this clinical significance, 
cytochrome P450s have been isolated that are overexpressed in pesticide 
resistant strains of house fly. CYP6A1 is a phenobarbital-inducible P450 of  
M. domestica which is highly expressed in pesticide resistant strains and has low 
levels of expression in highly susceptible strains (Carino et al., 1994). Chemicals 
such as DDT, known to induce other P450s in house flies, did not induce 
CYP6A1, which shows that metabolic resistance in the house fly involves the 
regulation of expression of more than one P450 gene. It also shows that the 
induction mechanism of P450 genes by pesticides is selective for some P450 
genes (Carino et al., 1992). These advances make efforts to control the pest 
species more targeted.  
Another pest of clinical significance is Anopheles gambiae, transmitter of malaria 
in sub Saharan Africa. It is estimated that 1 million children a year die from 
malaria, meaning that research into detoxification mechanisms in the vectors of 
the disease is vast (Lehane, 2005). It is thought that 68 % of the 663 million cases 
of malaria worldwide have been prevented using long-lasting insecticide treated 
bed nets (LLINs) (Bhatt et al., 2015; Churcher et al., 2016). The only class of 
insecticides which are currently used to treat LLINs is pyrethroids, and resistance 
to pyrethroids is widespread in African malaria vectors, such as A. gambiae 
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(Ranson and Lissenden, 2016; Gleave et al., 2018). Increased production of 
P450s is considered the most effective mechanism of pyrethroid resistance in 
malaria vectors and studies have shown up regulation of 5 out of 6 cytochrome 
P450s in A. gambiae in response to infection with plasmodium. These over 
expressed P450s belong to CYP4, CYP6 and CYP9 families of cytochromes 
which are associated with detoxification rather than biosynthetic pathways (Felix 
et al., 2010; Feyereisen, 2006). Similarly, parasite infection resulted in the 
overexpression of a GST gene (GSTD5), making GST expression in PRM of 
interest to this study (Felix et al., 2010). GSTs are also a major contributor to 
pesticide resistance in Anopheles funestus from Kpome, with GSTe2 being the 
most upregulated detoxification gene in both DDT and permethrin resistant 
mosquitoes, also a blood feeding species (Tchigossou et al., 2018).  
Without advances in the knowledge of specific drug metabolising mechanisms in 
the PRM, it is difficult to develop new acaricides which will have lasting efficacy 
over a prolonged period of time, as they are likely to be metabolised by the same 
mechanisms that cause resistance to previous products (Flochlay et al., 2017). 
An important step in such an advance, is to isolate cytochrome P450s from the 
PRM which are putatively involved in the metabolism of pesticides, and 
additionally to isolate the accessory proteins which have a role in the functioning 
of the P450 complexes themselves. P450s have been identified as having a 
leading role in drug metabolism in humans since the late 1940s (Mueller and 
Miller, 1948). More recently, P450s have been recognised as having a role in 
pesticide metabolism and resistance in insects such as the fruit fly and mosquito 
(both from the order diptera) (Pavlidi et al., 2018; Mo et al., 2018). Culex pipiens 
pallens, northern house mosquito, is also a blood-feeding arthropod showing 
increasing signs of pesticidal resistance. Significant increases in P450 enzyme 
123 
 
activity, specifically in the CYP6 family, are observed in the mosquito following a 
blood meal which leads to increased resistance to both organophosphates and 
pyrethroids (Chang et al., 2017).  
This overexpression of P450s in resistant species, which are genetically similar 
to the PRM, leads to the conclusion that P450 complexes are of key interest in 
the study of resistance in the mites. To isolate and characterise P450s in the 
PRM, in order to develop new acaricides which bypass the P450 complex 
mechanism, all components of the P450 complex must be identified and isolated.  
Cytochrome P450 found in bacteria and eukaryotic mitochondria are type I P450s 
and those found localised to the endoplasmic reticulum of eukaryotic cells are 
type II P450s. These type II enzymes are commonly found to be involved in 
xenobiotic metabolism (Werck-Reichhart and Feyereisen, 2000).  
Cytochrome P450s have an approximate molecular weight of 50 - 55 kDa and 
function with two accessory proteins, 15 kDa cytochrome b5 and 77 kDa 
cytochrome P450 oxidoreductase (POR) (Figure 4.1). P450s are so named on 
account of their characteristic as hemoproteins and their unusual spectral 
properties in the presence of carbon monoxide, which on reducing the heme 
produces an absorption maximum at 450 nm. 
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Figure 4.1: Model structures of P450 complex. Model structures showing 
cytochrome P450 with cytochrome b5 on the left and cytochrome P450 with 
cytochrome P450 oxidoreductase on the right. Figure taken from Barnaba et al. 
(2017).  
P450s catalyse the incorporation of a single atom of oxygen into the substrate 
and the remaining oxygen atom is reduced to water (Bernhardt, 2006). This is 
shown by the equation: 
RH + O2 + NAD(P)H + H+                          ROH + H2O + NAD(P)+ 
This reaction is known as a monooxygenase reaction and RH depicts the 
substrate. Cytochrome P450s belong to external monooxygenases which implies 
they have an absolute requirement for an external electron donor to transfer the 
electrons required for oxygen activation and substrate hydroxylation from a 
reducing equivalent i.e. NADPH (Bernhardt, 2006). Cytochrome P450 requires 
two electrons to be sequentially delivered from its redox partners, POR and b5, in 
order to carry out the oxidation of molecules and POR is capable of donating both 
electrons whilst b5 is only capable of donating the second electron not the first 
(Zhang et al., 2015; Guengerich, 2006; Gruenke et al., 1995; Zhang et al., 2008; 
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Im and Waskell, 2011). Cytochrome b5 has a varied role in the activity levels of 
P450s and hence on the levels of detoxification and resistance to a product. It 
has been shown to both stimulate and inhibit the action of P450s, as well as 
having no effect at all on the activities of P450s in vivo and in vitro in both human 
and mice studies (Finn et al., 2008; McLaughlin et al., 2010; Im and Waskell, 
2011; Gruenke et al., 1995). The stimulatory effect is due to its ability to produce 
active oxidising species more quickly than POR and its inhibitory effect comes 
from competing with POR for a binding site on the proximal surface of the P450 
(Im and Waskell, 2011; Zhang et al., 2008), with no effect being shown when the 
two events cancel each other out. It has also been suggested that the presence 
of different substrates can cause different affinities between b5 and the P450 
(Zhang et al., 2005; Gruenke et al., 1995).  
The role of POR in the detoxification process is more established. POR is a 
member of a relatively small family of diflavin redox proteins which consists of 
two lobes, one has an FMN domain and one has an FAD domain (Hrycay E and 
Bandiera, 2015). Eukaryotic P450s are located in the endoplasmic reticulum and 
the electrons flow from NADPH to FAD to FMN and then reach the P450 (McLean 
et al., 2005; Munro et al., 2007). In most organisms only one 680 amino acid POR 
encoding gene exists, suggesting POR can reduce many different P450s in one 
species (Cordova et al., 2017). POR is folded to allow the FMN and FAD domain 
to be located close together to facilitate the quick and efficient passing of one 
electron after another. POR allows for the transfer of electrons to the P450 
protein, but also allows for electrons to pass to other proteins, such as 
cytochrome b5 (Laursen et al., 2011). POR transports the electrons from NADPH 
to all the microsomal (type II) cytochrome P450 enzymes.   
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POR has a specific change of shape for its role as an electron donor. The FAD 
domain of the POR accepts electrons from NADPH which prompts a 
conformational change in the POR (Figure 4.2). This change allows FAD to be 
aligned with the FMN domain of POR and the electrons can flow to the FMN 
domain, which causes POR to return to its previous configuration. This return of 
shape allows the FMN domain to dock with the P450 via electrostatic interactions.  
Figure 4.2: Schematic of type II P450 complex. The lobes of the POR (blue 
protein) containing flavin adenine dinucleotide (FAD) and flavin mononucleotide 
(FMN). P450 is represented by the purple protein and cytochrome b5 as the grey 
protein. The arrows represent the flow of electrons in the chain.  
POR has been isolated from many pest species due to its indisputable role in the 
functioning of the P450 complex (Chen and Zhang, 2015; Liu et al., 2014; 
Etzerodt et al., 2017; Tsou et al., 2018). Both POR and b5 have been 
characterised as playing a role in resistance mechanisms of species such as 
Plutella xylostella (diamondback moth). Both genes were found to be 
overexpressed in cypermethrin resistant strains and low concentrations of 
cypermethrin could induce expression of both P450 redox partners (Chen and 
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Zhang, 2015). In Helicoverpa armigera (cotton bollworm), the overexpression 
pattern of b5 was identical to the overexpression of CYP6B7, which highlighted 
an involvement of b5 in CYP6B7 mediated pyrethroid resistance (Ranasinghe and 
Hobbs, 1999). Similarly, a recent study showed H. armigera was significantly 
more susceptible to a pyrethroid after knockdown of CYP6B7 as well as POR and 
b5 (Tang et al., 2012). Knockdown of the POR gene in Nilaparvata lugens (brown 
planthopper) increased susceptibility to both cypermethrin and imidacloprid, a 
neonicotinoid (Liu et al., 2015). Despite the role of redox partners in P450 
mediated resistance mechanisms, few have been isolated from arthropod 
species. The first hematophagous acari species to have POR and b5 isolated in 
order to create a full functional cytochrome P450 is R. microplus, although work 
has not yet been done to characterise the genes in order to gain clues into the 
mechanisms of resistance in the arthropod species (Graham et al., 2016).  
Other detoxification mechanisms of interest include the Glutathione S-
transferases (GSTs). P450s are involved in phase I of detoxification by catalysing 
the addition of polar groups to xenobiotics. GSTs are often associated with phase 
II metabolism and involve the conjugation of reduced glutathione (GSH) to the 
xenobiotic (Bartley et al., 2015; Sheehan et al., 2001). GSTs are of importance 
to the metabolism of xenobiotics in haematophagous parasites and so are of 
interest to this project to target the mechanisms of pesticide metabolism in PRM 
(Bartley et al., 2015; van Rossum et al., 2004; Toh et al., 2010).  
The aim of this chapter is to express and purify the PRM cytochrome b5, which 
has been identified using bioinformatics in Chapter 3, and use this to create a 
baculovirus expression system which can be used to monitor the effects of b5 on 
pesticide metabolism. As well as this, cytochrome b5 from two other tick species, 
R. microplus and I. scapularis will be expressed and purified for use in further 
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downstream applications. A PRM GST has been provided by collaborators and 
the aim is to also use this in the expression system, which could provide 
comparison of its effect on xenobiotic metabolism with cytochrome b5.  
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4.3 Methods 
4.3.1 RNA Extraction and standard production of cDNA from Dermanyssus 
gallinae 
RNA was extracted from PRM using the method described in section 3.3.4. In 
order to carry out PCR and generate the b5 gene, cDNA was generated using 
Precision Reverse Transcription all-in-one Premix (Primer Design Ltd, 
Hampshire, UK), according to the manufacturer’s protocol. Briefly, 9 μl of the RNA 
(2 µg) extracted was added to 20 μl of the RT premix and was incubated for 20 
minutes at 42 °C before being incubated for a further 10 minutes at 72 °C. The 
final volume of cDNA was 29 μl.  
4.3.2 Amplification of Cytochrome b5 gene using PCR 
The putative b5 sequence had been identified using transcriptomic sequence data 
from the PRM with b5 from the R. microplus as bait (see section 3.3.2). The 
aligned sequence was extended by 123 and 120 nucleotides in the 5’ and 3’ 
direction respectively to facilitate the incorporation of the predicted start and stop 
codons and parts of the untranslated 3’ and 5’ regions. Primers were designed to 
this region, to ensure the whole coding region was present in the sequence 
amplification and a standard PCR was used. Standard PCR was done using the 
primers in Table 4.1.  
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Table 4.1: PCR primers b5. Two sets of primers were designed, known as set 1 
and set 5, in order to have the best chance of isolating PRM b5.  
 PRM b5 Set 1 5’-3’ PRM b5 Set 5 5’-3’ 
Forward  TCC CAT CCA GGT CGG AAG AT CCA CCA GAA CGC TGA CTG AT 
Reverse TAT AGC CCA CTC GTG GTG GA ATG ACG ATG GAT AGC CCA CC 
 
PCR reactions were set up as follows using VELOCITY DNA Polymerase 
(Bioline, London, UK) with a total reaction volume of 12.5 μl; 7.5 μl distilled water, 
2.5 μl 5x Hi-Fi reaction buffer, 0.5 μl dNTPs (10 mM), 0.5 μl of each forward and 
reverse primer (10 μM), 0.25 μl MgCl2 (50 mM), 0.5 μl of PRM cDNA, 0.25 μl 
polymerase enzyme. The following PCR conditions were used; 1 cycle of 98 °C 
for 2 minutes, followed by 35 cycles of 98 °C for 30 seconds, 54 °C for 30 seconds 
and 72 °C for 20 seconds, with a final step of 72 °C for 10 minutes. 
PCR products were run on a 1 % agarose gel and correct size bands were 
extracted from the gel using a gel extraction kit (Qiagen, West Sussex, UK) 
following the manufacturers protocol and the final elution step was carried out in 
50 μl of sterile distilled water.  
4.3.3 Cloning Cytochrome b5 into pCR Blunt and Transformation into 
Competent Cells 
The purified gel extraction sample was cloned using Zero Blunt PCR Cloning kit 
(Life Technologies, Paisley, UK) and One Shot TOP10 Chemically Competent E. 
coli cells (Life technologies, Paisley, UK).  
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5 μl of the purified PCR fragment was ligated with 1 μl of pCR Blunt vector, 2 μl 
of 5 X ExpressLink T4 DNA ligase buffer, 1 μl ExpressLink T4 DNA Ligase and  
1 μl of sterile distilled water to give a reaction volume of 10 μl. This was incubated 
at room temperature for 1 hour.  
3 μl of ligation mixture was added to 50 μl of chemically competent TOP10 cells 
and gently mixed. The mixture was incubated on ice for 30 minutes before heat 
shocking at 42 °C for 45 seconds. The cells were returned to ice for 2 minutes 
and 450 μl of sterile LB broth was added. The cells were shaken at 45 minutes at 
37 °C and 225 rpm and then plated on LB selective plates with the appropriate 
antibiotic (for pCR Blunt 50 μg/ml Kanamycin). The plates were incubated 
overnight at 37 °C to allow growth of colonies.  
4.3.4 Colony Screen via Restriction Digest and Sequencing Confirmation 
Colonies visible on the plates were deemed to be kanamycin resistant and were 
removed from the plate and added to 10 ml of LB broth with 50 μg/ml Kanamycin 
followed by incubation in a shaking incubator (225 rpm) at 37 °C overnight. 
Plasmid DNA was purified from 3 ml of culture for each colony using a Qiagen 
QIAprep spin Miniprep Kit (Qiagen, West Sussex, UK) according to the 
manufacturer’s protocol with plasmid eluted in 30 μl of sterile distilled water. An 
EcoRI (NEB, Hertfordshire, UK) digest was done to confirm the presence of 
appropriate sized PCR product. A restriction digest was set up as follows; 5 μl of 
plasmid DNA, 1 μl of 10 X reaction buffer, 0.5 μl of enzyme and 3.5 μl sterile 
water. The digest was incubated for 2 hours at 37 °C before being analysed on a 
1 % agarose gel.  
Colonies which appeared to have the appropriate size insert were sent for 
sequencing using M13 primers.  
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4.3.5 Cloning Cytochrome b5 into pET15b  
To allow the successful expression of b5 in bacterial cells, the coding DNA 
sequence (CDS) was amplified to include the restriction sites for NdeI (5’ CAT 
ATG 3’) and XhoI (5’ CTC GAG 3’) (NEB, Hertfordshire, UK) and cloned into pCR 
Blunt to confirm correct incorporation of the restriction sites. The primers used 
can be viewed in Table 4.2.  
Table 4.2: Gene specific primers for b5. Forward and reverse primers for b5 
designed to ligate with pET15b with the restriction sites underlined.  
 Forward 5’-3’ Reverse 5’-3’ 
PRMb5pET  GCC ATA TGA CGA CGA 
CGA CGC CAG C 
GCC TCG AGT TAT CGG 
GAA TGG TAC AGG A 
 
PCR was completed using Pfu DNA polymerase (Promega, Madison, USA);  
0.2 μl of plasmid, 1.5 μl of each primer, 0.5 μl of enzyme, 5 μl of 10 X buffer, 1 μl 
of dNTPs (10 mM), 40.3 μl of sterile distilled water. The conditions were as 
follows; 1 cycle of 95 °C for 3 minutes, followed by 35 cycles of 95 °C for 30 
seconds, 63 °C for 30 seconds and 72 °C for 1 minute, with a final step of 72 °C 
for 10 minutes. PCR products were run on a 1 % agarose gel.  
PCR products were gel extracted and cloned into pCR Blunt as described in the 
above sections 4.3.2-4.3.4. Three colonies (C1, C4, C10) showing bands of the 
correct size were confirmed using sequencing with M13 primers (see section 
4.4.2).  
Both the pCR Blunt NdeI/XhoI b5 (with restriction sites) and the pET15b were 
digested with NdeI followed by XhoI as follows: 50 μl of plasmid DNA, 6 μl of  
10 X reaction buffer, 2 μl enzyme and 2 μl sterile water. The digest was incubated 
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for 2 hours at 37 °C before being analysed on a 1 % agarose gel. Bands of the 
appropriate size were excised from the gel using a gel extraction kit as described 
in 4.3.2 before being ligated using T4 DNA ligase. Briefly; 1 μl of 10 X DNA ligase 
buffer, 1 μl T4 DNA ligase, 3 μl pET15b plasmid DNA, 3 μl b5 DNA and 2 μl sterile 
distilled water were mixed and incubated at 16 °C overnight. 
This ligation was then transformed into TOP10 cells as described in section 4.3.3 
and the transformation was spread on ampicillin (50 μg/ml) plates and 
miniprepped as per section 4.3.4. An NdeI and XhoI (NEB, Hertfordshire, UK) 
double digest was done to confirm the presence of appropriate sized b5 product. 
A restriction digest was set up as follows; 6 μl of plasmid DNA, 1 μl of 10X reaction 
buffer, 0.5 μl of each enzyme and 2 μl sterile water. The digest was incubated for 
2 hours at 37 °C before being analysed on a 1 % agarose gel.  
Colonies (C3, C4) which appeared to have the appropriate sized insert were sent 
for sequencing using T7 primer; T7 (20) TAA TAC GAC TCA CTA TAG GG, to 
confirm the insertion of the b5 in frame with the His-tag. 
4.3.6 Expression and Purification of Cytochrome b5 from Dermanyssus 
gallinae, Ixodes scapularis and Rhipicephalus microplus 
To express cytochrome b5, the PRM-b5-pET15b construct was transformed into 
E. coli cells (BL21(DE3)pLysS) using the transformation protocol from 4.3.3. As 
well as transforming the PRM b5 gene, b5 from two other tick species (Ixodes 
scapularis (deer tick) and Rhipicephalus microplus (cattle tick)) were also 
transformed into BL21(DE3)pLysS cells. Transformants were grown on selective 
LB agar plates with 50 μg/ml ampicillin and 34 μg/ml chloramphenicol. Colonies 
that were grown on the plates were then put into LB broth (50 μg/ml ampicillin 
and 34 μg/ml chloramphenicol) and grown at 37 °C overnight, at 225 rpm. 5 ml 
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of the overnight culture was then added to 500 ml of TB (terrific broth) media  
(50 μg/ml ampicillin and 34 μg/ml chloramphenicol) and incubated at 37 °C, 225 
rpm until the O.D.600 reached a value between 0.6 and 0.8. 1 ml samples were 
then taken (before the samples were induced) for analysis using sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Expression was 
induced by adding 1 mM IPTG and 1 mM ALA to the culture and incubation 
continued overnight at 30 °C, 225 rpm. Post incubation, 1 ml samples were taken 
for analysis on an SDS-PAGE gel. Uninduced and induced samples from each 
species were then run on a 15 % SDS-PAGE gel. The culture was then spun at 
3795 xg (Sorvall RC-5B Plus, SLA 1500 rotor), at 4 °C.                 
Pellets were resuspended in 25 ml of 2X TSE (100 mM Tris acetate, 500 mM 
sucrose and 0.5 mM EDTA), followed by 30 ml of cold, sterile distilled water.  
4.8 ml of 0.26 mg/ml lysozyme was added to each pellet and then the 
resuspended pellets were spun at 4 °C for 1 hour on an automatic tube spinner. 
The fractions were then spun at 3795 xg (Sorvall RC-5B Plus, SLA 1500 rotor) 
for 20 minutes at 4 °C and the pellet resuspended in 60 ml spheroplast 
resuspension buffer (100 mM potassium phosphate pH 7.6, 6 mM magnesium 
acetate with 20 % v/v glycerol). 1 cOmplete™, Mini, EDTA-free Protease 
Inhibitor Cocktail tablet was dissolved in 1 ml sterile water and added to the 
fractions before sonication for 30 seconds 3-4 times. The suspension was 
diluted 1:2 with 100 mM spheroplast resuspension buffer and centrifuged at 
15,180 xg (Sorvall RC-5B Plus, SLA 1500 rotor) for 15 minutes at 4 °C. The 
supernatant was then spun at 273,620 xg (Beckman Coulter Optima L-100XP, 
rotor SW41 Ti) for 60 minutes at 4 °C and the pellet resuspended in 1 ml of 
binding buffer (20 mM Tris-HCL (pH 7.4), 500 mM KCl and 20 % v/v glycerol). 
Membranes were stored at -70 °C. 
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For purification, membranes were solubilised with 40 ml solubilisation buffer (20 
mM Tris (pH 7.4) 500 mM KCl, 20 mM CHAPS, 5 mM imidazole and 20 % v/v 
glycerol) at 4 °C on a magnetic stirrer overnight. Samples were centrifuged at 
273,620 xg (Beckman Coulter Optima L-100XP, rotor SW41 Ti) at 4 °C for 45 
minutes. A 5 ml HisTrap column (GE, Buckinghamshire, UK) was equilibrated 
with 50 ml of solubilisation buffer before the b5 membranes were loaded on to the 
column. The column was then washed with 50 ml solubilisation buffer and a red 
band was visible at the top, confirming the b5 protein had bound to the column. 
The column was then washed with 15 ml of solubilisation buffer with increasing 
concentrations of imidazole (15 mM, 30 mM, 50 mM) before being eluted in Ni-
agarose elution buffer (20 mM Tris (pH 7.4), 500 mM KCl, 20 mM CHAPS, 500 
mM imidazole and 20 % v/v glycerol). 1 ml of every fraction eluted was stored for 
analysis on a 15 % SDS-PAGE gel. The final fraction, which was red in colour, 
was buffer exchanged (using a PD10 column) into a low salt storage buffer (20 
mM Tris (pH 7.4), 100 mM KCl, 10 mM CHAPS and 20 % v/v glycerol) and were 
stored at -70 °C before running on a 15 % SDS-PAGE gel (for protocol, see 
appendix B).  
Protein was quantified using a b5 spectrophotometer assay. 50 μl of protein was 
added to 2 ml KPh (100 mM) pH 7.4. This was divided equally between 2 matched 
UV cuvettes and absorbance was read between 380-580 nm. The 
spectrophotometer was zeroed and a baseline was run before 10 μl of 30 % H2O2 
was added to the sample cuvette. The spectrophotometer was zeroed again and 
a scan run of the oxidised spec. A small quantity of sodium hydrosulphate was 
added to the sample cuvette and mixed and the absorbance at 409 and 426 nm 
was read. Concentration of b5 was calculated using the equation: 
nmoles/ μl= [(Abs 426 – Abs 409)/185] X dilution factor 
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4.3.7 Testing the Cross Reactivity of Mosquito Antibody Using a  
Western Blot 
The presence of PRM b5 was further checked using a Western blot. Firstly, a dot 
blot was completed to ascertain a suitable dilution of the primary b5 specific 
antibody (provided by Dr Mark Paine). A piece of nitrocellulose paper was taken 
and split into 6 sections using a pencil. 2.77 μl of PRM b5 (50 ng) was taken and 
added to each section of the nitrocellulose. The blot was blocked with Tris-
buffered saline with tween 20 (TBS-T) containing 5 % NFM (non-fatty milk) for 1 
hour at room temperature under rocking conditions. 6 different concentrations of 
primary were then added to the blot (1:625, 1:1250, 1:2500, 1:5000, 1:7500, 
1:10,000) in the TBS-T milk for 1 hour at room temperature under rocking 
conditions. Following the incubation, 3 X 5 minute washes were carried out in 
TBS-T before incubation with the secondary antibody (Goat Anti-Rabbit 
Immunoglobulins/HRP, Agilent, Dako, California, USA) for 1 hour at room 
temperature under rocking conditions in TBT-T milk. Three, 5 minutes TBS-T 
washes were then carried out before enhanced chemiluminescence (ECL) was 
added (Amersham ECL Western blotting reagent, GE, Buckinghamshire, UK). 
Images were taken using a Syngene G:Box.  
A Western blot was completed in order to check the sensitivity of the primary 
antibody at a specific dilution, 1:2500 and 1:5000 were used after confirming they 
provided clear detection of 50 µg of protein on the dot blot. A 15 % SDS-PAGE 
gel was then run (see appendix B) with varying amounts of b5 protein (5 ng, 10 
ng, 25 ng, 40 ng, 50 ng and 100 ng). Nitrocellulose was cut to the size of the gel 
and placed on top of the gel in between two filter papers. This sandwich was then 
placed inside the immunoblotting cassette and loaded into a running tank with 1 
X transfer buffer (25 mM Tris, 190 mM glycine, 20 % methanol). The blot was run 
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for 1 hour at 120V before being blocked with Tris-buffered saline with tween 20 
(TBS-T) containing 5 % NFM (non-fatty milk) for 1 hour at room temperature 
under rocking conditions. The blot was then placed in the primary antibody (b5 
specific 1:2500 and 1:5000) in the TBS-T milk overnight at 4 °C under rocking 
conditions. Following the overnight incubation, 3 X 5 minute washes were carried 
out in TBS-T before incubation with the secondary antibody (1:2000) (Goat Anti-
Rabbit Immunoglobulins/HRP, Agilent, Dako, California, USA) for 1 hour at room 
temperature under rocking conditions in TBT-T milk. Three 5 minutes TBS-T 
washes were then carried out before enhanced chemiluminescence (ECL) was 
added (Amersham ECL Western blotting reagent, GE, Buckinghamshire, UK). 
Images were taken using a Syngene G:Box.  
4.3.8 Production of Baculovirus Expression System for Cytochrome b5 and 
Glutathione S-transferases 
High level expression of the recombinant b5 and GST proteins was achieved 
using the Bac-to-Bac Baculovirus Expression System (Thermo Fisher, Paisley, 
UK). The genes were cloned into pFastBac 1 vectors according to the 
manufacturers protocol (Figure 4.2). Briefly, b5 and pFastBac were grown from 
glycerol stocks and mini prepped before being run on a 1 % agarose gel and gel 
extracted. They were then digested using XhoI followed by BamHI (NEB, 
Hertfordshire, UK) in the following reaction: 50 μl of plasmid DNA, 6 μl of 10 X 
reaction buffer, 2 μl enzyme and 2 μl sterile water. The digest was incubated for 
2 hours at 37 °C before being analysed on a 1 % agarose gel and bands of the 
appropriate size were gel extracted and ligated using T4 DNA ligase and grown 
overnight as described in 4.3.2. Colonies were checked for the presence of b5 
using a restriction digest with XhoI and BamHI, as described in section 4.3.4, and 
bands showing the correct molecular weights were confirmed with sequencing 
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using Polyhed fwd (18) AAA ATG ATA ACC ATC TCG. This recombinant plasmid 
was then transformed into DH10Bac E.coli cells and grown on selective plates 
(50 μg/mL kanamycin, 7 μg/mL gentamicin, 10 μg/mL tetracycline, 100 μg/mL 
Bluo-gal and 40 μg/mL IPTG). A white phenotype was indicative of successful 
transformation and white colonies were screened using PCR. PCR primers were 
as follows: M13 forward 5′- TGT AAA ACG ACG GCC AGT -3′ and PRM b5 pET 
rev 5’ GCC TCG AGT TAT CGG GAA TGG TAC AGG A 3’. PCR was completed 
using Taq DNA polymerase (NEB, Hertfordshire, UK); 1 μl of plasmid, 1.25 μl of 
each primer (10 mM stock), 0.5 μl of enzyme, 5 μl of 10 X buffer, 1 μl of dNTPs 
(10 mM), 1.5 μl 50 mM MgCl2 and 38.5 μl of sterile distilled water. The conditions 
were as follows; 1 cycle of 93 °C for 3 minutes, followed by 30 cycles of 94 °C for 
45 seconds, 63 °C for 45 seconds and 72 °C for 2 minute, with a final step of  
72 °C for 10 minutes. PCR products were run on a 1 % agarose gel. A Plasmid 
DNA Midiprep Kit (Thermo Fisher, Paisley, UK) was made of successful colonies 
and was then used to transfect insect cells of the cell line Sf9 (Thermo Fisher, 
Paisley, UK), using Cellfectin II Reagent. 
In order to create a GST expression system, GST required amplification. GST 
primers were designed in order for it to be cloned into pCRBlunt; Forward GST: 
5’GCC ACC AGT TCG TGA TGG GC 3’ and reverse GST: 5’ GCC CAT CAC 
GAA CTG GTG GC 3’. PCR was completed using Q5 DNA polymerase (NEB, 
Hertfordshire, UK). 2 μl of plasmid, 1 μl of each primer (100 mM stock), 0.25 μl of 
enzyme, 5 μl of 5 X buffer, 0.5 μl of dNTPs (10 mM), 5 μl of 5 X GC enhancer 
and 10.25 μl of sterile distilled water. The conditions were as follows; 1 cycle of 
98 °C for 30 seconds, followed by 30 cycles of 98 °C for 10 seconds, 72 °C for 
20 seconds, with a final step of 72 °C for 2 minutes. PCR products were run on a 
1 % agarose gel. GST was ligated with pCRblunt using T4 DNA ligase and 
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transformed into TOP10 cells (see section 4.3.3). The presence of GST was 
checked using an EcoRI restriction digest as set up in section 4.3.4 before being 
sent for sequencing with M13 primers; M13 uni (21) 5’ TGT AAA ACG ACG GCC 
AGT 3’ and M13 rev (29) 5’ CAG GAA ACA GCT ATG ACC 3’.  
GST and pFastBac were then digested with BamHI followed by KpnI (both NEB, 
Hertfordshire, UK) in a restriction digest, excised from a 1 % agarose gel and 
ligated using T4 DNA ligase before being transformed into TOP10 cells as 
described in section 4.3.4.  
Colonies were screened for the presence of GST fragment using a restriction 
digest with both KpnI and BamHI as well as screening by PCR. Colonies were 
screened using GST specific forward and reverse primers. Forward GST: 5’GCC 
ACC AGT TCG TGA TGG GC 3’ and reverse GST: 5’ GCC CAT CAC GAA CTG 
GTG GC 3’. PCR was completed using Q5 DNA polymerase (NEB, Hertfordshire, 
UK). 2 μl of plasmid, 1 μl of each primer (100 mM stock), 0.25 μl of enzyme, 5 μl 
of 5 X buffer, 0.5 μl of dNTPs (10mM), 5 μl of 5 X GC enhancer and 10.25 μl of 
sterile distilled water. The conditions were as follows; 1 cycle of 98 °C for  
30 seconds, followed by 30 cycles of 98 °C for 10 seconds, 72 °C for 20 seconds, 
with a final step of 72 °C for 2 minutes. PCR products were run on a 1 % agarose 
gel. The positive colonies confirmed by sending for sequencing with Polyhed fwd 
(18) AAA ATG ATA ACC ATC TCG. These colonies were then transformed into 
DH10 cells (the same protocol as pFastBacb5 colonies) and screened on 
antibiotic plates as well as screening by PCR. PCR primers were as follows: M13 
forward 5′- TGT AAA ACG ACG GCC AGT -3′ and reverse GST: 5’ GCC CAT 
CAC GAA CTG GTG GC 3’. PCR was completed using Taq DNA polymerase 
(NEB, Hertfordshire, UK); 1 μl of plasmid, 1.25 μl of each primer (10 mM stock), 
0.5 μl of enzyme, 5 μl of 10X buffer, 1 μl of dNTPs (10 mM), 1.5 μl 50 mM MgCl2 
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and 38.5 μl of sterile distilled water. The conditions were as follows; 1 cycle of  
93 °C for 3 minutes, followed by 30 cycles of 94 °C for 45 seconds, 69 °C for 45 
seconds and 72 °C for 2 minute, with a final step of 72 °C for 10 minutes. PCR 
products were run on a 1 % agarose gel. A Plasmid DNA Midiprep Kit (Thermo 
Fisher, Paisley, UK) was made of successful colonies and was then used to 
transfect insect cells of the cell line Sf9 (Thermo Fisher, Paisley, UK), using 
Cellfectin II Reagent. 
For the purpose of producing recombinant Baculovirus, Sf9 cells were routinely 
cultured as a cell monolayer in Sf-900 II serum free media (Thermo Fisher, 
Paisley, UK) containing 1 % v/v penicillin (10,000 U/mL) and 1 % v/v Amphotericin 
(Thermo Fisher, Paisley, UK). Cells were routinely split 1:4 every 3-4 days at  
90 % confluency, fed every 2-3 days and grown at 27 °C in a controlled humidity 
incubator. Cells had a density of 1.6 X 106 before proceeding with transfection.  
To transfect the cells, for both b5 and GST, cells were seeded at 1.6 X 106 in a 6 
well plate and allowed to attach for 15 minutes at room temperature before  
2.5 ml of plating medium was added per well (0.375 ml Supplemented Grace’s 
Insect Medium and 2.125 ml of Unsupplemented Grace’s medium). Cells were 
then transfected with 8 μl of Cellfectin reagent and 1 μl baculovirus DNA and left 
to incubate for 3 hours. Transfection mixture was then removed and 2 ml of  
Sf-900 II serum free media was added per well. Cells were incubated for 7-10 
days until signs of viral infection were apparent and the medium was collected 
(P1 stock) and stored with 2 % final concentration fetal bovine serum at 4 °C. 
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Figure 4.3: Baculovirus protocol overview. The generation of the recombinant 
baculovirus and the expression of b5 and GST using the expression system. 
Diagram adapted from manufacturer’s protocol.  
Once Sf9 cells had been transfected with the recombinant bacmid DNA, the viral 
titre was amplified twice in order to ensure a high level of protein expression. 
Briefly, cells were seeded at 2 X 106 in a 6 well plate. Cells were incubated for 1 
hour before DNA was added (18 μl for b5 or 7 μl for GST based on protein yield) 
Cells were incubated for 7-10 days until signs of viral infection were apparent and 
the medium was collected (P2 stock). This process was then repeated in order to 
collect P3 stock which was stored at 4 °C until use.  
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4.3.9 Pesticide Assay and Confirmation of Protein Expression 
Healthy cells, at 95 % confluency were used to seed 6 well plates (density 5 X 
105). These plates were treated with 1 μl, 5 μl, 10 μl, 20 μl and 50 μl of the b5 and 
GST viral P3 stock and one well was left as a control. This plate was monitored 
for cell viability over 5 days, to ensure a high level of virus would not cause cell 
damage. No excessive damage was observed, even in the highest viral 
concentration (1:40) and so three 96 well plates were seeded with Sf9 cells 
(density 5 X 105) in log phase of growth and 2.5 µl (1:40) of P3 viral stock added 
per well. 1 plate had P3 cytochrome b5 viral stock added, one had P3 GST viral 
stock added, and one plate was used as a control plate with no viral stocks added 
to the cells. After 72 hours of exposure to the virus, media was changed and 
pesticides were added to the cells. Pesticides used were permethrin, bendiocarb 
and deltamethrin at final concentrations of 1 μM, 10 μM, 50 μM, 100 μM 
(Boonsuepsakul et al., 2008). Pesticides were dissolved in 1 % Dimethyl sulfoxide 
(DMSO) due to their relative insolubility in water. Six replicates were done of each 
concentration of each pesticide as well as 8 X 1 % DMSO control and 4 X 0 % 
DMSO control wells. Each of the three 96 well plates were treated identically and 
incubated at 27 °C for 48 hours.  
All three plates underwent a MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl 
tetrazolium bromide) assay (Vybrant MTT cell viability assay kit, Thermo Fisher, 
Paisley, UK) on three of the six replicates. This was carried out following the 
manufacturer’s ‘quick protocol’ option. Briefly, the media was removed from the 
cells and replaced with 100 μl of fresh culture medium. 10 μl of 12 mM MTT stock 
solution was added to each well and incubated for 4 hours at 37 °C. 85 μl of media 
was removed from each well and 50 μl of DMSO was added. This was then 
incubated at 37 °C for a further 10 minutes before mixing and reading the 
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absorbance at 540 nm on a FLUOstar Omega (BMG LABTECH). The remaining 
cells needed collecting to test for protein expression. 12 wells of cells expressing 
b5 and 12 wells expressing GST were collected and stored in 1 X laemmli and 
GST buffer (10 mM Tris, 0.5 M NaCl pH 7.4) respectively. GST samples were 
snap frozen and stored at -80 °C and b5 samples were stored at -20 °C.  
The assay for GST activity was adapted from Bartley et al. (2015). 99 μl of 
phosphate buffer (100 mM potassium dihydrogen phosphate, 1 mM EDTA (pH 
6.5) and 2 mM GSH) was added to each well followed by 10 μl of Tris buffer (10 
mM Tris, 0.5 M NaCl (pH 7.4)). 10 μl of GST sample was added to three wells 
and 10 μl of control cells not treated with GST baculovirus was added to another 
three wells. 1 μl of 100 mM 1-chloro-2,4-dinitrobenzene (CDNB) was added to 
each well and the absorbance was read at 340 nm.  
Cytochrome b5 activity was tested via a Western blot using b5 specific antibodies 
as per section 4.3.7.   
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4.4 Results and Discussion  
4.4.1 Extraction of RNA from Dermanyssus gallinae 
To isolate and express the putative accessory proteins, as found in section 3.3.2, 
RNA needed to be extracted from the PRM. RNA extraction was carried out as 
described in section 4.3.1. The samples were analysed via Nanodrop to 
determine the quality and purity of the samples and run on an agarose gel as 
described in section 4.3.1. The first sample taken had a 260/280 reading of 2.13 
which is deemed ‘pure’ for RNA and was run on a gel as seen in Figure 4.4.  
 
 
 
 
 
 
Figure 4.4: RNA extraction from PRM. 1 % agarose gel showing the RNA 
integrity. Lane 1 contains 5 μl of PRM RNA.  
Results from the RNA extraction show three bands on the agarose gel, which 
was unexpected, due to RNA normally showing two bands in mammalian RNA 
and one band in other tick species. Mammalian RNA has two bands because as 
the RNA is denatured it splits into two, which are the 18s and the 28s subunit. 
Ticks and other insects commonly have one band on an RNA agarose gel 
because when the RNA is heated and denatured, the 28s subunit splits into two 
 1 
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further units which are both the same size as the 18s subunit, meaning only one 
band can be viewed on a gel (Winnebeck et al., 2010)(Figure 4.5).  
 
 
 
 
 
 
 
 
 
Figure 4.5: Assembly of rRNA into its subunits in insects. In Eukaryotes each 
ribosome is comprised of 4 different molecules of RNA, two larger named 18s 
and 28s (after their sedimentation properties) and two smaller named 5s and 
5.8s. The smaller ribosomal subunit is made from 18s and the larger unit is 
comprised of the other three units (5s, 5.8s and 28s). 5.8s, 18s and 28s rRNA 
are transcribed as a single precursor molecule and post-transcriptional 
processing of this molecule yields separate rRNAs which combine with ribosomal 
proteins to form ribosomal subunits. Insects have an additional processing step 
which cleaves 28s rRNA into α and β fragments. ETS: externally transcribed 
spacer region, ITS: internally transcribed spacer region. Diagram taken from 
(Winnebeck et al., 2010). (Gillespie et al., 2006).  
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The band visible on the agarose gel (Figure 4.4) had very little smearing and so 
the RNA was converted into cDNA (see section 4.3.1). Several PCRs were 
completed in order to amplify cytochrome b5 which resulted in empty gels. It was 
decided that a comparison gel should be run, using RNA extracted by a previous 
PhD student (Kirsty Graham) comparing the RNA sample from the I. scapularis 
and also a practice RNA she had completed using PRM (Figure 4.6).   
 
 
 
 
 
 
 
 
Figure 4.6: RNA comparison from 3 species. Lane 1= Mammalian RNA 
showing 28s and 18s subunits, run by Kirsty Graham (former PhD student). Lane 
2= PRM RNA, Lane 3= I. scapularis RNA; both previously extracted by Kirsty 
Graham and show the 1 band expected of an insect sample at 18s.  
The gel showed one band for both I. scapularis and for PRM, although PRM was 
a weaker band. This prompted a new RNA extraction from the PRM in order to 
get a strong signal on a gel which did not show three bands like the previous 
extraction (Figure 4.7).  
 
 2   3 1 
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Figure 4.7: 2nd PRM RNA extraction. RNA was re-extracted from the PRM and 
run on a 1 % agarose gel in lane 1.  
The RNA was extracted from the PRM for a second time and run on an agarose 
gel. The result was a strong band on the gel which appeared to consist of two 
bands of a similar size. This could be consistent with the denaturing of the RNA 
and could show two fragments of the 28s that are a similar size. The band was a 
clear band with little smearing and had a 260/280 reading of 2.01 on the 
Nanodrop so was deemed of high purity. This was therefore used in subsequent 
downstream applications.  
4.4.2 Amplification of Cytochrome b5 and Cloning into Vector pET15b  
Once RNA was deemed of high integrity, and had been converted to cDNA (see 
section 4.3.1), b5 was amplified using the primers shown in Table 4.1. The results 
of this were run on a 1 % gel and can be viewed in Figure 4.8.  
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Figure 4.8: PCR of b5 from cDNA. Lane 1= Low molecular weight marker (NEB, 
Hertfordshire, UK), Lane 2= PCR product using primer set 1, Lane 3= PCR 
control with primer set 1, Lane 4= PCR product using primer set 5, Lane 5= PCR 
control with primer set 5.  
A low molecular weight ladder was used to analyse the size of the PCR product. 
The b5 gene is 627 bp from the start of the GSP to the end. Both sets of primers 
appeared to produce a product of approximately the correct size but the smearing 
of the PCR product using primer set 1 led to primer set 5 being used to go forward. 
The PCR product from lane 4 was excised from the gel and cloned into pCR Blunt 
as described in section 4.3.3 and transformed into TOP10 cells (see section 
4.3.3). Positive colonies were identified using kanamycin selective plates. pCR 
Blunt contains a lethal gene and ligation of the b5 disrupts the expression of this 
gene, which allows growth of the colony and potentially only positive 
recombinants will grow on the plate.  
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A restriction digest with EcoRI (see section 4.3.4) was done on the colonies taken 
from the plate in order to identify positive colonies containing the correct size 
insert corresponding to the b5 gene.  
 
 
 
 
 
 
 
 
 
Figure 4.9: Results of EcoRI digest. 7 colonies of pCRBluntb5 were digested 
with EcoRI and the results were run on a 1 % gel. Lane M= 1kb GeneRuler 
(Thermo Fisher, Paisley, UK), Lanes 1-7= colonies 1-7.  
The restriction digest (Figure 4.9) showed 3 colonies which seemed positive for 
the presence of the b5 insert. The vector, pCR Blunt, is 3.5 kb and therefore 
should be one band higher on the molecular weight ladder than the 3000 bp line. 
The insert should be 627 bp long and therefore should be under the 700 bp line 
on the molecular weight ladder. Three colonies were a visual confirmation of this, 
and therefore colonies C2, C5 and C7 were sent for sequencing using M13 
primers; M13 uni (21) TGT AAA ACG ACG GCC AGT and M13 rev (29) CAG 
1000bp  
6000bp  
3000bp  
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GAA ACA GCT ATG ACC. Sequence data was compared to the transcriptomic 
sequence data to confirm successful amplification. 
Characterisation of the P450 accessory proteins requires them to be expressed 
and purified. To facilitate this, b5 needed transferring into an expression vector 
which was suitable. pET15b allows expression of an N-teminally Histagged 
protein which can then be purified on a column using metal affinity 
chromatography. Primers were designed with the addition of the restriction sites 
NdeI (5’ CAT ATG 3’) and Xhol (5’ CTC GAG 3’) so the sequence could be ligated 
with pET15b (Table 4.2). 
The first step in the process was the amplification of PRMb5 to include the 
restriction sites required for cloning into pET15b. PRMb5C2 was chosen to 
continue with and was amplified using PCR as described in section 4.3.5 (Figure 
4.10).  
 
 
 
 
 
 
Figure 4.10: PCR of PRMb5C2. M= molecular weight ladder. L= PCR of 
PRMb5C2. 
This PCR product, which now contained restriction sites for cloning into pET15b, 
was ligated with pCR Blunt and transformed into TOP10 cells. Overnight cultures 
       M                  1 
500bp 
151 
 
were made of ten colonies from the antibiotic selective plates which were then 
purified by miniprep and digested with EcoRI. EcoRI was chosen as there is a 
restriction site in the pCR Blunt vector at each side of the fragment insert which 
allows the fragment to be cut out of the vector and be visible on a 1 % agarose 
gel (Figure 4.11).  
 
 
 
 
 
 
Figure 4.11: EcoRI digest of PRMb5pCRblunt. Gel is a 1 % agarose gel and 
the lanes 1-10 represent colonies 1-10. M= molecular weight marker, 1 kb 
GeneRuler (Thermo Fisher, Paisley, UK).  
The restriction digest showed 5 colonies which appeared to have a band at the 
correct migration for PRMb5 as well as having the pCR Blunt vector at the correct 
migration of 3.5 kb. Colonies 1, 4 and 10 were sent to be sequenced using M13 
primers and all three colonies came back with 100 % identity to the PRMb5 gene.  
With this confirmation, the fragment could now be ligated into pET15b. Both 
pET15b and PRMb5 were digested with NdeI, as described in section 4.3.5, and 
can be viewed in Figure 4.12. Initial digest with NdeI was successful with pET15b 
and yielded one clear band. Digestion of PRMb5pCRBlunt was only partial (Figure 
4.12, lane 2) and so was further digested until only one band was present  
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on a 1 % agarose gel. These fragments were then put though a second digest 
using XhoI and the results of this can be seen in Figure 4.12, lanes 3-6. The 
bands were excised from the gel, pET15b was weaker than hoped but was 
successfully extracted from the gel, and the lower band from Figure 4.12, lanes 
5 and 6, (b5) was also extracted.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 
 
 
 
 
 
 
Figure 4.12: Restriction digest of PRMb5pCRBlunt and pET15b. M= 
Molecular weight markers. Lane 1= pET15b after digestion with NdeI. Lane 2= 
PRMb5pCRBlunt after initial digest with NdeI. Lanes 3 and 4= digestion of 
pET15b after 2nd digest with XhoI. Lanes 5 and 6= digestion of PRMb5pCRBlunt 
after 2nd digest with XhoI.  
With both bands extracted and having ‘sticky ends’, the two fragments could be 
ligated using T4 DNA ligase (see section 4.3.5) and transformed into TOP10 
cells. The transformation was grown on ampicillin plates (50 μg/ml ampicillin) as 
pET15b contains an ampicillin resistance gene, meaning only colonies containing 
the pET15b construct will be viable on an ampicillin plate. 7 colonies were taken 
from the plates and grown overnight in LB containing 50 μg/ml ampicillin before 
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they were purified using a miniprep. A double digest using both NdeI and XhoI 
was performed to isolate colonies containing the b5 gene and results were run on 
an agarose gel (Figure 4.13).  
 
 
 
 
 
 
 
 
Figure 4.13: XhoI and NdeI digest of pET15bPRMb5. M= molecular weight 
ladder, 1 kb GeneRuler (Thermo Fisher, Paisley, UK), lanes 1-7= Colonies 1-7.  
The gel showed the presence of a band in approximately the correct weight for 
the b5 gene in 5 of the colonies and the upper band was of approximately the 
correct weight for the pET15b vector (5.7 kb). Colonies C3 and C4 were sent for 
sequencing using T7 primers (see section 4.3.5).  
This sequencing confirmed the presence of the b5 gene in both sequences 
(Figure 4.14). 
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Figure 4.14: Sequencing results of PRMb5pET15b. The cloning of the Cytb5 
fragment into pET15b. Query= in silico sequence to encode His-tagged PRM 
Cytb5. Subject= results of the sequencing for colony 3 returned from a 
sequencing company. The start and stop codons are highlighted by green and 
red boxes respectively. The six histidine tag is underlined. Alignment run in NCBI 
BLASTn. 
Sequencing confirmed the successful ligation of PRMb5 into the pET15b vector, 
this has created a polyhistidine-tagged protein which can be purified using metal 
affinity purification.  
4.4.3 Expression of Cytochrome b5 from Dermanyssus gallinae, Ixodes 
scapularis and Rhipicephalus microplus 
Having successfully cloned PRMb5 into pET15b, a transformation was required 
to transform the recombinant plasmid into BL21(DE3)pLysS cells using the 
protocol from section 4.3.3. The cells were chosen because pET15b has a T7 lac 
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promoter which allows transcription of the gene inserted, therefore the plasmid 
needed transferring into a cell line that contains a copy of T7 RNA polymerase 
gene (DE3), hence the choosing of BL21 DE3 cells which have such a genotype 
and contain a lacUV5 promoter. The T7 promotor and then lacUV5 promoter are 
both controlled by the lac repressor gene which causes the transcription of the 
T7 RNA polymerase gene in the host polymerase but halts the T7 lac promoter 
in the vector to stop transcription of the gene of interest by any RNA polymerase 
produced. pET15b vectors show a small level of expression but IPTG induces 
expression which allows the RNA polymerase to access the T7 promotor and 
cause transcription of the gene of interest.  
BL21 DE3 cells can express high levels of protein without being subjected to 
proteolysis as they are lacking in OmpT and Lon proteases which could cause 
the proteolysis of the expressed b5. The strain pLysS was chosen as a 
chloramphenicol resistant plasmid which codes for T7 lysozyme which naturally 
inhibits T7 RNA polymerase. Cells produce T7 lysozyme which supresses base 
expression of the T7 RNA polymerase before the cells are induced using IPTG. 
This allows the recombinant plasmid to remain stable whilst the cells are in the 
exponential growth phase, before being induced. 
The Cytb5 gene has been isolated from two veterinary important acari, 
Rhipicephalus (Boophilus) microplus (RM), Ixodes scapularis (IS) as well as from 
Dermanyssus gallinae (PRM). Cytb5 was identified and isolated in these species 
by a former PhD student (Kirsty Graham) and the expression and purification of 
the genes allows comparisons with other arthropod species. Monitoring the 
changes in expression of b5 when exposed to pesticides in different species in a 
baculovirus expression system will allow for more information on the potential 
role of b5 in resistance mechanisms in arthropods and may allow for changes to 
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acaricide development. b5 modifies the P450 complex and can donate the 2nd 
electron required in the P450 cycle, instead of the electron donation coming from 
POR. In doing so b5 is around 10-100 times faster than POR and has been shown 
to stimulate, inhibit or have no effect on the activity of the P450 complex. The 
effect of b5 has also been found to be dependant not only on specific P450 genes 
but also on the specific substrates of P450s, making knowledge of their intricate 
mechanism of great interest (Im and Waskell, 2011; Zhang et al., 2015). 
Downstream modelling of cytb5 in these species will provide a molecular basis for 
the design of new acaricides or synergists targeting b5 and thus provide a means 
of controlling populations of acari which have become resistant to the acaricides 
currently in use. 
Transformations of PRM, IS and RM into BL21(DE3)pLysS were completed and 
grown on double antibiotic plates (50 μg/ml ampicillin and 34 μg/ml 
chloramphenicol) before being used to inoculate sterile TB (see section 4.3.6). 
Samples were taken of the unexpressed protein before IPTG and Aminolevulinic 
acid (ALA) were added to initiate protein expression. IPTG is a molecular mimic 
of allolactose, which functions by binding to the lac repressor and releasing the 
lac repressor from the lac operator which allows transcription of the gene inserted 
into the lac operon (Figure 4.15). ALA is an endogenous non-protein amino acid 
which is part of the porphyrin synthesis pathway which leads to heme production, 
this is added as the level in the cell can be a limiting factor.    
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Figure 4.15: IPTG-inducible protein expression. IPTG is a molecular mimic of 
allolactose and is represented by a green square. This binds to the lac repressor 
and releases the repressor from the lac operator in an allosteric manner, which 
allows the transcription of genes in the lac operon (lacO), such as b5.  
Firstly, both C3 and C4 PRMb5pET15b constructs were expressed as described 
in section 4.3.6 and one flask was left unexpressed as a control. The colonies 
were induced at 30 °C overnight and then spun down before the images were 
taken (Figure 4.16). The pink/red tone of the expressed samples suggests that 
the hemoprotein has correctly folded and has been significantly expressed. This 
first experiment was completed on a smaller scale to prove principle and then 
scaled up to produce large volumes of expressed protein.  
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Figure 4.16: Expression of cytochrome b5 from PRM with the expression 
vector pET15b. Image showing the pellet obtained from expressed b5 and non-
induced b5. Tube 1= colony 3 without being induced by IPTG, tube 2= colony 3 
after inducing with IPTG and tube 3= colony 4 after inducing with IPTG.  
Samples were taken of each colony before and after induction with IPTG and the 
results run on an SDS-PAGE gel (Figure 4.17), which confirmed the higher levels 
of protein expression in the samples induced with IPTG. Protein expression is 
seen to increase in the induced samples below the 25 kD mark, b5 is expected to 
show up around the 17 kD mark and so the gel supports the observation of the 
presence of b5 from the pink pellet. 
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Figure 4.17: SDS-PAGE gel of induced and uninduced samples from PRM. 
Lane 1= Colony 4 induced sample, Lane 2= Colony 3 induced sample, Lane 3= 
Colony 4 uninduced sample, Lane 4= Colony 3 uninduced sample, Lane M= 
weight marker.   
Cytochrome b5 was then taken from RM and IS and expressed under the same 
conditions as PRM (see section 4.3.6). This was done in a larger culture for PRM 
(using colony 3) and produced three large pellets which indicated a successful 
expression of the protein. The results of the expression can be viewed in Figure 
4.18.  
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Figure 4.18: Expression of cytochrome b5 from D. gallinae, R. microplus and 
I. scapularis. Tube 1= R. microplus, Tube 2= D. gallinae, Tube 3= I. scapularis. 
All three tubes were expressed using IPTG overnight at 30 °C.  
4.4.4 Purification of Cytochrome b5 from Dermanyssus gallinae, Ixodes 
scapularis and Rhipicephalus microplus 
Purification of the protein is essential to establish its role in the mechanisms of 
pesticide resistance and using biochemical characterisation to determine the 
effect of b5 on P450 function. The value of this to PRM is great, as determining 
the cause of resistance mechanisms allows the ability for targeted product 
development, which in turn gives the farming community effective products and 
improves egg production. This would also be a significant advance to the IS and 
RM tick species, as they are both of veterinary importance due to their 
transmission of disease and both species are facing issues of resistance, similar 
to the PRM. Advancing the knowledge of one species of arthropod will assuredly 
advance the understanding of others and therefore having three species of 
veterinary importance at a purified stage and ready for biochemical analysis is of 
huge value to the field.  
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Purification of cytochrome b5 was carried out using metal affinity chromatography 
on a 5 ml HisTrap column (GE, Buckinghamshire, UK) as described in section 
4.3.6. IS b5 was solubilised first and loaded on to the HisTrap column, 
immediately the binding of b5 was visible as a red band and this aided the 
purification by allowing the accurate collection of the purified sample (Figure 
4.19).  
 
Figure 4.19: Loading of HisTrap column. ISb5 was first to be loaded on to the 
column and the red band was immediately visible, confirming binding.  
Samples were run on a 15 % SDS-PAGE gel and can be viewed in Figure 4.20. 
Protein expression is clearly increased in the induced sample in lane 2, 
(highlighted) compared to the uninduced sample in Lane 1. The first wash to 
come through the column shows very little protein, indicating the protein has 
162 
 
successfully bound to the column. The following washes show very little protein 
which ensures the protein was not washed off the column. The eluted and purified 
sample in Lane 8 shows a band of approximately the correct weight (15-17 kD). 
The two bands visible could be due to slight degradation of the protein sample, 
potentially due to the difficulty of keeping the sample chilled whilst purifying. 
Cytochrome b5 is a polypeptide consisting of two distinct domains, a short 
hydrophobic C- terminal membrane binding domain and a large globular segment 
containing the heme domain. In other purifications of b5 the loss of the C-terminus 
binding domain is seen, which could result in the different sized bands seen on 
the gel (Begum et al., 2000; Strittmatter et al., 1978; Sobrado et al., 2008).  
 
 
 
 
 
 
Figure 4.20: Purification of ISb5. M= molecular markers, Lane 1= protein before 
it was induced with IPTG, Lane 2= protein after it was induced (highlighted in 
blue), Lane 3= solubilised protein. Lane 4= flow through of solubilised protein 
through the column, Lane 5= flow through of the 15 mM imidazole wash, Lane 6= 
flow through of the 30 mM imidazole wash, Lane 7= flow through of the 50 mM 
imidazole wash, Lane 8= the eluted and salt exchanged sample.  
Following the purification of ISb5, RMb5 was purified using the same techniques 
(Figure 4.21). The prep of RMb5 appeared the same in colour as the other species 
25kD 
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protein preparations (Figure 4.18) but the SDS-PAGE revealed a more 
concentrated stock of protein than ISb5. A dense band was present at ~15 kD 
mark.  
 
 
 
 
 
 
Figure 4.21: Purification of RMb5. M= molecular markers, Lane 1= protein 
before it was induced with IPTG, Lane 2= protein after it was induced, Lane 3= 
solubilised protein. Lane 4= flow through of solubilised protein through the 
column, Lane 5= soluble fraction first wash, Lane 6= flow through of the 15 mM 
imidazole wash, Lane 7= flow through of the 30 mM imidazole wash, Lane 8= 
flow through of the 50 mM imidazole wash, Lane 9= the eluted and salt 
exchanged sample.  
Two samples were prepared from PRM, both soluble b5 (the form in erythrocytes) 
and membrane bound b5 (found localised to the endoplasmic reticulum and 
commonly found involved in pesticide metabolism). The membrane bound form 
is essential for in vivo studies of b5 biochemistry and the soluble form could be 
used in the future for antibody purification. After the ultracentrifuge spin, as 
described in section 4.3.6, the supernatant was stored as the soluble fraction and 
the pellet was resuspended and stored in 1 X TSE buffer as the membrane bound 
15kD 
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fraction. After the full purification, induced and uninduced samples as well as all 
washes and final purified samples were run on a gel as seen in Figure 4.22.  
 
 
 
 
 
 
 
Figure 4.22: SDS-PAGE gel of both soluble and membrane bound b5 in PRM. 
Figure A= membrane bound protein, Figure B= Soluble protein. M= molecular 
markers, Lane 1= protein before it was induced with IPTG, Lane 2= protein after 
it was induced, Lane 3= solubilised protein. Lane 4= flow through of solubilised 
protein through the column, Lane 5= soluble fraction first wash, Lane 6= flow 
through of the 15 mM imidazole wash, Lane 7= flow through of the 30 mM 
imidazole wash, Lane 8= flow through of the 50 mM imidazole wash, Lane 9= the 
eluted and salt exchanged sample.  
Both PRM preps provided a strong purified band of protein at a similar molecular 
weight to one another. The bands appear heavier in molecular weight than that 
of IS and RM b5, which is likely due to slight differences in protein weight in the 
different species, for example, IS b5 is predicted to be 14.74 kDa, RM b5 is 
predicted to be 15.1 kDa and PRM is predicted to be 15.51 kDa (Graham et al., 
2016).   
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The benefit of having purified protein for all three of the pest species is invaluable. 
These proteins can be used in a host of downstream applications which have 
potential to make large breakthroughs in combatting resistance. The summary of 
this purification can be seen in Figure 4.23.  
 
 
 
 
 
 
 
 
Figure 4.23: Summary of purification of cytochrome b5. M= molecular 
markers, Lane 1= R. microplus, Lane 2= D. gallinae soluble fraction, Lane 3= D. 
gallinae membrane bound fraction, Lane 4= I. scapularis. 
The PRM b5 membrane fraction was confirmed using a Western blot with specific 
b5 antibodies which were sent by a collaborator in Liverpool (Dr Mark Paine). The 
specificity of the antibody was first trialled using a dot blot (Figure 4.24), before 
being used in a Western blot. 
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Figure 4.24: Dot blot using PRM membrane bound b5. Dot 1= 1:625 µl of 
antibody, Dot 2= 1:1250 µl of antibody, Dot 3= 1:2500 µl of antibody, Dot 4= 
1:5000 µl of antibody, Dot 5= 1:7500 µl of antibody, Dot 6= 1:10,000 µl of 
antibody.  
50 ng of PRM membrane bound b5 was added to each dot and decreasing 
concentrations of antibody were added to ensure the antibody had a high 
specificity for cytochrome b5. Strong signals were picked up from all 
concentrations of antibody used, but in particular from the highest three 
concentrations, so a working concentration of 1:2500 was used going forwards in 
the project. Once it was ascertained that the b5 could be easily detected using 
the antibody, a Western was completed using a range of b5 amounts (Figure 
4.25).  
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Figure 4.25: Western blot of membrane bound PRM b5. Lane 1= 100 ng b5 
loaded, Lane 2= 50 ng b5 loaded, Lane 3= 40 ng b5 loaded, Lane 4= 25 ng b5 
loaded, Lane 5= 10 ng b5 loaded, Lane 6= 5 ng b5 loaded, 
The Western showed a clear decrease in band density when the concentration 
of b5 was lowered. The Western is sensitive for low concentrations of b5 with 5 ng 
of protein being detected by the antibodies. This was essential for reliability of the 
Western results after expressing b5 in the baculovirus system. The splitting of the 
b5 into two bands on the Western was unexpected and could be due to the 
sensitivity of b5 to the temperature variability. It could also represent an 
unidentified protein which may have been co-purified in the mosquito prep, which 
cross-reacts with the Anti-rabbit b5 antibody (Sacco and Trepanier, 2010).  
4.4.5 Generation of Baculovirus Expression System for Cytochrome b5 and 
the Glutathione S-transferase from Dermanyssus gallinae 
The success of the expression of b5 in bacteria allowed the possibility of 
expressing the gene in a baculovirus expression system. Expressing proteins in 
a baculovirus system allows for functional assays to be carried out which allow 
the function of the b5 gene to be monitored in terms of pesticide metabolism. 
Insect expression systems require the production of a recombinant baculovirus, 
which is time consuming, for use in Sf9 insect cells. The stages of the process 
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can be seen in Figure 4.26 and were carried out using adhering Sf9 cell culture 
grown in Serum Free media.  
As well as taking b5 through the process of the baculovirus expression system, a 
Glutathione S-transferase (GST) gene isolated from PRM was sent by a 
collaborator at the Moredun Institute, Kathryn Bartley. GSTs are known to 
facilitate the detoxification of drugs by catalysing the conjugation of reduced 
glutathione (GSH) to xenobiotic substrates, thereby playing a role in xenobiotic 
resistance (Bartley et al., 2015). Therefore, it was of interest to investigate the 
over expression of GST as well as the over expression of b5 on the toxicity of 
three common pesticides at varying concentrations. 
Figure 4.26 shows the first stage of creating the baculovirus expression system 
is to create a pFastBac recombinant bacmid, whereby the gene of interest is 
ligated into pFastBac before transforming into DH10 E. coli cells. pFastbac vector 
allows for the high level expression of the gene of interest in insect cells and 
contains a gentamycin resistance gene. This was first carried out with the b5 gene 
from PRM, followed by the PRM GST.  
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Figure 4.26: Overview of the work process of Bac-to-Bac Expression 
System. Flowchart documenting the stages taken to produce a recombinant 
baculovirus and using the baculovirus to express the gene of interest in Sf9 cells. 
Flowchart taken from manufacturer’s protocol.  
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Figure 4.27: BamHI and XhoI digest of pFastBac and b5. M= molecular 
markers for all gels. A; Lane 1= pFastBac digest with BamHI followed by XhoI, 
Lane 2= pFastBac digest with XhoI followed by BamHI. B; Lane 1 and 2= 
PRMb5pCRBlunt 
The first stage of the process was to miniprep and digest pFastBac and PRM 
cytochrome b5 with both BamHI and XhoI in order to cut the vector in one place 
to allow for the insertion of the b5 gene which can be viewed in Figure 4.27.  
Following this step, the 5.5 kb pFastBac band and ~600 bp b5 band were excised 
from the gel and ligated using T4 DNA ligase before being cloned into TOP10 
cells. These cells were grown overnight and checked for the presence of the b5 
gene using a restriction digest and PCR, with no success. This process was 
repeated, this time being digested with new EcoRI, in an attempt to negate any 
issues with ineffective enzymes (Figure 4.28).  
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Figure 4.28: EcoRI digest of pFastBac and b5. M= molecular markers. Lanes 
1 and 2= b5 digested with EcoRI, Lanes 3 and 4= pFastbac digest with EcoRI. 
Both the presumed b5 band and the pFastBac band were excised from the gel 
and ligated using T4 DNA ligase, before cloning into TOP10 Cells. These cells 
were grown overnight and checked for the presence of the b5 gene using a 
restriction digest and PCR, with no success. 
A third transformation of both pFastBac and PRM b5 was completed and the 
miniprep of this transformation was used for a digest with new stocks of BamHI 
and XhoI (Figure 4.29). This digest was successful and bands were once again 
excised from the gel, ligated and cloned into TOP10 cells.  
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Figure 4.29: Repeat BamHI and XhoI digest of pFastBac and b5. M= Molecular 
weight markers. Lanes 1 and 2= b5 digested with BamHI and XhoI, Lanes 3 and 
4= pFastBac digested with BamHI and XhoI.  
A BamHI digest was used to screen the colonies for the presence of the b5 
fragment in the pFastBac vector. The results of this can be seen in Figure 4.30, 
with two colonies showing bands at the approximate correct molecular weight for 
the b5 gene insert. The colonies were sent for sequencing which confirmed the 
full gene sequence for b5 was present in the pFastBac vector of two colonies 
(Figure 4.30, lanes 6 and 8) and could be transformed into DH10 cells. The 
colonies from the transformation were screened using the PCR conditions from 
the manufacturer’s protocol and colonies were found to be of the correct 
molecular weight according to the protocol (2300 bp plus fragment size; 2900 bp).  
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Figure 4.30: BamHI digest of pFastBacPRMb5 colonies. M= molecular weight 
markers. Lanes 1-4= colonies 1-4 from type 1 TOP10 Cells, Lanes 5-8= colonies 
1-4 from type 2 TOP10 cells.  
With the b5 successfully transformed into DH10 cells, the GST was next to be 
prepared. The first step was to design GST primers which would amplify the 
sequence and allow it to be ligated with pCRBlunt; Forward: 5’GCC ACC AGT 
TCG TGA TGG GC 3’ and reverse: 5’ GCC CAT CAC GAA CTG GTG GC 3’. 
Amplification with this set of primers produced a clear band at ~600 bp on the 
agarose gel, as seen in Figure 4.31, which allowed the excising of the GST 
fragment from the gel for ligation with pCRBlunt.  
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Figure 4.31: PCR amplification of GST. M= Molecular weight markers, Lane 1= 
Amplification of GST.  
The ligation was transformed into TOP10 cells and digested with EcoRI to check 
for the presence of the GST fragment. Colonies appearing to contain the correct 
size fragment were confirmed with sequencing using M13 primers. With 
sequencing confirming the correct GST sequence had been amplified and ligated 
with pCRBlunt, it was then digested with BamHI and KpnI before being gel 
extracted, along with pFastBac, and the fragments ligated together using T4 DNA 
ligase (Figure 4.32).  
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Figure 4.32: Agarose gel showing GST and pFastBac before gel extraction. 
M= molecular markers, Lanes 1 and 2= GST samples digested from the 
pCRBlunt vector using BamHI and KpnI. The band of ~600 bp was excised from 
the gel, Lanes 3 and 4= pFastBac vector digested with BamHI and KpnI.  
The ligation was transformed into TOP10 cells and checked via PCR using the 
GSP for GST and Q5 high fidelity polymerase, the results can be seen in Figure 
4.33 and show 24 of the 25 clones tested to have a fragment at the approximate 
correct size of the GST fragment. This was also checked using a restriction 
double digest with KpnI and BamHI with 9 of the positive PCR colonies (Figure 
4.34). 
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Figure 4.33: PCR of GST pFastBac construct using GST GSPs. M= molecular 
weight ladder. Lanes 1-25= clones 1-15.  
 
 
 
 
 
 
Figure 4.34: Restriction digest of GST pFastBac construct with KpnI and 
BamHI. M= Molecular weight ladder.  
Two colonies that contained the correct size band were sent for sequencing 
(Figure 4.34, lanes 7 and 9) and were confirmed to contain the GST sequence, 
allowing them to be transformed into DH10 cells. GST pFastBac DH10 colonies 
were checked using the same method as the b5 pFastBac DH10 colonies, using 
the PCR recommended by the manufacturer’s protocol (Figure 4.35).  
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Figure 4.35: Agarose gel showing PCR of transformed GSTpFastBac 
colonies. M= molecular markers, Lanes 1-10= colonies 1-10.  
Clones 1 and 10 were kept as successful transformations and used to proceed 
with the Sf9 cell based pesticide assay.  
4.4.6 Pesticide Toxicity Assay Using Baculovirus Expression System 
Sf9 insect cells were transfected with the recombinant baculoviral bacmids that 
had been produced in order to isolate and propagate recombinant baculoviral 
stocks to allow recombinant proteins expression. Cells were transfected with the 
baculovirus and the viral stock was amplified over time to give a high titre viral 
stock for both b5 and GST expression as described in section 4.3.8. A sample of 
this stock has been stored at both 4 °C and -80 °C for future research.  
The first aim was to ensure the cells were expressing the GST and b5 genes as 
expected. The b5 plate was assessed using a Western blot with b5 specific 
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antibodies, which was run with control cells which had not been exposed to the 
b5 baculovirus (Figure 4.36). The cells expressing GST were assessed using a 
GST assay, which is described in section 4.3.9, and was adapted from a 
recommended protocol (Bartley et al., 2015).   
 
 
 
 
 
Figure 4.36: Western blot of cells expressing b5. Lane 1= Control cells not 
exposed to baculovirus, Lane 2= cells transfected with b5 baculovirus. Loading 
control= Ponceau red.  
The Western blot (Figure 4.36) shows a strong band at approximately the 20 kD 
marker, which is consistent with the binding of the b5 specific antibody to the 
protein from the cells transformed with the b5 baculovirus. The faint band in the 
control well, from cells not transfected with the b5 baculovirus, could be 
representing the baseline expression of b5 in normally functioning cells.  
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Figure 4.37: Graph of GST assay results. GST assay was measured at 340 nm 
and the results were measured at 1 minute and 20 minutes for both the control 
plate (blue) and the cells expressing GST (orange). Standard deviation is shown 
for both results and n= 3.  
The ability of the GST to catalyse the conjugation of GSH to CDNB was assessed 
by measuring the absorbance at 340 nm at both an initial time point and after 20 
minutes (Figure 4.37)(Lee et al., 2002; Bartley et al., 2015). The results of the 
assay show a clear increase in absorbance in the samples transfected with the 
GST baculovirus versus control at both 1 minute (P = 0.0225) and 20 minutes  
(P = 0.0083) and indicates the increased metabolic functioning of those cells.  
Once protein expression had been confirmed, the pesticide assay was carried 
out using bendiocarb, permethrin and deltamethrin. These active ingredients of 
common pesticides were chosen to give results for a range of different types of 
pesticides. Bendiocarb is part of the carbamate family which inhibits AChE, the 
role of which is to terminate nerve impulses (David et al., 2013; Antonio-Nkondjio 
et al., 2016). Permethrin and deltamethrin are part of the pyrethroid family which 
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is a major class of neurotoxic insecticides. They are synthetic analogues of acids 
found in a flower, Chrysanthemum cinerafolis, and the alcohol moiety of the 
pyrethrins has natural variations which leads to different classes of pyrethroids. 
Chrysanthemic acid produces Type I pyrethroids and pyrethric acid produces 
Type II pyrethroids (Davies et al., 2007). Permethrin is a Type I pyrethroid which 
induce repetitive firing in nerve axons that results in incoordination, hyperactivity 
and finally, paralysis (Gross and Bloomquist, 2018). Type II pyrethroids, such as 
deltamethrin, cause a convulsive phase which is caused by irreversible nerve 
axon depolarisation. Type II pyrethroids are often more effective pesticides as 
their effects last several seconds compared to milliseconds in type I pyrethroids 
(Davies et al., 2007).  
The pesticides were added to the plate as described in section 4.3.9 and an MTT 
assay was carried out in order to determine the number of viable cells in the well 
post treatment. The MTT assay functions by active cells reducing MTT to a 
strongly pigmented formazan product. The absorbance of the formazan can be 
measured on a plate reader and hence provides a measure of cell viability. Three 
plates were set up and treated with the range of concentrations, as described in 
section 4.3.9; a b5 plate, a GST plate and a control plate.  
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Figure 4.38: Results of the pesticide toxicity testing. The graphs show the 
viability of cells exposed to the pesticides as a percentage. Standard deviations 
are shown for all results. N= 3 for all results. Viability has been corrected for the 
control from each plate (b5, GST and control) and the MTT control plate was not 
exposed to baculovirus. A= bendiocarb, B= permethrin and C= deltamethrin.  
The results of the toxicity testing can be viewed in Figure 4.38. Overall, the cells 
showed high viability levels after exposure to the pesticides for 48 hours. This 
could be due to the range of lower concentration levels used than other similar 
studies. Lower concentrations had to be used due to the difficulties with solubility 
of the pesticides in water. The actives are readily soluble in solvents, however 
levels of over 1 % solvents are not recommended to be used on Sf9 cells and 
hence 1 % was the maximum concentration able to be used (Boonsuepsakul et 
al., 2008; Duangkaew et al., 2011).  
Cells exposed to b5 baculovirus have been most effected by bendiocarb (Figure 
4.37, graph A), with an LD50 of 10 µM compared to 50 µM in permethrin and 
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more than 100 µM in deltamethrin. Carbamates work via a different pathway to 
the pyrethroids, with no role for P450s in their metabolism, which is demonstrated 
by their increased effect on PRM (Oduola et al., 2012). Permethrin (Figure 4.38, 
graph B) shows increased cell viability in b5 cells compared to the control plate 
for both 1 µM and 10 µM concentrations but deltamethrin (Figure 4.38, graph C) 
shows reduced cell viability in the b5 cells. Deltamethrin is a type II pyrethroid 
whereas permethrin is type I. The increased cell viability in cells b5 when exposed 
to permethrin could indicate the different pathways of detoxification and suggest 
b5 plays a greater role in the detoxification of type I pyrethroids and could 
potentially inhibit the P450 complex when exposed to a type II substrate.  
GST appears to have a positive affect at improving cell viability overall, with 
increasing survival rates from the control cells for both bendiocarb up to 50 µM 
and permethrin up to 50 µM and being equally effective at metabolising 
deltamethrin other than at the 100µM dose. These results show that greater 
research needs to be carried out in order to fully understand the role of GSTs, 
which preliminary data suggests, play a role in detoxifying pesticide.  
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4.5 Conclusions and Further Research Plan  
As well as further investigation into the role of GSTs, greater work needs to be 
carried out in order to understand the role of cytochrome b5. This project has 
developed a baculovirus system which allows for the monitoring of the effects of 
b5 on xenobiotic metabolism. Going forward, this system can be used with 
increased doses of pesticides as well as upregulation of P450s once identified, 
for more in depth study of specific pesticides. As well as the study of b5, once 
POR has been expressed and cloned into the baculovirus expression system it 
can be used in co-expression studies with cytochrome b5 to allow for a deeper 
understanding of the role of accessory proteins in detoxification. It has been 
previously suggested that the role of b5 in detoxification is dependent on the 
increased expression of P450s. The isolation of P450 complexes, made easier 
by this project, will be vital to assessing the role of b5 in the detoxification of 
pesticides. Once P450s complexes have been identified, their use in co-
expression studies with the GST baculovirus system could investigate multiple 
changes in expression as GSTs are expected to play a role in pesticide 
metabolism based on research in both PRM and similar species (Bartley et al., 
2015; Tchigossou et al., 2018; Saldivar et al., 2008) .  
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Chapter 5: Conclusions and Further Work 
5.1 Survey Data and Toxicity Testing 
The data generated in Chapter two of this study has been vast, with the first 
nationwide study of perceived resistance being carried out aimed at mapping 
acaricide resistance in PRM here in the UK or any European country. While the 
results are partly based on the perceived effectiveness of products by the egg-
producing community, it is clear that this data has some guidance value in 
determining which products are potentially most effective on the whole, thus 
allowing the industry to take a more informed decision in their efforts to control 
PRM infestations and additionally facilitate efforts to limit the spread of resistance. 
For example, on average across the entire country, Milben Ex scored highest out 
of products tested with more than three responses, with an average perceived 
effectiveness of 7.74/10. However, Milben Ex is from the pyrethroid class of 
pesticide, and resistance to this class has already been noted in this study. 
Toxicity testing shows that this is not enough to rely solely on the data from the 
survey. Resistance appears to be widespread across the UK with PRM tested 
from farms in close geographic proximity from one another having different 
mortality rates in PRM for the same product. This suggests individual farms need 
to be toxicity tested in order to fully determine the best practice to use on a per 
farm basis, and that a sweeping approach to mite control across the UK is not 
the best practice. It is likely that PRM have formed different genetic mutations 
that confer resistance and these appear different on an individual farm level.  
5.2 Analysis of Cytochrome P450s 
As well as resistance mapping, this project aimed to characterise the 
mechanisms responsible for inferring resistance and to investigate novel ways of 
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targeting such mechanisms. From the analysis of PRM transcriptome data, a 
database has been created of potential pesticide metabolising P450 sequences, 
the first of its kind in PRM. This database is a result of extensive gene comparison 
to known xenobiotic metabolising sequences from other species, which have 
resulted in 35 putative pesticide metabolising sequences in PRM. These 
sequences are of value to research into the resistance mechanisms within PRM 
and the future work in maintaining the efficacy of products already on the market.  
Using Activity Based Probes to identify the pathways of pesticide metabolism is 
essential for this preservation of efficacy. This project has attempted to adapt and 
develop a protocol for microsomal preparation containing active P450 proteins, 
similar to that used for several insect species (Ismail et al., 2013). Different 
microsome preps have been made in order to determine the most effective 
method of producing a microsome prep containing active P450s for PRM. 
However, only samples containing inactive P450 were found and further work 
needs to be done to modify the protocol in order for those P450s to remain active 
in the sample. 
Once this microsome preparation technique has been adapted such that active 
P450s are present in the sample, any peptides isolated using the ABPs can be 
compared to the sequence database generated and provide confirmation of gene 
function. There is then the ability to clone and isolate P450s in a targeted manner 
which function in the metabolism of specific acaricides. This production of a 
library of sequences with probable pesticide metabolising functions is novel in the 
PRM and allows a wealth of future work to be done which could allow greater 
understanding of pesticide metabolism in PRM.  
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5.3 Isolation of Cytochrome P450 Oxidoreductase 
The importance of understanding the role of accessory proteins in the function of 
metabolising enzymes is vital to developing control methods for the pest species 
PRM. 
The sequence that was isolated as potentially being PRM POR was found in two 
sections, the 3’ end and the 5’ end, and in order to find the full-length sequence, 
RACE (Rapid Amplification of cDNA Ends) ready cDNA was prepared using the 
GeneRacer Kit. PRM POR was expected to be around 2200 bp long in total, 
based on the length of the R. microplus POR sequence.  
PCR of the sequence using gene specific primers as well as the RACE primers 
was attempted to be optimised over many different PCRs. One PCR provided a 
band for the 5’ RACE product which was the correct presumed size for the PRM 
POR gene, but this band could not be reproduced in order to make a larger prep 
of the PCR for the band to be excised from the gel. Attempts were made to 
optimise this PCR over several months however the band could not be 
reproduced on the gel. As well as extensive optimisation, the original RNA 
extraction from PRM was repeated in order to remake RACE ready cDNA. This 
new cDNA preparation was also used for PCR and was repeated several times 
with several optimisation steps.  
Ultimately, POR was not amplified using the GeneRacer kit, and the band that 
was initially seen could never be reproduced. Similar issues occurred when 
scaling up PCRs in a project with R. microplus, that had originally produced a 
band using a smaller scale PCR, and may represent a difficultly when amplifying 
acari sequences.  
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There is great importance in isolating the POR gene in PRM as it allows for the 
production of a fully functioning cytochrome P450 model which could then be 
tested with both pesticides and synergists to enable to full picture of pesticide 
metabolism within PRM for the first time. 
5.4 Expression of Cytochrome b5 
It was essential to isolate the PRM b5 sequence using the transcriptomic data 
provided in order to characterise its function as part of the P450 complex. Using 
the cytochrome b5 sequence from R. microplus as bait, a highly similar sequence 
was identified from the PRM transcriptomic database (Graham et al., 2016). This 
sequence was isolated and ligated into a pET15b vector for expression.  
As well as the expression of cytochrome b5 from PRM, the same procedure was 
used to ligate cytochrome b5 from R. microplus and I. scapularis into pET15b 
expression vector. All three species could then be expressed and purified which 
has allowed for the storage of three novel purified cytochrome b5 proteins. This 
will be of future value to researchers of metabolic resistance mechanisms in 
either of the three pest species as this protein has been shown to have a 
modifying effect on P450 activity (Gruenke et al., 1995).  
PRM b5 was not only expressed and purified, but used to create a recombinant 
baculovirus which was used for pesticide studies in the Sf9 cell line. This research 
was the first to show Sf9 cells expressing PRM b5, with the expression confirmed 
using a Western blot with b5 specific antibodies.  
The effect of cytochrome b5 on the ability of the Sf9 cells metabolism of pesticides 
was tested, and it was determined that increasing the expression of cytochrome 
b5 alone did not increase the rate of metabolism of the pesticides. It is therefore 
suggested in the project that cytochrome b5 does not play a role in resistant in 
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PRM, or that the resistance is co-dependent on the increased expression of 
accessory protein POR or the increased expression of the P450 itself. This is 
different from other species, where cytochrome b5 has been found to directly 
affect the function of the P450 complex by either stimulation or inhibition of the 
complex (Finn et al., 2008; McLaughlin et al., 2010; Im and Waskell, 2011; 
Gruenke et al., 1995).  
As well as creating a recombinant baculovirus expression system for the PRM 
cytochrome b5 gene, the same system was created for a PRM GST gene which 
was provided by collaborators at the Moredun institute. Cells which had been 
transformed with the GST baculovirus had an increase in metabolic function when 
tested using a GST assay, however pesticide toxicity testing results were 
inconclusive and further work is required to full determine the effects of GST 
expression on pesticide metabolism.  
5.5 Future Recommendations  
From this project, it is known that all farms need to be tested for resistance levels 
on an individual farm basis. As current research into resistance mechanisms in 
PRM is lacking, current control method advice is of great use to the farming 
community, and the knowledge that each farm has entirely unique pesticide 
requirements is vital. This knowledge needs to be passed on to the farming 
community, by publications which make this data accessible.  
Further to this knowledge, the lack of detoxifying mechanism data in the PRM is 
evident. Methods undertaken in this project have been extensive and involved 
various steps of optimisation. Now this initial step has been taken, future work on 
establishing a functioning P450 complex assay is closer, and can answer some 
important questions into the role of P450 and its accessory proteins in resistance 
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in PRM. This is of great value to future control of PRM. If work could be continued 
on this project, an imperative step would be to optimise the isolation of POR in 
order to gain both accessory proteins for use with the P450 complex and the 
recent publishing of the draft genome assembly of PRM may aid future efforts to 
this end (Burgess et al., 2018). Development of the microsome preparation assay 
to include active P450s would allow for the use of Activity Based Probes which 
could isolate specific pesticide metabolising sequences in PRM. This would allow 
for a fully functioning P450 complex when combined with cytochrome b5 and 
POR, allowing for characterisation of pesticide metabolism in PRM for the first 
time, and would allow for best practice treatment recommendations for farmers.  
Data generated from knowledge of PRM detoxification mechanisms, including 
knowledge of the role of the accessory proteins, would also be of great value to 
pesticide development, which could be developed in order to bypass the 
mechanism causing resistance and therefore allow treatments to be effective in 
control of PRM, reducing costs for farmers and improving farming productivity.  
This data will allow future links between D. gallinae genetics and 
resistance/susceptibility to be established which could facilitate the development 
of rapid testing kits for resistance and the real-time tailoring of treatment 
programmes to ensure maximum efficacy. All of the work contributed in this 
project has provided new knowledge of an important, but under researched pest, 
which will be of use to the farming community whilst establishing methods and 
resources for continuation of this research in the future.   
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Appendices 
A. Terrific broth 
250 g modified Terrific Broth and 43 ml glycerol (both Sigma-Aldrich, Gillingham, 
UK) was dissolved in 5 L of distilled water and autoclaved.  
B. SDS-PAGE 
Running Buffer: 
0.2 M Tris  
0.2 M Glycine  
10 % SDS  
 
2x Sample Buffer: 
100 mM Tris  
4 % SDS  
20 % Glycerol  
Bromophenol blue  
 
Coomassie Blue Stain:  
45 % Methanol  
45 % H2O  
10 % Glacial Acetic Acid  
Coomassie blue 252  
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Destain: 
45 % Methanol  
45 % H2O  
10 % Glacial Acetic Acid  
 
Components of SDS-PAGE gel (15 %): 
Separating Gel Stacking Gel 
40 % acrylamide 3.75 ml 40 % acrylamide 1 ml 
1.5 M Tris-HCL pH 8.8 2.5 ml 0.6 M Tris-HCL pH 6.8 2.5 ml 
Distilled water 3.75 ml Distilled water 6.5 ml 
10 % APS 100 µl 10 % APS 200 µl 
TEMED 6 µl TEMED 20 µl 
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C. Survey 
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D. PRM trap instructions 
Mite Trap Usage 
Ensure the black corrugated plastic sheet is in the slot inside the blue trap. 
Find areas inside the unit to attach the traps. Best areas are places where mites 
have been observed before (mainly in dark cracks/crevices near the birds).  
Use the cable ties through the holes in the blue traps to secure the traps to the 
housing. 
Leave the traps in place for 7-14 days. 
Cut the ties and remove the traps from the sheds. Quickly place traps into the 
plastic tub provided (ensure corrugated card is still inside trap). 
Place tub inside plastic bag and then post back in envelope provided.  
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E. Product usage instructions 
Milben Ex (Schopf): 100 ml to 5 litre water (sufficient for up to 150 m²) at normal 
infestation. 
Interkokask (Hysolv): Ready to use.  
Ficam (Bayer): 15g of powder in 5 L of water.  
Perbio Choc (Digrain): Ready to use.  
CBM8 (Hysolv): 200 ml in 10 L of water.  
Fendona (BASF): 5 ml in 1 L of water.  
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F. Ethical approval 
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G. Conference contributions and workshops 
05.03.2015  AgriFood Charities Partnership (AFCP) student forum Poster          
‘Identification of Pyrethroid Metabolising P450s in Poultry Red Mite using 
Bioinformatics’ 
Joanne Atkinson, David George, Olivier Sparagano, Robert Finn 
 
20.05.2015 Northumbria Research Conference Poster 
‘Identification of Pyrethroid Metabolising P450s in Poultry Red Mite using 
Bioinformatics’ 
Joanne Atkinson, David George, Olivier Sparagano, Robert Finn 
 
24.06.2015 Experimental Poultry Centre Poultry Red Mite Workshop   
 
05.04.2016 WPSA Conference Chester Oral presentation and Poster 
(poster prize awarded)  
‘A preliminary assessment of the current state of resistance/susceptibility to the 
active compounds used in Acaricides for Poultry Red Mite, Dermanyssus 
gallinae, in the UK’ 
Joanne Atkinson, David George, Olivier Sparagano, Robert Finn 
 
27.04.2016 Coremi COST action meeting  Invited Speaker 
‘A preliminary assessment of the current state of resistance to active compounds 
used in Acaricides for Poultry Red Mite, Dermanyssus gallinae, in the UK’ 
Joanne Atkinson, David George, Olivier Sparagano, Robert Finn 
 
01.08.2016 International conference of parasitology Poster 
‘A preliminary assessment of the current state of resistance/susceptibility to the 
active compounds used in Acaricides for Poultry Red Mite, Dermanyssus 
gallinae, in the United Kingdom’ 
Joanne Atkinson, David George, Olivier Sparagano, Robert Finn 
 
08.09.2016 STVM-AITVM joint conference Berlin  Poster  
‘A comparison between the cytochrome b5 gene in Dermanyssus gallinae, 
Rhipicephalus microplus and Ixodes scapularis and their host species – potential 
for a new acaricide target’ 
217 
 
Joanne Atkinson, Kirsty Graham, David George, Olivier Sparagano, Robert Finn 
 
05.04.2017 AFCP student forum  Oral presentation and Poster  
‘A preliminary assessment of the current state of resistance/susceptibility to the 
Acaricides used for Poultry Red Mite, Dermanyssus gallinae, in the UK’ 
Joanne Atkinson, David George, Olivier Sparagano, Robert Finn 
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H. PRM transcriptomic data (127 sequences)  
 
>isotig29458|cytochrome P450, putative [Ixodes scapularis] 
cttgcacggggtccaatggaggaatagtcgaaatgtggtgattcagtgtttcgacgaatctcgcctgatagaagtcctgccggttgtagc
cgaagtgtcacggacatttaccgagatggttatggactatgcacgactcgcacgagatgcaaacgtttcatctctagctgacaggttctc
gcttgaggtgctggctcgcactgcgctggccatcgaagccgactgtctccgaagcaaaaccaccatcgaggagtacgcactcggac
gaccctgcaatctgctgagtctactacgtcatgttccttttattcgacacttacggggtgtgctgaactattttacacaatacggtcgcgcaa
cagccgatgtcgttacgcatgttcgttcagtggtcgagctccgccatgagggcgagctcccaccaaaggaggacctcttgcagtttctc
ctcgacgccgtcgaaaagccaaaagaccaatgtttggttgtcgccaatgcgctgcagttcctcagcgcatttcaggcgatcggctctcg
cctcacatttctcgtacacg 
 
>G9NSEKQ01BEANL|cytochrome 
ggcatctctggtccgaaacctgacctgctgttcggcaatatctatcatcttaagcaggaccgagtggaggtgatgtcaaagtgggttag
gcagtacggcaaacatttcggctactacgttggtgggactcccgtgatcgtttgcactgacgttgatacgctacggcagatcttcgtcaa
ggaatcggccaactttcccgatcggccagtagctgcggttggcgggagccatttgacagctcgattatctttctgaagggagacacttg
gaaaagcgtccgtaacgcacttacgccctcgttcagcgccgttaagactgcgtctcatgacgggcatcatgcaggactgcgtgactac
cttcgtcgacctgatcgt 
 
>G9NSEKQ01BJ0HY|cytochrome 
ttatcgacttcagcgaccgcccagaccttttaacaggaggaaaaatctggcgaatttgattcaatgctcactgtgctcaaaggtcagcg
gtggaaggatgttcgctcgacgctgacgccttcttttaccgcccgaaaactcaaacagattgcgccggaggtttcgaaaacgatcgac
gagtttatggagaatatcgacacggcttttgcgtcgggcggccacgccttggacatttatgagctgttccaggctctcacacttgagacta
tctgtcgttcggcaatgggagtcgactttgccattcagaagaatataccgaactc 
 
>G9NSEKQ01BPDX3|cytochrome 
aagtgcaggcgaaaatccaggaggaaatcgatgctgtgtttcagggcgacaccgaagcagaggtgactgccgaatgcgtcaaac
agatgaagtatttggaaatggcgcttaaggaaacccagcgtttgctgccatccgttccggtgatttcacgcaccgtgacggaggagttc
aagcttgatggaaagccagtacctgtaggcaccgaactaacctgccatataatcgttctgcatagagacccag 
 
>G9NSEKQ01DEXZM|cytochrome 
atctcggatttggaaagacgccgattatggaacagtgtttgcaggaagagcttcgggacctcatcgcgcagatcgagacagagcaa
ggccggccgtttaacgttcaggatcttcttgttgcctcgacgtcaaacaacatcgcatcgctcgtgtttggcgaacgactatcgtacgatc
atccgaagcggcaggagctgaacagtcttctgacggcgttcaataacgagaccaggatatttatcgctatagcgttcattcctaagctg
aagattctttacaaactaaacattggaattggagcgaagctaacgaacgtgattagaaggttccggaaactagtggagaatgatgt 
 
>G9NSEKQ01EMW20|cytochrome 
atctcggatttggaaagacgccgattatggaacagtgtttgcaggaagagcttcgggacctcatcgcgcagatcgagacagagcaa
ggccggccgtttaacgttcaggatcttcttgttgcctcgacgtcaaacaacatcgcatcgctcgtgtttggcgaacgactatcgtacgatc
atccgaagcggcaggagctgaacagtcttctgacggcgttcaataacgagaccaggatatttatcgctatagcgttcattcctaagctg
aagattctttacaaactaaacattggaattggagcgaagctaacgaacgtgattagaaggttcc 
 
>G9NSEKQ02F7YHC|cytochrome 
attccagtgtttatgtctagccggtctgcccacccaccacctcgcgattgatttcaccgtgttgtcgctttgcaattgcatacgggcggccat
ttcagagccgcagagtcagagcgatgatggaattcgccatagcccttcttctagtcgtgatatcagtgatcgtcctctggcttgttcggcg
acgttttgtcgagcgcacgatactctcgcgacacggcgtctctggtccgaaacctgacctgctgttcggcaatatctatcatcttaagcag
gactgagtggaggtgatgtcaaagtgggttaggcagtacggcaaacnttttggctactacgttggtgggactcccgtgatcgtttgcact
gacgttgatacgctacgtcagatcttcgtcaaggatcggccaactttcccgatcggccagtagctgcggttggcgggga 
 
 
>G9NSEKQ02FKZUD|cytochrome 
aatcacgatccggacatctggggtgaagatgctgaccgctttaatgcgaaacggttcctaacggcgacaaaggagcagcttagccgt
ggaaccacgacgttcggtatcggtgctcgatcgtgtccgggagaaaagatggcgcttgcggacttcacctatgtgttgacacgattcct
gcagcgagttcgactttcctgtcctggaggccccgcaacggccaatttcagctcaaccaatggcgacatttcccttgaccccgttcaac
aagacgtcgtgattcaccaactgtagaacttttgttacgctattcgtcgctcgtgtatcttacgcccgtattcaggcttcaggctttgccagtg
cactttttgttgtttgtctctgtctttttaataagtaattcaaatacatatatctttgtatgtatta 
 
>G9NSEKQ02GJC6Q|cytochrome 
aacggagcccgtttgcattcgtgccgttttcgggcggaccacgcaactgtatcggtcaacggtttgctcttctcgaggagaagattaccc
tctgccatcttctcgccaggtacaactggcgttcgatgaatcctcgagacgagatgcagcacgaatcggcaattgtcttacggccgaa
aattaaattagaatgcaatttcgactgagaaccggcaaatacaccagaagcggtctaaaacgagccgcaaaaaatcgtagcaaac
ncatatctag 
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>G9NSEKQ02HU0WL|cytochrome 
tcgtttggcaccgggccgcggtcgtgcccaggcgagaaaatggcgcaggccggcattctctacgtgatcgtgcgtgtgttacagcga
gtgcgactaagctgtcccaacggccctgggactgctgatttggagagcatcgactctggcatattgctcgacgtacggcgacaggatc
ttatctttgaactgttatgatgctcgttactacaaaatacgttaatgtggtcgagaaacatgacttagtgactaagtcaaaaaggtgcatat
cggtcctcccattagtatcgaaaaaagctacgctttgaagctagcacgtaactttactccactatgtataattgtacaaaaacactgagtg
tatatctatacaataaaattccaaaagaacgg 
 
>G9NSEKQ02IHTVF|cytochrome 
gatgcacgacgttatcactggcgacagcttcttgatattgtctttgccatataatggagttagcttgtctcgaagccggtgccagtcgtctcc
acgtaggcaggaaacggaatttggtacgcccggcacgttgaagatcgccgatctgctggaaaacttgtcggactcatctttgaacacc
ttacgaagaacagccggatcggagacgagtaaaaccggatctttgccgtaaaacaaacccacaacagggccaaattttcgatgcc
aatcgttgacagcccaaagtgcgtttttcaagtagatttcatgaagactaccgaagagaaggtttggctttgggccgggaatgccgagg
cgttggaagaaacgaaagtg 
 
>G9NSEKQ02IIAQI|cytochrome 
tgtctcgcatgcgttgcactccttctcggacagtggctgcggcgtcggagagagcactttcgtttcttccaacgcctcggcattcccggcc
caaagccaaaccttctcttcggtagtcttcatgaaatctacttgaaaaacgcactttgggctgtcaacgattggcatcgaaaatttggccc
tgttgtgggtttgttttacggcaaagatccggttttactcgtctccgatccggctgttcttcgtaaggtgttcaaagatgagtccgacaagtttt
gcagcagatcggcgatcttcaacgtgccgggcgtaccaaattccg 
 
>G9NSEKQ02JCQAS|cytochrome 
tcccacgtggatccgacgtcgtaatagccctattcggattgcatcgcgaccctgacgtttttcctcgacccgatgaatttctaccggagcg
tttctttaccgagtcagccaaacggagcccgtttgcattcgtgccgttttcgggcggaccacgcaactgtatcggtcaacggtttgctcttct
cgaggagaagattaccctctgccatcttctcgccaggtacaactggcgttcgatgaatcctcgagacgagatgcagcacgaatcggc
aattgtcttacggccgaaaattaaaattagaatgcaatttcgactgagaaccggcaaacacaccagaagcggt 
 
>G9NSEKQ02JFPMM|cytochrome 
ctgaggaaaagtatcgcatactgttggaacttaaagcaatggatcggttcattctggagaccctcaggatgaatccatcagtgcccgtg
cttgtggctcgcactgcaagttactcatttgaacacgagggagtccggtatccaaaaggactggttgtccaagcgcccgtatttcaactt
caccacgaccctaaattacactcgaatcctgacgagtttgatcctgacaggttcttggacaggataccaacgatgggttttctgg 
 
>G9NSEKQ02JXVSF|cytochrome 
tttcttgacgccgttttctgcgagacgttgcggttcttcccgccaaaacctcacttcgtaaccagagagtgtccacgcaactacacgttga
atggcttcttcttccctgccggatgctcggttctcgtacccgtctttcatgtacatcgtgacccacagttgtgggtggcacccgacgagttct
gcccagaacgctttacgaatagcgaatcgttgtcgaccatgcaaccattgcgacatccggcacaatacttgccgtttggattagggcc
gcggtcatgtatcggttcgaggttcgtcgccctagtggtaaaactagccgtcgtgcatttactgcgcgaaatgcgctttcggcccggcgt
cggcttccagtcg 
 
>isotig03764|cytochrome 
tctgaccagtacagtgggctgcggttcgcgaggtaagtggggaacaacaggctcaaaccagcttcaagcttcaggccctcgagttcc
gttgtggttgttacccttcgagtggtaaatatgccgactggtggaaacaatcggagcgcctcatgcgtacagtagtcgaggtacttgttgg
tcatgaccttcgtgtagaccctatctgtatccgcatttcgagtgccctcgtctccgagcatcgtgacgatttcgtgccgcagccgctcctgta
tctcgggatgcttcgccaagcagtagagaacgcatgccagccccgtactcgtcgtctcgtagccggcaacgaacataatcaccgaat
tgcctatcacctggtcttcggacagcgttatcctcctcttaccattgtcggtgactaaacatgcatcatcgccttcacccgaagccattagc
gaccggtcgcatccttcttccacgttggcgtcgagaaacgtttgtaataagtcgtttctcttcgccccaccgtccttacgccgggctctcac
aatcttcttcacctcaatggcaaagtttgtgctaacatgagacaagaggttgaaccgaaacatcagcgctataaggctactcaagctgt
tgttaataaacgtgaaactgttcgccaacaggtcggtcgttcggcctagagcggagtcaatcaactgaagagcggcactgagaagc
ggtcccgttgccgatgggtcggcctgcgagtttacgttgatgccgaacgccactcggccaatgttgtccagcgttagccgcttgagcagt
gggtagacatcgaactcgttcgaaccctgctttcgaagattctcctcaaactgctcgataccctcgacgatgagcggcaccatcgcctt
catgcgtgccgtggagaacgagggcgtaatggcgctgcgcagattcttccagcgtgcgtccgtctcgtgcacgagcatcgtcctgacc
atggggtgcgcttgctcgagcgcaaacagcggcgcgcgattgacaaagtttgaaaactccttgatgagcactttctgctgaaggtcga
ggttcgtcgagacgagcaacggtctgtcgccccagaacacgccgaatgtgtcgccgaactcgttcgaccacttctcgagccagaag
gcgtgattgtctcgcaactgcgtgtagtgaccccacagaaagtgcggccgaggcccggggatgccgcgtttctcaaagaagcgaaa
ttgctcccatcgtcggcggacaacctcgaacaggctgatgaccgcgatcacgaccagcagacccgtcgccagcatgttggcgccgg
caact 
 
>isotig06153|cytochrome 
atgggcattttctcgacggtctgaacgggaaatgccagcccgaaagctgttcgacctacggagtccattgctagccgttttaagggctc
ggtgatttcgaactcctgaccgtctgcactggcggattttatcactgagaggaatgtgcgaacgctttcttcagatatgtcgattgccttcttg
agtttatttgccgtgaacgtagaagtaaactgtgtccgaatggcctttatttcggcgggttctcgtagaatgtgcaactgttttccagccgtc
ggatgaggtgtatccaggttaaactgaaacgcacgattgtagaaattgtgggcgtccttgaagatgactttgtgtagcagctctttgtccg
ttgtcacgatgactggttggacaccgtagaagtaaccgaaggtgttcccgtagcgccgagaccagtcgtcgaacgccttcgtgaagc
ccattgtggtaaactgtataaggtttcccgtcaacagtgagggcgcaggccccggtaggccaagccggcgaaacaggccaaagtgt
gctcgacgacgtatcgcgaggacggccgtgagcagagcagctagcagaaggagaacgatcggacccatgacgctcacagttag
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caacggcagaacggccggagacagtctcagccaatcagcaccaacggtcggagaacgcgcgaaccagcgcagagttgcaatct
agtactgaataaggtagtaagtataaggtagccggcaacggacgcgatgctcatagcatccgcgttgcaactgagacgaatccacc
agcgtcc 
 
>isotig06154|cytochrome 
atgggcattttctcgacggtctgaacgggaaatgccagcccgaaagctgttcgacctacggagtccattgctagccgttttaagggctc
ggtgatttcgaactcctgaccgtctgcactggcggattttatcactgagaggaatgtgcgaacgctttcttcagatatgtcgattgccttcttg
agtttatttgccgtgaacgtagaagtaaactgtgtccgaatggcctttatttcggcgggttctcgtagaatgtgcaactgttttccagccgtc
ggatgaggtgtatccaggttaaactgaaacgcacgattgtagaaattgtgggcgtccttgaagatgactttgtgtagcagctctttgtccg
ttgtcacgatgactggttggacaccgtagaagtaaccgaaggtgttcccgtagcgccgagaccagtcgtcgaacgccttcgtgaagc
ccattgtggtaaactgtataaggtttcccgtcaacagtgagggcgcaggccccggtaggccaagccggcgaaacaggccaaagtgt
gctcgacg 
 
>isotig07728|cytochrome 
actattcaaatactttctaagcacagcttacgaagcacacagtaacagtggcaacagcagagttgtcgtgtttatcttgtccgcgtttttcgt
cgctcgagcgtgcagtagtgctcggtcatcagacagatgacgttgccgatttattagcagaggcttcaaggcgatcatcaacggaaa
gtgtggacgacgccgctaaacaaacaatttcattgccgctagtaactaaccagttgccggcgccaacatgctggctacgggtctgctg
gtcgtgatcgcggtcatcatcctgctcgaggttatccgccggcgatgggagcaatttcgctacttcgagaagcgcggcattcccgggcc
tcggccgcaccttctgtggggtcactacacgcagctgcgagacaatcacgccttctggctggagaagtggtcgaacgagttcggcga
cacgttcggcgtgttctggggcgacagaccgctgctcgtctcgacaaacctcgatcttcagcagaaggtgctcatcaaagagttttcga
actttgccagtcgggcgccgctgttcgcgctcgaacaggcgcaccccatggtccggacgatgctcgtgcacgagacggacgcacgc
tggaagaacctgcgcagcgccattaccccgtcgttctccacggcacgcatgaaggcgatggtgccgctcatcgtcgagggtatcgag
cagtttgagaagaatcttcgaaagcagggttcgaacgagttcgacgtctacccactgctcaagcggctaatgctggacaacattggcc
gagtggcgttcggcatcaacgtaaactcgcaggccgacccatcggcaacgggaccgcttctcagtgccgctcttcagtcgatcgact
gcgctctaggccaaacgaccgacctgttggcgaacagcttcacgtatatcggtaacagcttgagtagctttatagcgctgatgtttcggtt
caatctaatttctcatgccagcacaaaccttgcctttgaagcggagaagatcgtaaaggcccggcgtaaggacgacggggcgaaaa
gaaacgacctactgcagacatttatcgacgcaaacgtggaagaaggatgcgaccggtcgctgatggcttcgggtgaaggcgatgat
gcatgtttagttactggcaatggcaagaagaaaataacgctgtccgaagaccaggtggtaagcaattcggtgcttatgttcgccgctgg
ctacgagacgaccagtacagggctggcatccgttctctactgcttagcgaagcatcccgagatacaggagcggctgcggcacgaa
atcgtcgcgatgctcggagacagggcactcgagatgcggacaccgacagggtctacacgaaagtcatgaccaacaagtacctcg
actattgtacgcatgaggcgcttcgactgtttccgccggtcggcatatttacctctcgacaggtaataaccacaacggaaatcgaaggt
gtgaagcttgaggctgggttgagcctgctgtttcccacctatctcgcgaaccgcagcccactgtactggtcaga 
 
>isotig07729|cytochrome 
actattcaaatactttctaagcacagcttacgaagcacacagtaacagtggcaacagcagagttgtcgtgtttatcttgtccgcgtttttcgt
cgctcgagcgtgcagtagtgctcggtcatcagacagatgacgttgccgatttattagcagaggcttcaaggcgatcatcaacggaaa
gtgtggacgacgccgctaaacaaacaatttcattgccgctagtaactaaccagttgccggcgccaacatgctggctacgggtctgctg
gtcgtgatcgcggtcatcatcctgctcgaggttatccgccggcgatgggagcaatttcgctacttcgagaagcgcggcattcccgggcc
tcggccgcaccttctgtggggtcactacacgcagctgcgagacaatcacgccttctggctggagaagtggtcgaacgagttcggcga
cacgttcggcgtgttctggggcgacagaccgctgctcgtctcgacaaacctcgatcttcagcagaaggtgctcatcaaagagttttcga
actttgccagtcgggcgccgctgttcgcgctcgaacaggcgcaccccatggtccggacgatgctcgtgcacgagacggacgcacgc
tggaagaacctgcgcagcgccattaccccgtcgttctccacggcacgcatgaaggcgatggtgccgctcatcgtcgagggtatcgag
cagtttgagaagaatcttcgaaagcagggttcgaacgagttcgacgtctacccactgctcaagcggctaatgctggacaacattggcc
gagtggcgttcggcatcaacgtaaactcgcaggccgacccatcggcaacgggaccgcttctcagtgccgctcttcagtcgatcgact
gcgctctaggccaaacgaccgacctgttggcgaacagcttcacgtatatcggtaacagcttgagtagctttatagcgctgatgtttcggtt
caatctaatttctcatgccagcacaaaccttgcctttgaagcggagaagatcgtaaaggcccggcgtaaggacgacggggcgaaaa
gaaacgacctactgcagacatttatcgacgcaaacgtggaagaaggatgcgaccggtcgctgatggcttcgggtgaaggcgatgat
gcatgtttagttactggcaatggcaagaagaaaataacgctgtccgaagaccaggtggtaagcaattcggtgcttatgttcgccgctgg
ctacgagacgaccagtacagggctggcatgcgttctctactgcttagcgaagcatcccgagatacaggagcggctgcggcacgaa
atcgtcgcgatgctcggagacgagggcactcgagatgctgacaccgacagggtctacacgaaggttatgaccaacaagtacctcg
actactgtacgcatgaggcgcttcgactgtttccaccggtcggcatatttaccactcgaaaggtaacgaccacgaccgaactcgaagg
tgtgaagcttgaggctggtttgagcctgctcttcccgacctatctcgcgaaccgcagcccactgtactggtcaga 
 
>isotig07730|cytochrome 
ctcaagcggctaacgctggacagtattggccgagtggcgttcggtatcgatgcaaacacgcaggccgacgcatcggcaacgggac
cgcttctcaatgctgcccttcagtttatcgactgcactctaggccaaacgaccgacctgttggcgaacagcttcacgtatatcggcaaca
aattgagtagcttcataacgctcatgtttcggttcaacctcatttctcatgccggcacaaaccttgcctccgaggccgagaagatcgtaa
aggcccggcgtaatgatgatggggcaaagagaaacgacctactgcagacatttatcgacgcaaacgtggaagaaggatgcgacc
ggtcgctgatggcttcgggtgaaggcgatgatgcatgtttagttactggcaatggcaagaagaaaataacgctgtccgaagaccagg
tggtaagcaattcggtgcttatgttcgccgctggctacgagacgaccagtacagggctggcatccgttctctactgcttagcgaagcatc
ccgagatacaggagcggctgcggcacgaaatcgtcgcgatgctcggagacagggcactcgagatgcggacaccgacagggtct
acacgaaagtcatgaccaacaagtacctcgactattgtacgcatgaggcgcttcgactgtttccgccggtcggcatatttacctctcgac
aggtaataaccacaacggaaatcgaaggtgtgaagcttgaggctgggttgagcctgctgtttcccacctatctcgcgaaccgcagcc
cactgtactggtcaga 
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>isotig07731|cytochrome 
ctcaagcggctaacgctggacagtattggccgagtggcgttcggtatcgatgcaaacacgcaggccgacgcatcggcaacgggac
cgcttctcaatgctgcccttcagtttatcgactgcactctaggccaaacgaccgacctgttggcgaacagcttcacgtatatcggcaaca
aattgagtagcttcataacgctcatgtttcggttcaacctcatttctcatgccggcacaaaccttgcctccgaggccgagaagatcgtaa
aggcccggcgtaatgatgatggggcaaagagaaacgacctactgcagacatttatcgacgcaaacgtggaagaaggatgcgacc
ggtcgctgatggcttcgggtgaaggcgatgatgcatgtttagttactggcaatggcaagaagaaaataacgctgtccgaagaccagg
tggtaagcaattcggtgcttatgttcgccgctggctacgagacgaccagtacagggctggcatgcgttctctactgcttagcgaagcatc
ccgagatacaggagcggctgcggcacgaaatcgtcgcgatgctcggagacgagggcactcgagatgctgacaccgacagggtct
acacgaaggttatgaccaacaagtacctcgactactgtacgcatgaggcgcttcgactgtttccaccggtcggcatatttaccactcga
aaggtaacgaccacgaccgaactcgaaggtgtgaagcttgaggctggtttgagcctgctcttcccgacctatctcgcgaaccgcagc
ccactgtactggtcaga 
 
>isotig13771|cytochrome 
gaattccttgccagctagcgcgatgtcgacagcttacctgttagcggctttagccgtcctattcttcgtgtgggtgcagcgtcgccgccag
catttccgtcatttcgagaagcgcggtatcaaagggccgaaacccaacctgttttttggtaacgcgttcgatatctattgccgatcggcga
cggtgtgctaccgcgagtggcagaagcggtacggcgatgtgttcggctacttcaacggcgtcattcccttgctggtggtctgcgacaag
gacatcctcaagcaggtccagatcaaggacttcaagtcgtttacggatcgcggcctggctaatgggccgtctccacggggaaaggc
gctcacgcagcttaacggcctggagtggaagcacacaaggtcaacgctgacgccgtcgttcacgatcagccgactgaaatcggtca
ccgaaagcatgtcgccgatcatcgacgagcttatggaacgcttcgacaagaccgcgactgccggccagtcgttcgacatataccgc
ctctttcaggcgctcacgacggacgtcatctgccgcaccgctatgggcatcaactatggagcgctgaacgagccagatcatccaatc
gtacccgaaaaacatcgacttcgagattctgcagaaacttccctatatggaggcggtaattaaagaggcccttcagaatgtatacgcc
cgtagtgcagcttaccaggacaggctaatgaggatatcgagttatcaacggtgagttcattagctagataattgttgtcgaaagcctgg
gcacgcagtgacataatttattataatcggcgtt 
 
>isotig21871|cytochrome 
ggctcgaggtgggcgctcagaagcacgccgaacacgcgtccagccttctgctgggacttcacgaggtttccgttggtgagatgcagg
gtgccctggatctgttggtaaacacgttcgaccttatcggtgtcactcttcgttggctagttgggtttctcctaaagcatcgcctgctcgattc
gatctaccacacgcttgggaatgaaattacagcaattattagagcacgacgagctggtcagcgaaataacgacgttcttcagcgcttc
attgacgcggtcgacgacgaaaacgacaacaacagcaacaacaacagcaacagcaacaacaacagccaagaagtctatacg
cagaccacacctgccgaccgggctcaaaggttacacatgaacaatggcgaattgctctgtaacagcgttggcatgtgccttgtcggttt
tgaaacaacgtccttcacgttatgctacttgttacacaccattggacaatacgtcgacgttcaagagaagttacgtgatgaaattcgcac
cacgtttgacgacaagtgtccggatgacaatgacgatggtgatgatgtcggtacgcactactacaaggtaatgcgcatgaagtacctc
gacgccgtgattaacgagacactccgactgtatcctactgcaacggggtttaccacacgaagtgccagttcaacgttcaactgcggcg
ttgttacgtttccagctggcaccagtgttctgttcgcaccctccattattcatcgagatcctcgcggttggaccgatcccctatcctatcgacc
cgagcgctttctggatccgtcgcttcggcgggaagcacaagggcttgcatttcagccttttggaggcggtcctcgaaattgtattggcatg
agattggccctcttgagtctcaaggtcgccctcatcagggttctagcgcgtcttcgaattcgctcatatggcgagattcaacgaatatcta
aagctgtgctaagtaccgaacaagagatttatatttctgtcgagccactaccaagtacggaacaaatagcccaacagctcggttaata
aatataaaggcgtactttcaaaactcacgccgggctcgactaa 
 
>isotig22816|cytochrome 
acaagcattcactatttttatttaaaaacatacaatgcgtagtgcatcatttaaattatatttactaagtactactactactagtatttcaacatg
tcccgacccatcaaggaagtggtcgcccatatagtgacttcggcggaggcatggagggaggcgacgaacttgttcgacgccgttttg
acactcaagacagccaattaaacggccagggttttgagcgggtctctcgggagagtggtcgagacgaggagccgagggaggggg
gaggcagagaagcctctcccacggcttcgaagtaatgccgggtttagtgggtttgcgagggtcacactagtcacgcaggccgctagt
ggcgcatgtgcatcatgcattcccaaaacctcccagaacaaaaaaaacgattacacgattgggaaagccgattagatacatttcgcc
cgaaccggcactccgcctttgggagtcagtatcacggtcggtacagtgaactccggacgcgttttaaaaccgtcgcctggttccagcc
gtaccttccgtaggagctcaacgacggccattttgatttctagagtggcgaatctcacgccgatacaggttctcgggcctagcccgaat
ggcagatactgtgccggatgaatggggcgttcggcgttggccgaaaaccgttccggccgaaattcgtccggctgatcccacagttcg
gcgtcatggtgaagctggtacaccggtgccatgacgtgcgagcccgccggaaacgtacgtccgttaatcgtacaggtccgcaaaca
ggcgcgcgtcacaaacaacacgaccggcggatagatccgcaaacactcgttgatcacctggtcgagatacttgagcgcgtgcagct
cttcgtagttgagcgtttcgtcggccgccatcttgtccggaaactcgcgacgcgcctcctcgacgatcctgtcctgcacgtccggtcgtttg
gcgagcgtgtgcgcaacgaacgacagcgccgtggcgc 
 
>isotig23075|cytochrome 
tctattcgagtagacgcttttgacaaggaagatgagtagatctatctagtttctcaacttagcttttccagatgttctattgctgcaacaaata
gacttcatagtcgcctattttcaatacctatgacaaaaatataaccaccattcgtattattgagaactttattcatacatagtttttaatctcaa
cttggatatcttaactttttgaagcacacaaaaccacgttagataacgcacaatctactaacgtgggtcagcgctgagtaaattcgtccc
accgattagtgccaaggttacgactagttaataagataggaactccacacggcaacaacgagagcctagctagtaattttggtaacgt
tgacgagaagcggatccttgatgttctgcatcaagagtgagtctacggtgtctatttcggccacacctagagtgtcgtactgtccgcccg
ataagcgatattttgtcagcagcttagccatggtcgtcttaatcaccaactgcgcgaatcgcatcccaatgcagttccgcggacctgctc
cgaatggctgccaggcgaacatcatgtcggccgtgcgattttcgggcagaaatctttccgggcggaattcctccgggtggggaaagat
tatgggatccttttgcactgcgcaggcacatgcgcccacgttcattcccacgggtattgtgagcccatcgtagtgcttactcttgttcgcca
cgcgaattgtaaggctaaacactggcggatagagccgcaagctctcctgaatgaccgcctcgaggtattgacaccgttgaagccgct
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caaaatcgaagtgcacgcctccgtcggtcacttctaagagttccccacgaaggcgctcctgtacttcgggaaaacggaccagaagg
cgagtcatgaaggccaacgacgatgatgttgtctcatagcctgcaagaagaatgaggaacgcattttgagaaacttc 
 
>isotig23857|cytochrome 
ctgatggtatatatgtatttgctctacgacgtctcttgacaactcgataagctaactgccgtcattgatttgcaaagcattcaaatcatcgcct
tccggcgctatctattagtgttctggaaggaggacttttgcaaatacagcaccttttatttctgtctctgtcggcaacctaggtgctcggcttgt
ttttactgctgctgctgcagcagacagtcagtcagtcttctctgtgtgacaccgcatctctgaaaatctttcctttctcagtcttagtttatgtatg
ttgataccgttgaagtattggataaccaatgtgtaaataaaatgtaaagacatgtgtacaagtctgtttataacgcgtggagagagaga
gagaaatatcgcaactatatttggctagcggcgcagctcgggtactctctcatccaacgcaattataagcggtttctttggcaaaggaa
gaaatggcattccttcggcccagtcgagctgatcaggggtttccgtgcagcggcccaggtgtagccgcgtcagtatacagctgagag
cgacggtgatttggaggagagctaagcgtttgccgaggcaaccttttgggccatcgccgaatgccaagaatgcatcgattttagacgg
accgtcaaggaatcgctcgggtcgaaactcgtccggatctggaaagtagctggaatcgcgttggatgaccggtataggtatttgaacc
gctgtgccaggcttgagctggaccccggcaatcgagcacggctcgacacacactcgatcaatgacgaagtctgttggacagagtcg
aagagtctcgagaacgcacgcttcgacgtacttcaacctgttgtagtagtcgaagcggctagttgttgttgttgttccctccgattggga 
 
>isotig24478|cytochrome 
gtgtgcgttaaatccgctgatttattgtaacacaatatcgtttttgcaaaaatcagatgtttgatcatatttatactgcaatatatctaatttccg
gtgataacaggtcgtcgccttgttttgaaacaacgtctggacgatggaatacaacgtggaaacgctgccccgttcggggcacacttgg
cttggctaatccatcgtgatacgtgtaacatgtacataatgtattatacggaaaataaattatatactatatatctcattgtaacacaaaata
aatacagcagtgctgattgaatgaaaataagtacagcagtgctgattgtaatgagctgttctgttggttatttcagcacagtttagacaaa
gctctacaaggtgctgtatgcgcacgctgggcggctgagcgagacgtctagtctgatgagtatgatgggccgatgttgaagagaggc
cgcgcagaggcgaccataggccgccccggttacaaaactttgcgaaatgtaccccctctacggaagaggccaaggcggttatcact
tggacatatgagaacctgttcaaagaggcgacgcccgacaacggagtccgttcttgagcttgagcaggcccgggtgtgccactaact
cgaccctcgactgcggaaggtattcaaacgtgtctatgcggtagttcaagacaagccgtgacaatgtcatacgtatcacctgaaaggc
aaactcgcgaccaagacagtttcgcgggcccaacccgaaaggcagccaaatgtcgtccaaatgctccgttgtgtcgctcatgaatct
gtccggatcaaacctttggggctcaggccaaatatcttcattataatg 
 
>isotig25796|cytochrome 
gaacgtgatcaccaacgtttatgctgtcaaccgcgatgaggaaatttggggccccgacgcaaggaagttcaatcccgaacggttcct
cacagcttcgaaggaacagatctctcaaggcttcacctcgttcggcattgggtccaggtcatgccctggagagaagatggctcagtcc
aacatcctattcatcctcgtgagggttctacagaaggtgcgccttggctgtcccaaaggaccgggtacagccagctttgccccagttga
ctcgaatatccagatcgacctgcagcgacagaatctgctgtttacgaaaatagaggcctaagccggccttgaaaacaagcacgttag
aacaagcctcgagatagtagcggatgctgtcgttcgggcaagggagaagatttgcgatggaaatacagggctttgtcagctgcgttca
gtttaggttgctatttatcgttttgaatttcgtctgaaaactacataaaaccacaccaaatacgcatctggcttgataaacacgcccaaagc
caacaaacgtcttcgtcactcgaagggctacgtggtttcgcgcgcttacctttcctttgaaatatctttaatatcaaaatatcttaatacgaat
acttccatctaccataaaggcgacctgacagtcagtgccgtaaagacataaccacatctagaacaggaactatgtagtatatttgtattt
tacacgacatcgtcaatgtatgaattgccactagaa 
 
>isotig30646|cytochrome 
Tttaaccatcacccgctggatcagctcgaggtcgcttgtgacaagaaacggcttgtcgccccaaaatactccaaaagttggtccaaa
ccgtgcgcaccattcgttcagcgtttctaaatgtaccttgcgaagaaggtgatagtggccccaaagtagatgaggacgtgggtaggga
atgcctagcttctcgaagtaacggaatgcattccagcggcgcctgaagaactcgatcacaagtgccagcagtacacatgttaacgaa
gcgaaaagcagcattttcttacactccgttcgtgaccgtcacgcacacgtttacccacacagcgcacacgcttactttgttactggtaatc
actttttgttttgttaattcgtcgctttgtcacatatacatatattcacaatagataaaaccagagaacaactccgcagaactactgtgcacg
ccgtccaaatagcaacagcagcaggcacgacaatgcgggttgccaaaaattagtgtcgtcgt 
 
>G9NSEKQ02F9NMO|cytochrome p450-like tbp protein 
aaaccacagccaagggaacgggcctggattgaacggcggggaaagaagaccctgttgagcttgactctagtctgactttgtgaaga
gacataggaggcgtagcataagtgggagactcgtcatcaatgaaataccactactcctattgtttctttacttacccaatgaagtaaatat
ggtctttccatgttttagacaaaagcatagttatttgtgtgatttatattgaggacatagtcaggtggggagtttgactggggcggtacatctg
tcaaaaaaaaataacgcaagtgtcctaaggccagctcagcgagaacagaaatctcgc 
 
>G9NSEKQ02GFV0T|cytochrome p450-like tbp protein 
aaaccacagccaagggaacgggcctggattgaacggcggggaaagaagaccctgttgagcttgactctagtctgactttgtgaaga
gacataggaggcgtagcataagtgggagactcgtcatcaatgaaataccactactcctattgtttctttacttacccaatgaagtaaatat
ggtctttccatgttttagacaaaagcatagttatttgtgtgatttatattgaggacatagtcaggtgggagtttgactggggcggtacatctgt
caaaaaaaatacgcaagtgtcctaaggccagctcagcgagaacagaaatctcgc 
 
>G9NSEKQ02IVX7L|cytochrome p450-4c3 
catccgtccatatgtcgatttgtgtgcgttgcttttaatacgtatgatgtttgcctcattctcagcgtcgatcaaggagcgtaaggcaaaaaa
gctcattgatcagaacagcggcgcgcctgatgtcaaaaagagactggccttctagatctactgcttgacgaacatctgaaaaatccgc
tattgcttcccgaggaggaccatacgagaagaagtggatacctttatgtttgagggccacgacacaaccgccatggctctgtcctgga
caatctt 
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>G9NSEKQ02IGZTS|cytochrome p450 partial 
ccaggacggcgttgacgtactacgtcgacatttgcactcgtccgcgcacgcacgtgctcaaagagctctcggagcactacacggatg
aggagcacaagagtaggctcaagctaatgtcatcgtccactcctgaaggcaaagccgagtactcgcattgggtacaagatgccgct
cgatctatcgtgcacattcccgaagatctgccctcatgcaagccgccgttggatctcatgctcgagtttatgccgcgtctacaacccagg
tactactccatttcgtcatcgtcgaaggttcatcccgaaaggtccacatcacggccgtcaagatcgaatacacgacttcgacgaatcgc
cg 
 
>G9NSEKQ01BZO8U|cytochrome p450 monooxygenase cyp72a5 
cgacccgcttgtgaagagcgtgggctcaatcattgacgctcgaaagagagcgacgttaaacgcggcgacatcatcgataacctcct
ctacaaaatatcctaggtcgacctatgactcggtcagaagtgattgccaacgcaacggtggcgtttttcgcgggttttgaaacgaccgc
gatcacgcttgctttgaccacatttcggctggcccaacatcccgagtggcaggagaagctccgagctgagatcaaagagttatgggat
gacaccgagccgtacgacagcttatgcagactgaagacgctcgatatgatcacttgcgagaccctaagactggatccgcctgcacc
agcgttcg 
 
>G9NSEKQ01C1IUK|cytochrome p450 monooxygenase cyp72a5 
cgacccgcttgtgaagagcgtgggctcaatcattgacgctcgaaagagagcgacgttaaacgcggcgacatcatcgataacctcct
ctacaaaatatcctaggtcgacctatgactcggtcagaagtgattgccaacgcaacggtggcgtttttcgcgggttttgaaacgaccgc
gatcacgcttgctttgaccacatttcggctggcccaacatcccgagtggcaggagaagctccgagctgagatcaaagagttatgggat
gacaccgagccgtacgacagcttatgcagactgaagacgctcgatatgatcacttgcgagaccctaagactggatccgcctgcacc
agcgttcg 
 
>G9NSEKQ01AN7Q9|cytochrome p450 mitochondrial-like 
catcaagcggggcctcttcttcatggacggccccgaatggcaggaacgtcggcgggccctggacaacatcttcctttggccgaagac
agtgtctgaccatgttggcgtattcaacgaggtcatcaccgacgtagttgataactggtcggcgacggccgccaaatcgaacggaca
gctgaccaacctcgaaagcgagctgtacaactggtcaatcgaatataagtgtgtcctcccgcaagcctaacaaagagcacgcttctg
tttcatcgttttcccgtctgcttcaagtgctgaacacaccaacactcaacgcatgcgcgcatgcacacacccattacg 
 
>G9NSEKQ01C02TX|cytochrome p450 mitochondrial-like 
catcaagcggggcctcttcttcatggacggccccgaatggcaggaacgtcggcgggccctggacaacatcttcctttggccgaagac
agtgtctgaccatgttggcgtattcaacgaggtcatcaccgacgtagttgataactggtcggcgacggccgccaaatcgaacggaca
gctgaccaacctcgaaagcgagctgtacaactggtcaatcgaatataagtgtgtcctcccgcaagcctaacaaagagcacgcttcn
gtttcatcgttttcccgtctgcttcaagtgctgaacacaccaacactcaacgcatgcgcgcatgcacacacccattacg 
 
>G9NSEKQ01D8ANI|cytochrome p450 mitochondrial-like 
caccgtaagggcggtttcggctatacgtcgtccaatacaggcacgtgcccccgagccgaacggcaacgaggtgtagtcgggtgaa
gttcctgcgtccagccaacgctcgggaaggaactcgttcgcgcgagtgaaataccgctcctgcacggacgctacctgattctgagtaa
atatcttagtccctgccggaacgtggtaaccgctcaatacgagatctcgtggagtaacccgaaatactcctggtaaaacaggtcgcag
ccgaagggtc 
 
>G9NSEKQ01DYOHU|cytochrome p450 mitochondrial-like 
agctgtccgttcgatttggccgccgttgccgaccagttatcaactacgtcggtgatgacctcgttgaatacgccaacatggtcagacact
gtcttcggccgaaggaagatgttgttcagggcccgccgacgttcctgccattcggggccgtccatgaagaagaggccccgcttgatgt
tctgctccttgttgtagatcgtccacgcctcgggcaccatgtgacgcggataccggccctcgttcgcgtacacctgctggatgagctcgg
aatcggcgacgaacagcgcctcgacgccctccagcgtctcccggtagacgggtccgagctgacggtgccgatagtcgcagtactc
atgggtntgcggcgagccgccgaacgtagaatactgagcgtcgtgccgataagcggcaacgcacgcggcgtcggaatctc 
 
>isotig11838|cytochrome p450 cyp2n 
cacacgctcccgaagtaaggatacgcctaaaagctctacttcgtttgcgctgagtatattgcagcccggtaaccagcgcgtgatttcgg
aggttgttgaacctgcgtcaagattccaaacgaacaattcgcaattcgaggcgttcaaggccaagcagcttaccctcttgaaatcggta
atcatctgtaagtcactaacgattgtggaggtgttgtctgccagtactccatcgtccaagtaccacatgttaagcgggctttcgagcgattt
gattagatcgttagctgccagacaaaacaaaggtggccctagggtctccttttgtatatctgtctcggactttattattgagtcagacgttac
aaggcgagatagacgtccgtatgagaactcgacataatggtgcatgtctacggtgaagttcttgactgtccttagcaaatagtctctcctt
accgtaacgaaggcatttaaaacatccagtcagctgtcgcaatagcaacaggtcggtcacgttttttgtgcgctctagtgttagtgtacta
tttgacaaaagtaactacaaggagaacccaaattgtgcacatgaggtcaatgaagtaaactgcttaagaagggcactgcgcgatac
aaggatggccggctttgacatcccgcgtggcacgatcgtcgtctacaacctacagagtgcccactatgacgagtcggtgtttgaaaac
cccgctgattttaggccgggcaggtttctcagtgcggaggggaaatttgtcgcctcaaatgacgttataccattcgctctcggaaagcgc
gcctgtccaggtgaagcgtttgccaggatggaaatctttctctacctcgcggctgtccttcagagcttccgaatcgaagcagtgaagggt
gaagaagtaaaacttacccgtgcgtcccagttcttatcggagcctattcagcagcccttgcaatttaggagccgacattaagataaactt
cataagctgtatcagctgttaaggttgtactggaacatacatttacgtaatatttatagcctctatggccgagtaagtgtcttaataggaca
gcagtgcaagaataaagctacacgaggcataaaccaca 
 
>isotig23426|cytochrome p450 cyp2n 
tcaccgcacggtttggcccgcgacggcatagcggcgtccgccccgtgtgtgacttgcttgacgtccctgcaccgttcacgacggcttgtt
cacgactgatgcggcggcgcagtggaatgagagaacatgtggacagttctacttgccctcgctgtgggctatctcgtctaccactacct
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gacgtggaagaagctactcggaggtgactgcagcgggccggcgcggccgaagcatccgccgagcttctacggactgccggtgctc
ggcagtttaccgttcttcgccattaagaagctccgcatccggctgctgcgcaagcttaccgaggatcccgcattcccggtcttcagaac
gcgattcttaggactcggagaggacgtgatcttcattaacggctgcaagcccgtacaggaggcgttgcgcaacaacgacctgctcgg
ccgcgaatggccggtcggctttcacgacgtcgccgaagagatcttcggcggggtgaagccgttctttcttctgcagggcgaggaatgg
cgagtgcagaagcgcttcctcatccacgcgctgaaagatctcggcggctatggcaagtcgacggtgctcgaacggatggtcctgga
ggaactcgagaagctgtccgatgagctggccaagacgaaaagtaagccggtgtacatcgacaaacttctgggccagtcaatgttta
acaacatcgcgtcgttcgttcgcggcaaccgcgtcgactacgacacgcacagcaagcgaaactaccccgacgtaatctgcggctca
ttccgctttgccgacaagatattggccgtgtgtgtgcctcgatgtgtattccagttcctcaagcagtttgacgtgttcggtataatggcgtacg
tgcgggttgccaacacgattaagagacgcttctttgccgagctcgaagagcacaagaaaacgtt 
 
>G9NSEKQ01A6PFM|cytochrome p450 4v2-like 
aacgttggcttccgagtcggtggtcctctcgactaaggtcgtgcagaacgccgacgcatgcttgttgatgatgacggcaaacttgtcga
gtatcttcaggtggaacgccggcgtcagcatcttacgtcgtcgcctccacttgcttcccgtactggtgagtagaccttgcttcagccacgg
cctgatcatctcgtacatgatgaacggcttggctatgttttcgctgtgcgtcatcaccgcctcgagctcgtcggccctgtagaccgcgacg
ttgggctcgagtccgctgtagaccgcac 
 
>G9NSEKQ01AQKK7|cytochrome p450 4v2-like 
ctgaatagtgaacgcttctggctgcttaaaatgctctttcagcaggaggtccatgaagggtttcttgcacaggaatacatcgccttcactc
atactgaggagctgtcgcaggcgctcgggttcggcttcgaaagattgacgccgctcctggataaccgactcggtaaacgagtgcgcc
cgggcgatcattcgatacatctcgcggccgctcggagtcagcgcat 
 
>G9NSEKQ01ARY86|cytochrome p450 4v2-like 
aggtggaacgccggcgtcagcatcttacgtcgtcgcctccacttgcttcccgtactggtgagtagaccttgcttcagccacggcctgatc
atctcgtacatgatgaacggcttggctatgttttcgctgtgcgtcatcaccgcctcgagctcgtcggccctgtagaccgcgacgttgggct
cgagtccgctgtagaccgcacagtgagcttgaaattgggtcgtcaggtcgatcagcgagtagaagagcgagctgaagaagctgcct
ccgccgaggccacgccgcagagctttgacggcgaccttgaccagtatccagctgtagagtggatcgtacggcccaccgaactgtcg
atatacttgtagtgcctgcggtgagctcgaacgatgcgcacagctacgcacaacacgaac 
 
>G9NSEKQ01B4Q34|cytochrome p450 4v2-like 
tctctggtctgtaggccaaaaccgccggtacattaaatatccacgcacggattaatgaaagttgagaaaactcatttgtgatgtccgtaa
tatagttgagcaccgcttcgccgacacgtggagtcgtccgcatatagatccatatgcccagctcagcaccgaacgggttccaccagct
tggtgcaattcctggcagtcgcattcggcgatcgatcgccagcctgcgcacgagatgggccaccagcagaagtaccaggccgacg
gttgtgatcttggcaatctgtgccgtcgcgtgtacaatgcctgtgcacactatcggagttagaacg 
 
>G9NSEKQ01D0UOJ|cytochrome p450 4v2-like 
tcgtgcccttcaaacataaggtgtcgacctcctctcgaatgtcctgaatagtgaacgcttctggctgcttaaaatgctctttcagcaggag
gtccatgaagggtttcttgcacaggaatacatcgccttcactcatactgaggagctgtcgcaggcgctcgggttcggcttcgaaagattg
acgccgctcctggataaccgactcggt 
 
>G9NSEKQ02FRVWZ|cytochrome p450 4v2-like 
catccgtccatatgtcgatttgtgtgcgttgccttttaatacgtatgatgttttgcctcattctcagcgtcatcaaggagcgtaaggcaaaaa
agctcattgatcagaacagcggcgcgcctgatgtcaaaaagagactggccttcctaggatctactgcttgacgaacatctgaaaaatc
cgctattgcttcccgaggaggacatacgagaagaagtggatacctttatgtttgagggccacgacacaaccgccatggctctgtcctg
gacaatcttcctgttgggtca 
 
 
>G9NSEKQ02FVIGH|cytochrome p450 4v2-like 
taacgttggcttccgagtcggtggtcctctcgactaaggtcgtgcagaacgccgacgcatgcttgttgatgatgacggcaaacttgtcga
gtatcttcaggtggaacgccggcgtcagcatcttacgtcgtcgcctccacttgcttcccgtactggtgagtagaccttgcttcagccacgg
cctgatcatctcgtacatgatgaacggcttggctatgttttcgctgtgcgtcatcaccgcctcgagctcgtcggccctgtagaccgcgacg
ttgggctcgagtccgctgtagaccgcacagtgagcttgaaattgggtcgtcaggtcgatcagcgagtagaagagcgagctgaagaa
gctgcctccgccgaggccacgccgcagagctttgacggcgaccttgaccagtatccagctgtagagtggatcgtacggcccaccga
actg 
 
>G9NSEKQ02H6UL6|cytochrome p450 4v2-like 
tcttgcacaggaatacatcgccttcactcatactgaggagctgtcgcaggcgctcgggttcggcttcgaaagattgacgccgctcctgg
ataaccgactcggtaaacgagtgcgcccgggcgatcattcgatacatctcgcggccgctcggagtcagcgcaataaaaccagtccg
gccattggtagggaatcatcgttcgaaacagtagcagctggcctattctcttgattgcgg 
 
>G9NSEKQ02ISTPJ|cytochrome p450 4v2-like 
aacctagccgtctacgataaagccaagacgacctcgtacctggccgcaatcaagagaataggccagctgctactgtttcgaacgat
gattccctaccaatggccggactggttttatgcgctgaccccgagtggccgcgagatgtatcgaatgatcgcccgggcgcactcgttta
ccgagtcggttatccaggagcggcgtcaatctttcgaagccgaacccgagcgcctgcgacagctcctcagtatgagtgaaggcgat
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gtattcctgtgcaagaaacccttcatggacctcctgctgaaagagcattttaagcagccagaagcgttcactattctggacattcgagag
gaggtcgacacctttatgtttgaagggcacgatacaacggcgatgg 
 
>G9NSEKQ02ITAES|cytochrome p450 4v2-like 
catccgtccatatgtcgatttgtgtgcgttgccttttaatacgtatgatgtttgcctcattctcagcgtcatcaaggagcgtaaggcaaaaaa
gctcattgatcagaacagcggcgcgcctgatgtcaaaaagagacctggccttcctaggatctactgcttgacgaacatctgaaaatcc
gctattgcttcccgaggaggacatacgagaagaagtggatacctttatggtttgagggccacgacacaaccgccatggctctgtcctg
gacaatcttcctgttgggtcatcaccctgaagtccagcgccgatg 
 
>G9NSEKQ02IZIF0|cytochrome p450 4v2-like 
ctttcgaagccgaacccgagcgcctgcgacagctcctcagtatgagtgaaggcgatgtattcctgtgcaagaaacccttcatggacct
cctgctgaaagagcattttaagcagccagaagcgttcactattcaggacattcgagaggaggtcgacacctttatgtttgaagggcac
gatacaacggcgatggcactctcgttcgccctattcctgctcggccaccatgacgacgtgca 
 
>isotig15261|cytochrome p450 4v2-like 
gagctgcttctcgtcctagaaggtgatgcagacagagacctgacagtgggaacgacgtgcgccagctgaagtatctcgaatgcgtgt
taagagtgtcttcgcctctatccctcggtgccaattgtgggccgccgcataactaaaaactaccagataaatggcaagaccgccccaa
agggcgccaatgtgtactgccctttttaccaattgcaccgcgaccccacttactttcccgatcctaagcggtttcagcctgagcgttttctgt
tggagaacgcagcgtgtcgtcacccagacgcgcacctgcc 
 
>isotig18160|cytochrome p450 4v2-like 
gagtccggttttgatcgacccgtgcgaccagccgttgctacacgctggtgagcgtagcgtagcaaatgaatcggctggcctagcgca
cactggagcatccgttccgaaactgtcgagtgtgcgatgatggaacagcgtaaccgacgtggagcacgcggcaagcaataagaac
aagcacaccaatacctgttacagcggctacgacaacagcaccggcagtaccggcaaaacaccctccttttctccttcttctgcttctgg
ctgtgagattcgtcgcaatcgcgcgggctttgcgatggacccggttctcgtggtggaggacgactggccgtcgccgcagctcacgccg
agactgcaaacggccctgctgacggg  
agcgctggtcgtggtcgtgccctggattggtgtcgttctgttcagaaaatggttcgatcgggattccactatcccgggaatggctccgtcct
ggtggagtccgctgggcgtcgagcagatcctgctcatgaactgggatcatcgcacacagagtctcaacgaagttgtgatgcagctcct
tgccgccgcgtcgcacatgtacgactacccgtgcggattgattcggggattcctgggatacgttccagcggtgatcgcattgaaagccc
aaagcgtggaggtgattctcggctcaagccgtctaatcgaaaaggctataccgtacaaattcctcgaagcgtggttaggccgaagca
ttctcacggacacgggtgccaagtggcgtgtccgtcggaagttgctcacgccggcgttccacttcaccattctcgagaactttatgccaa
tatttgaaatgcactcgcgaaagctggtcgaaaacctgaaaaagcagggagaccagaagccgatcgatattaccaaatttgtcgca
ctcgccgccctcgatatcatctgcgaaaccgccatgggagtgaagctcggagcacagtcgaacggtaacacaaaatacgttcaaac
tgtcggcgaggtcggcgacagcatcttgcgtcgggtgaccaagccttggttgtggcccgatttcatctactacctcacaccagaaggcc
gtcgcttcggtaaaaacgtagccgttttgcactcgttcacggaaaaggtgatcaaggagcgcaaagctgagctaattaagcagcgag
atcctgacaagcccgaggttgatgagccctacgacagcaccgatccagatctgcatcgaatccgaaagaagcgaccgttcctcgac
cttctgctcgaggagcacttgtacggcaaagatcgactgttcaccgtcggcgacgttcgggcagaggtcgacacgtttatgtttgaggg
ctacgatacgacctcgacgggattatcgtggacgttgtttttgctcgccgacaaccctgacgctcagcgcaagatccacgaggaacttg
atgagatcttcggtgacgatctggagcagccgattactcaggagcacctaggcagaatgaagtacctggaagcctgccttaaggaa
actctacgaatatatccaccagtaccactaatcatccggcgcatcagcgaagacgtgagccttggtgaccgtactattaaaaaaggg
acgaccgcattgatagatatttaccatttgcaccgcgaccctgaagtatatcccaagcctgaggtgttcatgcccgaaagattcttggcg
gaaaactccgcgggcagacacgcttttgcttatgttcccttctctgctggcccacggaactgtatcggccagagattcgccatgatggag
gaaaaagtcgttttggcgacgatcatgcgccacttctcatttcggccgaccataaagcgggatcagcttcgtgtcataaacgagcttattt
tgcgcgcaaaagacggacttccagtgtatgtgattccccgccgcaagtgaagagtatatttattgcagctttctttgacgacactcttctttg
caataaaagtaaaagtggca 
 
>isotig18435|cytochrome p450 4v2-like 
atggtaataaggtagcgttatttattagtgagacagttagcaatgccgacggctgtgctacacggctggttccactctaggagaccgga
gttgtacgcggtacaatcattgtttttagtccgttcttcgaatgcaggacgatgtcttgcacgagctcgaggtcttccttgcgctcgagcgac
accatgttgtggttcttcaggatctgtgtgatcacgaccttctcgaccatgcgcgcgtagcgctgaccgatgcacgaccgtgggccagc
actaaacggcacataggcgaacgcgttgcgacctgccgcgttttcgggcaggaatctgtcagggtcgaacttctccgggttggcgaa
gacttccgggtctcggtgaagcgagtagatgtggataaacacgtgtgtgcccttcggcacaggattgttgttaaacaccatatcctcatc
gagtacacgaccaattagcgccactggaggaagcactcggtgacactccttgatcacgatgtcgaggtactttaactccttcagcttttc
ggccgtaacaggtgcgtcacggtcgtccgcgaatacgcagtcgatctcctgctggattttttcctgcacgtcgggatagcagccgatga
ggaacatgcagaacatgagacctagggctgtggtgtcgtggcccgagaaagtgaatgtgtcgacttcctcctgaatgttgagcgtagt
catgctttggggatcctgcaggtgcagatccagcagaatgtcaagcagtgggcggcacttgtcgggtgtttcgggcatcttcttgcctttgt
tggcctcctgttccttcagcagtatctgtttgcgttcctcgatgatgttggcggtaaagccccagagcttcttgagaagctcgtcgtgtttacg
cgccttcggtagtaggcggaacgtcgacatgttccactcatgggggaatactcctcgggtgagaatgatcctcgagaagtccgacac
ggactgcaggtactcggctccgtcggcgcccagcagtgagtccatgggaacgccgagaatcgtcgacgaaatgaggtcgagcga
cagcttgttcacgtacggaacgatatctgcctgatctttcgtgcgcttcgagagcacgtcggcaaatcggagcgcctgctcgttgatgat
ctcgttgtagttgtcgaggtttcggtagtggaacacggggttgagctgccttcggcgagccttccacttggcgccgtccgaggtcagc  
aggccgcgtcgcagccacggaatgaaggtgttgtacagctcacccttgcgaatgttcgtgctgtggctgagaacctgctcgacgtggt
cggcgcgaaacacgaacacgagcggcgtgaagatgcggtgcagatggaacaggccgctgtcgcggtgcttggtcgacatctggc
agaggaagcggtgcatcatcgtgtcgagcgggtgcgtgaaggtcagctgccgcaggagatcgaggccaatcgaaagcgtgccgg
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agaacggaatgttgagcacatcgcgaggtccgggcagtgagctcagctgcttaaacagcaccttctgatggtagtaggcgtaggcg
aagaacaatgtggccaggctcgttaacgatgtgagtaaggccagatacgatgtcccgaatgacatcagcgaattgctgagcaataa
gctgcccaccgtcaacacgcccatggctgctggtgtctttgggggtgcgtgcgtgcgtgtggagggagggagggggggagcacgta
ttcgacgacgaacgaagaaacgtgtcgctcggaggccgctgttcttctgctgttgttcactgcgcgatcaaccgatcgccaccaatcgc
cgaactgatctc 
 
>isotig21249|cytochrome p450 4v2-like 
gaatgcaagagcacactagaagaagagaagccgctagcaactgacgggtcaacctcgtcgccgccgagcgtttctcgatctgctta
tctcggaataccgacgaactggaagtgccattgaccccgaggagattcgggaacaagtcgacacgttcatgtttgctggacatgaca
ctactgccatgggcattggctggtcactgtacctgattggacaccatcccgaagtacaggcgcgagtccacgaggaacttgacgcgg
tgatcggaccagatagcacgtggcccattacattggaggacattaaacaaatgaaatacctcgaagctgtcataaaggaggcgcag
cgcctgtacccatcggtaccctttatggggagatgcctcgatgatgacatcactgtcggtgaataccacattccccgaggcaccaacat
cttcgtttttgtcacggcgcttcatcgagacccgcgctactttcctgatcccctgcgtttcgacccgctgcgattttacggcttgccggatggc
gagtcagcggacaagttaggccctgcgctgttccaggcagacgaaaagacacctccaactgctaatgcccgacacccatttgcattt
gtgcctttctctgctggcccaaggaattgcattggccagcgctttgctatgtacgaggagaaggtcgtcctagctagtgtacttcgccggtt
cagcgttgaatctgtccggccattggacgagatcccagtccgcgcccttcacgatgatcaacttcagcgttgtaacttctgtgtctttctga
gttaattgctgctactactactgcagtgactattaccaatactattactattgtacagtgttatccttttatgtgactgcgcttgccagaattggt
gcagccataatatcaaatgtgtatacttttcgatcaaacagtgtgataaacgagctagcattatcggggggcaaagttaggacatgcctt
actgtttcattcatgcaggcatggttttcttggtgcaaaggcgcaaatattggacgctgccaacgagctacttgtgttaatcagcgttggttt
cgcggagatagtcatctgcatgtttgatggcaattgacgaggtgtgcaagaaggttcgttgccctccaatgtgataagcaaattaataa
ataacaacatcacagttggttgt 
 
>isotig29635|cytochrome p450 4v2-like 
tcccttggcttggtcgcggattgttgacgagctccggacaaaagtggaagactcgtcggcgtctgctgacaccggcatttcattttcgaat
ccttgagaagtttgcaccgatcatgaatcgggaggcaaaagtgtttgttgaaaggctggcgcacaaagatcctaacgaagacattgtg
ccttacatatccgccgttacgttggcgatagcctgcgaagcaatcatgggcgttaatctcggctgccaaacggttggcaccggccggc
ggtacctcgagtcgatcggcgctctcgaggagctcttctttgagcgtgtgcaatcaccgcttaattgggtggattggatctacaatatgac
gaaggccggccgggcgaatcgcaagtatctcagcgagttgcacgccttcacacttcaggtgatccgcgagcgcaaacaagagctc
caggccaaccccgaagaactcgagcgcatcgccggtgcagaagaaaatctctttaagtctaaaaaacttttccttgatattctgttgatc
gaacatctacaaa 
 
>isotig31063|cytochrome p450 4v2-like 
caaacataaaggtgtcgacttcttctctgatatcttgaattgtaaaaccttttggctgccgggaatgctctctcaacataagatccaaaaa
gggtttcttacactgaaatgcattatcctcggtcgttttgagaagctgttgcaggcactcaggttggtcttcgaaaaaatgcttccgctcctg
gataactgtttcggtaaaataatgcgcctgagcaataacccgatgtatctcgcggccactaggagttattttgtagagccactcaggcca
ttgatatggaagtaccgtccgatataataaaagctgacctattcttttgattgaagttaggtatgatctagtcttcgttttatcataggtagaca
gattgacgcccatcacagtttcacagatgacacttaacgttaggttctcgacgaacggtataacgttggttccaagtcggtcctcttggcg
agagtagagcagaacacacgcgcatgccgattgat 
 
>isotig34451|cytochrome p450 4v2-like 
gacaagctatgtttatgtttaattcacacaacttgagtataatatacttcataatgctttatcttctttgcgcttccggcgatagaagtagtgcc
acgatttttgatccaatgctgtgcattcctctgcatggtacttggtacatctcggcaggccgaaccggcaggtgcacaactcataacagc
gcatatgacgtccagcgtacacctggtaaccgccggaacaatgtcgaagtttgtgccgaccttcgcatcgagacagtgggcgaaca
cttctgcctgttcgttcatcaccggtagaaagtcctcgagaattcgaaagtggaacgccggggtcagcatcttcctgcggcaacgccatt
tactgccccagc 
 
>G9NSEKQ02HLDP6|cytochrome p450 4v2 
caaatggcgatcaagtcgaaactgttgacgtcctcgttccactttgagatacttaacgactttatcggtgtattcagcgaacaagccgaa
gtcatgaataccctcatccacaaaactgtcggccaggagatagatattatgaagctcgtcaagaacgccacactggacattatctgcg
agacggctatgggcttaaaggttgatgcccagaccaccgagtcggaatatcttcgtgcccaattaattgttagtgaaaagttcctggag
cgcgttctcagcccctggcagtggcccgcgctcatatatcc 
 
>G9NSEKQ02JCWD2|cytochrome p450 4v2 
caaatggcgatcaagtcgaaactgttgacgtcctcgttccactttgagatacttaacgactttatcggtgtattcagcgaacaagccgaa
gtcatgaataccctcatccacaaactgtcggccaggagatagatattatgaagctcgtcaagaacgccacactggacattatctgcga
gacggctatgggcttaaaggttgatgcccagaccaccgagtcggaatatcttcgtgcccaattaattgttagtgaaaagttcctggagc
gcgttctcagcccctggcagtggcccgcgctcatatatccaatg 
 
>G9NSEKQ01BSUN6|cytochrome p450 4c3-like 
cttttcactaacaattaattgggcacgaagatattccgattcggtggtctgggcatcgacctttaggcccatagccgtctcgcagataatgt
ccagtgtggcgttcttgatgagcttcataatatccatctcctgcccgacagttttgtggatgagggtattcatgacttcggcttgttcgctgaat
acaccgac 
 
>isotig12928|cytochrome p450 4c3-like 
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ctgttgatcgaacatctcaaacatgggactctgacagaacgtgacattcgtgaggaagtggacacgcttatgtttgaagggcatgaca
caacatcgatgggtatcacgtgggcagtataccttgtgggcctctatcccgatgttcagaaacgacttcacagcgagattgacgcggta
atgggtgcagacgagtgcctcgaagaagtgacagtggaacacattaagcaatgtcgatatcttgacatggttcttaaggaatcgcagc
gaatctacccgtcggttcccatgattgcgcgacgcgttaccgagccgctgacaattttagacaagccagttccaattggtagtgagctg
aacatcaatctgatcgggcttcatcgcgatccgtctgtgtttcctcggccagaagtcttcgatcctgatcgtttctcggccgagaacatacg
tgatcgcaatcaattcgcctttgtgccattttcggcgggacctcgcaactgtatcgggcagcggtttgcgttcatcgaggagaaaatcatt
ctcgtttggctgttgagacgcttttggcttcgttcactcgatcctcgcgatacgattaaaatggctgccgagatggtgctccgtcctagggta
ccaattcggatcgaatttactccccggcttggctaggtacagaagaccatctttacatgcgcgtatacatgcgtacttatccaaattgaat
acccacctttatctgtacatgcgtctaaatctttcgtcgtcatataaacaatgcaaaacaataaatggaccactaaaacggcaagctac
gtgggcctcataccttgctggtcacaaacagatcttgtctggtcacgacgccttcctttattttatcacgtatggctctcccaatttccgcctc
attttcatagacaagtgcgcagtccaggtggcggtaaccgatgtcgatggcacgacacactgccttatacccctcgtccgcgtttgactt
ccatgttcccaacccaattgcgggaatttcatttccgtctgagagtttaaattttggacacgaagccgccattctcgcagagtttccgtgtg
caaacagatccaaacgctgttctgtctacgttgaggttgcctgaaatgtagatcaacgaccaaacaatccacaacagcaagaactca
tat 
 
>isotig12504|cytochrome p450 3a9-like 
agtacatgttacgatagcatgcttttctgaggatgctaacgtttattaaacagggtgcatgccaaagagaactgccggaatcgatcatga
tcgggcctaaagcaagacagacatacacgtactcgatctgagcacacttgttccgtttatcggttgtctgagtgttgcggcgtttggaata
ctgcagtgtgacatttgcgatgatttttctcgagaaggaatgcctgtatggactactcacgaggtgtcagcgcgcacgtaaggggtttcc
ggaacatgtcgccaaaacgtaagccgactgctagttccagaggaactggtgttgaggaacagcgatctagacgaaactttagtagc
atattggcaaggagaacttgcatattcattatggctaaacgtttcccgatgcatccctttggtccatcgccaaaggccaggaatgctgtcg
tatcggatgtgacgtcaccgttcttcatgaagcgctgcgggatgaatttttccggctccggaaagtaagtggggtcttgctgcatccacgc
gatagggaactctactacggtgccttttttgatagaaattccggcgacttcagtgtcgtttgaagcaatacgatcgattgagtaaatcagc
ggcaccatccgtaacgatt 
 
>G9NSEKQ02H37HD|cytochrome p450 3a6-like 
cctcaagtacaatcccgaccgttttgccgagagacgcgcgcacccactggcgtatcagtcgttcggagacggaccccgaaactgtgt
cggaatgcgtatggcgatcatgtcaattaagcttacattgtgtcatattttgccgcgaataaggttcacgaccaaaggcgactccgtgtg
gaaatgtaagcatgtcctctatcagccggagaaggtcctcttacgcaccgagctaatttaagaagtatagctggtcacatgaacagctt
cagcagagacgagggcagacaaccagcttcgacaatcggcggcactgcacgacgaagacatcggcgaggcgctcattgacag
aataccgccgtgtggatag 
 
>isotig03761|cytochrome p450 3a6-like 
tacgattttgcgaacgtaaacaatattagcttatcaggaatacaatggctatccgtagcccgtagcgtagttaaagtacatacgtattaaa
tacacacttcaaagaaaggctgtggtagatattcaaagtttagccttcgcataacaaaacaaatattgaaaacgaaatacagtcaccg
cagtcttcttcaatccgttaggcagacgtatccgtagtcagtgcctatatgaacttgattcggtatcttagcttaagcgcgagccttgtggaa
actactcacgcgtcggtatgctgtcaatgagcgccttccccccgtcgtgcagcgccgccgattgtcgaagctggctacctgctcttttccc
ttctgaatctgtccatgacaccagctatacttacttaaattagctcggcacgtaaaatgaccttctccggttggtagaggatatgcttacattt
ccacacgggctcgcctttggtcgtgaaccttattcgaggcaaaatatgactcagtgtaagcttaattgacatgagcgccatacgcattcc
gacacagtttcggggtccatcgccgaacgtctgatacgccagtgggtgcgtgcgtctatcggcaaaacggtcgggattgtacttgagg
gggtctgaccagtacagtgggctgcggttcgcgagataggtggggaacagcaggctcaaaccagcctcaagcttcaggccctcga
gttccgttgtggttgttacccttcgagtggtaaatatgccgactggcggaaacatcgagcgcctcatgcgtacagtagtcgaggtacttgt
tggtcatgaccttcgtgtagaccctatctgtatccgcatttcgagtgccctcgtctccgagcatcgtgacgatttcgtgccgcagccgctcct
gtatctcgggatgcttcgccaagcagtagagaacgcatgccagccccgtactcgtcgtctcgtagccggcaacgaacataatcaccg
aattgcctatcacctggtcttcggacagcgttatcctcctcttaccattgtcggtgactaaacatgcatcatcgccttcacccgaagccatt
agcgaccggtcgcatccttcttccacgttggcgtcgagaaacgtttgtaataagtcgtttctcttcgccccaccgtccttacgccgggctct
cacaatcttcttcacctcaatggcaaagtttgtgctaacatgagacaagaggttgaaccgaaacatcagcgctat 
aaggctactcaagctgttgttaataaacgtgaaactgttcgccaacaggtcggtcgttcggcctagagcggagtcaatcaactgaaga
gcggcactgagaagcggtcccgttgccgatgggtcggcctgcgagtttacgttgatgccgaacgccactcggccaatgttgtccagcg
ttagccgcttgagcagtgggtagacatcgaactcgttcgaaccctgctttcgaagattctcctcaaactgctcgataccctcgacgatga
gcggcaccatcgccttcatgcgtgccgtggagaacgagggcgtaatggcgctgcgcagattcttccagcgtgcgtccgtctcgtgcac
gagcatcgtcctgaccatggggtgcgcttgctcgagcgcaaacagcggcgcgcgattgacaaagtttgaaaactccttgatgagcac
tttctgctgaaggtcgaggttcgtcgagacgagcaacggtctgtcgccccagaacacgccgaatgtgtcgccgaactcgttcgaccac
ttctcgagccagaaggcgtgattgtctcgcaactgcgtgtagtgaccccacagaaagtgcggccgaggcccggggatgccgcgtttc
tcaaagaagcgaaattgctcccatcgtcggcggacaacctcgaacaggctgatgaccgcgatcacgaccagcagacccgtcgcc
agcatgttggcgccggcaact 
 
>isotig03762|cytochrome p450 3a6-like 
tgtgggtttaaacaaattaaacagcaaagcactaacgtaaagttaaagtagataggtattgaagacacacttcaaaggaaggcggc
ggtggacattcaagacagcacccatatgaacttgactcggtaccttcgtttaagctcaaacattgtggaaactatctacacggcggtttct
gtcaatgagcgccttgccatggtcgtgcagtggcgccgattcgaaggtcgaagctggttgtctgctctcgtctcggcggaagctgtccat
gacaccagctatactcacttaaattagctcagcgcgtaaaaggaccttctccggttggtagaggatatgcttacttatccacacggggtc
gcctttggtcgtgaacctaattcgaggcaaaatatgactcagtgtaagcttaattgacatgagcgccatacgcattccgacacagtttcg
gggtccatcgccgaacgtctgatacgccagtgggtgcgtgcgtctatcggcaaaacggtcgggattgtacttgagggggtctgaccag
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tacagtgggctgcggttcgcgagataggtggggaacagcaggctcaaaccagcctcaagcttcaggccctcgagttccgttgtggttg
ttacccttcgagtggtaaatatgccgactggcggaaacatcgagcgcctcatgcgtacagtagtcgaggtacttgttggtcatgaccttc
gtgtagaccctatctgtatccgcatttcgagtgccctcgtctccgagcatcgtgacgatttcgtgccgcagccgctcctgtatctcgggatg
cttcgccaagcagtagagaacgcatgccagccccgtactcgtcgtctcgtagccggcaacgaacataatcaccgaattgcctatcac
ctggtcttcggacagcgttatcctcctcttaccattgtcggtgactaaacatgcatcatcgccttcacccgaagccattagcgaccggtcg
catccttcttccacgttggcgtcgagaaacgtttgtaataagtcgtttctcttcgccccaccgtccttacgccgggctctcacaatcttcttca
cctcaatggcaaagtttgtgctaacatgagacaagaggttgaaccgaaacatcagcgctataaggctactcaagctgttgttaataaa
cgtgaaactgttcgccaacaggtcggtcgttcggcctagagcggagtcaatcaactgaagagcggcactgagaagcggtcccgttg
ccgatgggtcggcctgcgagtttacgttgatgccgaacgccactcggccaatgttgtccagcgttagccgcttgagcagtgggtagac
atcgaactcgttcgaaccctgctttcgaagattctcctcaaactgctcgataccctcgacgatgagcggcaccatcgccttcatgcgtgc
cgtggagaacgagggcgtaatggcgctgcgcagattcttccagcgtgcgtccgtctcgtgcacgagcatcgtcctgaccatggggtg
cgcttgctcgagcgcaaacagcggcgcgcgattgacaaagtttgaaaactccttgatgagcactttctgctgaaggtcgaggttcgtcg
agacgagcaacggtctgtcgccccagaacacgccgaatgtgtcgccgaactcgttcgaccacttctcgagccagaaggcgtgattgt
ctcgcaactgcgtgtagtgaccccacagaaagtgcggccgaggcccggggatgccgcgtttctcaaagaagcgaaattgctcccat
cgtcggcggacaacctcgaacaggctgatgaccgcgatcacgaccagcagacccgtcgccagcatgttggcgccggcaact 
 
>isotig03765|cytochrome p450 3a6-like 
ttcgtgtgtttcgcttttaaaaatcgagctggctcaagtcatgtatcgattgcaagatagaaaccttgcatcggttgcagtttagttatataac
ataagatctcagatatgcggtgactcaccgttggcgtcgagaaacgtttgtaataagtcgtttctcttcgtcccaccgtccttacgccggg
ctctcacaatcttcttcacctcaatggcaaagtttgtgctggcatgagatatgaggttgaaccgaaacatcagcgctataaggctactca
agctgttgccgataaacatgaagctgttcgccaacaggtcggtcgtttggcctagagtgcagtcgacaagctgaagggcagcattaa
gaagcggtcccattgccgatgggtcggcctgcgagtttacgttgatgccgaacgccactcggccaatgttgtccagcgttagccgcttg
agcagtgggtagacatcgaactcgttcgagtgtgccgcgcttctcaaagtcgaaattgctcccatcgccggcggacaacctcgaaca
ggctgatgaccgcgatcacgaccagcagacccgtcgccagcatgttggcgccggcaactggttagttactagcggaaatgaaattgt
ttgtttagcggcgtcgtccacactttccgttggtgatcgccttgaagcctccgctaatacgtcggcaacgttatcctccgatggccgacca
ctactactacactgcacgctcgagcggcggaaagtcaattggcctcctgtgctcaagcaaacgcgaacacgacgatcaacacgac
aaccttgcggttgctactgttactgtgtgattctagctacataagctgtattagaaagtttttgaatactggcaaatactatgagcctgttcga
cttctaccgccggttacggcagccacaacaac 
 
>isotig03766|cytochrome p450 3a6-like 
ttcgtgtgtttcgcttttaaaaatcgagctggctcaagtcatgtatcgattgcaagatagaaaccttgcatcggttgcagtttagttatataac
ataagatctcagatatgcggtgactcaccgttggcgtcgagaaacgtttgtaataagtcgtttctcttcgtcccaccgtccttacgccggg
ctctcacaatcttcttcacctcaatggcaaagtttgtgctggcatgagatatgaggttgaaccgaaacatcagcgctataaggctactca
agctgttgccgataaacatgaagctgttcgccaacaggtcggtcgtttggcctagagtgcagtcgacaagctgaagggcagcattaa
gaagcggtcccattgccgatgggtcggcctgcgagtttacgttgatgccgaacgccactcggccaatgttgtccagcgttagccgcttg
agcagtgggtagacatcgaactcgttcgaaccctgctttcgaagattctcctcaaactgctcgataccctcgacgatgagcggcaccat
cgccttcatgcgtgccgtggagaacgagggcgtaatggcgctgcgcagattcttccagcgtgcgtccgtctcgtgcacgagcatcgtc
ctgaccatggggtgcgcttgctcgagcgcaaacagcggcgcgcgattgacaaagtttgaaaactccttgatgagcactttctgctgaa
ggtcgaggttcgtcgagacgagcaacggtctgtcgccccagaacacgccgaatgtgtcgccgaactcgttcgaccacttctcgagcc
agaaggcgtgattgtctcgcaactgcgtgtagtgaccccacagaaagtgcggccgaggcccggggatgccgcgtttctcaaagaag
cgaaattgctcccatcgtcggcggacaacctcgaacaggctgatgaccgcgatcacgaccagcagacccgtcgccagcatgttgg
cgccggcaact 
 
>G9NSEKQ01C888X|cytochrome p450 3a31-like 
tttttgagggcggcgatcggattcgaaccgctgttgtacatcctcagttgcagcttgtgcatggccatgccagcaattcgaccaagtatgg
agaacgatacgaaaggaattgccacaatcgtgaacttgatttgaaacatgacgcgcatctgcttgagaatcagtgagttcggtatattct
tctgaatggcaaagtcgactcccattgccgaacgacagatagtctcaagtgtgagagcctggaacagctcataaatgtccaaggcgt
ggccgccgacgcaaaagccgtgtcgatattctccataaactcgtcgatcgtttcgaaacctccggcgcaatctgtttgagttttcggg 
 
>G9NSEKQ01CMVYR|cytochrome p450 3a31-like 
ctgccatgctagcgtttggcgagggccccaagggctgcacgggacgccgcctcgcccatttacagctcactatcgcgctgtgttcgatc
ctgaaacgagcgcgcctcgttgcttccgaagccagcccacgcgtcgaggcagggaagttgccgttccgactagctgagggcgccct
gttcgttccgctgccaaaggacccattgtatattcgtctagagcctagaacctaactaaccttagacttagatttgtcagacacagcctat
accgacacccgtatatatatatatatgagtcttgcc 
 
>G9NSEKQ02J2W0U|cytochrome p450 3a31-like 
ctcgacgcgctgccacaacggcttcgcactgctttttgagggcggcgatcggattcgaaccgctgttgtacatcctcagttgcagcttgtg
catggccatgccagcaattcgaccaagtgtggagaacgatacgaaaggaattgccacaatcgtgaacttgatttgaaacatgacgc
gcatctgcttgagaatcagtgggttcggtatattcttctgaatggcaaagtcgagctcccattgccgaacgacagatagtctcaagtgtg
agagcctggaacagctcataaatgtccaaggcgtggccgcccgacgcaaaagccgtgtcgatattctccataaactcgtcgatcgttt
tcgaaacctccggcgcaatctgtttgagtttttcggcggtaaaagaaggcgtcagcgtcgagcgaacatccttcc 
 
>G9NSEKQ02F57XU|cytochrome p450 3a30-like 
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actgtggtcgtggcaattcgtcgtgatttgtcgtgtccgctacccagcaggtggctacgactgactagcgttgtagccgtgctgctggcca
ctaggcatgatgatatttgccgacgcagcaacgtcgatcctaacgtggacgcttgccgtcggtgccgtcattgcggcaggtctaacgta
tcgagcatgggtcgcatgttcatactggcgacgaaagggcataccccatgaaggatacctttcgtacctctacaccagcctggttcggt
tccgccacgaagacgtgtaccaggtgctggaagaactgcacagccgctacgggccggtctacaaacgtacagtggattccggcca
gtgttgcgagttacgacgctcgatggcgtcaaggacgcgctggtacgtagg 
 
>G9NSEKQ02GWOVH|cytochrome p450 3a30-like 
cggcaggtctaacgtatcgagcatgggtcgcatgttcatactggcgacgaaagggcataccccatgaaggatacctttcgtacctcta
caccagcctggttcggttccgccacgaagacgtgtaccaggtgctggaagaactgcacagccgctacgggccggtctacggaacgt
acagtggattccggccagtgttgcgagttacgacgctcgatggcgtcaaggacgcgctggtacgtaggttttccgtcaaccatgagcg
aacactgttcgtgccaacgggctcgcctctctgggacaacaacatcctcgcgctcgactaccatcgatggaagagcgttcggcccctg
tccggactggcgttcaccccatcgaggctcaaggcgatgaagtgcagaatcgaaagcatcgccgatcggctagccgcgcgaatgct
ggcctgcgcg 
 
>G9NSEKQ01AMRQ7|cytochrome p450 3a28-like 
agggtaagcctttgtccgagatcgaagaagcatagagtgcttccatcggccgaacgctctttgataaccttgaccagctcgagagccg
agttgttaatcagcgatgtcataaccttgagcttagcggcgctgaaccgctgggctaaatacggaacgcgttttcttccagcgatcgtag
gctaggcacagaagcgtgttagtaagagggtagctctgtacggcaaacggcggccgctcgctgaagntcgctgccttcttcacgaag
agat 
 
>G9NSEKQ02HCZIP|cytochrome p450 3a24-like 
agaacgatacgaaaggaattgccacaatcgtgaacttgatttgaaacatgacgcgcatctgcttgagaatcagtgagttcggtatattct
tctgaatggcaaagtcgactcccattgccgaacgacagatagtctcaagtgtgagagcctggaacagctcataaatgtccaaggcgt
ggccgcccgacgcaaaaagccgtgtcgatattctccataaactcgtcgatcgttttcgaaacctccggcgcaatctgtttgagttttcggg
cggtaaaagaaggcgtcagcgtcgagcgaacatccttccaccgctgacctttgagcacagtgagcattgaatcaaattcgccagattt
tctcctgttaaaaggtctgggcgtcgctgaagtcgataaaatcgcgaagtagtatattcttcagaacgtttctgtcggttactagtagaagt
ggt 
 
>isotig20277|cytochrome p450 3a24-like 
tcaaatgtcggagtgctcgatctggttgtaaatagcttccgtacgattggtgaaggcatgcggagtctgctgcggttttatttacctacaac
ctgataggacacaccagcaatgacctcctccttgagtgtcttcaaattgtcacacttcgaagacgctcaggccagcgtcgagttgatttg
ctgcaagctctgctggacgccaatgaagcgaccactgacgaaaactccttggctgccaccgacggggatgagaaggtggagagc
ctacgggacaacctcgccaaacgactgtctacatcgctcactgatgaagaggtgatcagcaatacgatcatcttctttttggccggctac
gagacgacaagtagcgctctcggctaccttctctacgtgctggccacgcactccgacgtgcaggagcggttgcggcgcacgacggc
cgaattcgaccaggacgatctctacacgtcggtgatgcgctgcaaatacctcgaccaggtcgtccacgaagccctgcggctctaccct
cctgtcacctcctttgtaacgaggtcagcgtcaaccagcttccaacatggatctcttacactccctgcgggcctgggcatctacgtgcctg
tgttccagctacatcgcaacccagatgtgtggcctgaccctctcgagttccggcccgagagatttgaacggcgcgactttcatccaatg
gcctaccaggcctttggagcgggtccccgaaattgtgtcgggatgaggtttgcccttctgacgatcaaactgctcgtctccgagattctgc
aatgctttcgcataacagctgagcaccccatgaagcccacatcgaagtatattgtctcgcagcccgacagagttgtcctaaagttcga
agcgctgcgttaattataatactatagcttaaccgacgtaccatatgggtcattaataaaacatggcatgttccactttgaggtatgcaagt
tatagagtccttggtacggaacctgtgcttctcaatcgcaaggttagaacgatgtagaactgccttgattctgagtctggtcagaaaacc
gacactgagaacggcccttatttagaagcgcctttgattccatattactgctcgccgcgcagtaaatgtacgcaataaacacttgatttca
aagcctattcaagtaatttcgcttgacgcctattttgatttcgttgtgggtttagataagatacatttatttatgctagccatcagaaagcaccc
ctttagtatacgatgttacttagtgtataaccgtgcaccatgtcttcgatataagacactaccttatactcgtctaaagagagat 
 
>G9NSEKQ01DNWU8|cytochrome p450 3a21-like 
gtttggatggcgaatcagcatgtttgtgatgaaacataacgcactcgacgtcgtctcgtaccctgtaagtatgttgagaatgccgctgtcg
acggcttcggtctcggaaacgggcgcgtcccctcgaagcattgcttcgagcagatccacagatgtctgccgctcagacgcacgtattt
gttgaacgcgctgtacgcaatcgccacgcagcttcccgattggggtgagccgcttctgaaagctgcccttcgaccaggttagcacaaa
ttcgtatagccgcttc 
 
>G9NSEKQ02G7EKB|cytochrome p450 3a21-like 
cacttgcatgttcattaaggcgagtcgccggcccacgcacgacttaggtccatctccaaacatgagaaatgccgccgtctcggagga
gatttcgccatcctttagaaatcgctccggaatgaacttttcaggttcgggaaagtagtccgggtttctgtgcataggtggcaaaggaattt
caaccatcattccttttttaaagggaacaccggccaccgtagtgtcccgtgtacagatgcggtccaccagcggaattatgggaacgag
acgtgtcgactccagcagactggcttctaaaagcttcattttctgcagtcatgatactggacgtcgctacggccatccatcacctggcgg 
 
>G9NSEKQ02GCXMA|cytochrome p450 3a21-like 
agatccggttttactcgtctccgatccggctgttcttcgtaaggtgttcaaagatgagtccgacaagttttgcagcagatcggcgatcttca
acgtgccgggcgtaccaaattccgcttcctgcctacgtggagacgactggcaccggcttcgagacaagctaactccattatatggcga
agacaatatcaagaagctgtcgccagtgataacgtcgtgcatcgacgacctggtggccaacgtgcgacgagaatgcagtgagggt
ggcagtgaacgcgagttcgacgtgtcgcgtctattcgaggctttctcgctggacg 
 
>G9NSEKQ02GMHEH|cytochrome p450 3a21-like 
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ctttataaagtcgttgtccggcttctcgatgcagtcgaggtcgattccgaaagcgagttgccaccattgagtccagtccgtatgcactgag
gtacttcttgagatcgagctggttctcgtcgccttttgcgatgtgttcaagcttggccacaagtcgtttggcgacgttatccagcttgggaatc
atcgagcgcatctttgacgatgtcatacagtagccccatcaccgtccgaacaagtttccactgctcgtacggtaggtgcgacaggctgtt
gtcccacag 
 
>G9NSEKQ02GO1J4|cytochrome p450 3a21-like 
cacaacagggccaaattttcgatgccaatcgttgacagcccaaagtgcgtttttcaagtagatttcatgaagactaccgaagagaagg
tttggctttgggccgggaatgccgaggcgttggaagaaacgaaagtgctctctccgacgccgcagccactgtccgagaaggagtgc
aacgcatgcgagacataatcgccgcaagagatcctcgaacattttgacgctgaaaccttgttcagtggacaaacgatgcgctgccaa
gcatgtcacgatatccttgcaattcgagcagtatcacagtagatcacacaggggcatacacatacgaaccgactgaggcgacggag
gcgctcgatcacgtcaagatatgactccaccag 
 
>G9NSEKQ02I4V33|cytochrome p450 3a21-like 
acaacagcctgtcgcacctaccgtacgagcagtggaaacttgttcggacggtgatgggctactgtatgacatcgtcaaagatgcgctc
gatgattcccaagctggataacgtcgccaaacgacttgtggccaagcttgaacacatcgcaaaaggcgacgagaaccagctcgat
ctcaagaagtacctcagtgcatacggactggactcaatggtggcaatcgctttcggaatcgacctcgactgcatcgagaagccggac
aacgactttataaagtacggttcaaatatcttcaagccgggcttcggtttgctaatgatg 
 
>isotig25683|cytochrome p450 3a21-like 
aggcctattgctactagtctagttcttccctctttggttgcttgacagtcgcctagaaaatataaattgtcaaaagtgaatagaatacttgtgt
gtatctacccgtgttgacagaatggaatggtcagcgtatctggcactaggagtggagtgatcggccccaaacatacccctccgaagc
gtttttaaagattcgcaggtttgggttaaggctttaaaaccattgatgaaaagaaaacgtatatacagctgcatctctgcttctcatgaagc
aaaaggagctcacttgcatgcggttgtttttaagtttgccgagggaccaagcgcacaactaggggctccttttcaaagttggtagtttgaa
ggccctttttcgcctgaagtgggtaaggtgtctctggcgcacgctcgaagcgtatcttcaataacatgttggccattgccgtcagcagatt
cataagagccaatcgccggccgacgcagaccttcggaccggctccgaaaatgagaaacgcactgatatcctgcccttcggcgacc
tcgccccccttgaggaaccgttcaggcatataacgttccggctctggaaagtacttcggatccctgtggattgcggcgaggggaaacg
caaccgtcattcccttgcgaattttaaaaccgtgcacttccgtatcggctgaacagatgcggtcaaagaaggttattaccggcgccaag
cgcagcgtctcgagaaggcacgcctcgaggtacttgagttta 
 
>G9NSEKQ02IHP0I|cytochrome p450 3a16-like 
cagcgccattacgacctcgttctccacggcacgcatgaaggcgatggtgccgctcatcgtcgagggtatcgagcagtttgaggagaa
tctccgaaagcagggttcgaacgagttcgatgtctacccactgctcaagcggctaacgctggacaacattgaccgcttctcagtgccg
ctcttcagttgattgactccgctctaggccgaacgaccgacctgttggcgaacagtttcacgcttattaacaacagcttgagtagccttat
agcgctgatgtttcggttcaacctcttgtctcatgttagcac 
 
>G9NSEKQ01A52GM|cytochrome p450 307a1-like 
aaatacggcagcctcgtcggtgtgcagatcggcagtcgctactgtctgctggtgaacagcgccgagtgcatccgggagattctcgtca
acaaggcgaaccagtttgctaaccggcccgacttccttcggtttcatgcaatcttccgctggaaccgacacctctcggtggccctatgtg
attggtcggcgaaacaga 
 
>G9NSEKQ01B9NTL|cytochrome p450 307a1-like 
gaaatacggcagcctcgtcggtgtgcagatcggcagtcgctactgtctgctggtgaacagcgccgagtgcatccgggagattctcgtc
aacaaggcgaaccagtttgctaaccggcccgacttccttcggtttcatgcaatcttccgctggaaccgacacctctcggtggccctatgt
gattggtcggcg 
 
 
>isotig21822|cytochrome p450 307a1-like 
aagtaaacaacaaacatttattattatatatacgtatacatatacattgtgtttaataatctatatacgaatatcacatatagcaccatcaac
gttggcaacatagacagccagatggacaggcagcggcagctacgactgtctaggttcaaacacgaaatgtggctcgctgtccataat
caccttgccacgcgcctcaatgtagttgagtggcgccgtgccgggcgccaggcgcacccgaaagtggccgaacagcgtcgacag
catcagatgtacaacgtggcgaacgatgccgtcgcccatgcaggcacgcttgcccgtgccgaatgggaagaagaagtccggcttct
gcaccatcccgtcacggatgaacctctctggcctgaacttcttaggctcttcccagtggtcgggattaaagttgaggtcgcatgtattaaa
catcaccattgtgtcttttgggacgtggtagcctttaagcgtagtgtcctctacggccacatgcggaattatgggcgagcacacaactcg
cattagctcgtacatagccccttcagcatatactagcgacttcttgtgttctgaatcacacaccccggaaccgttgacgctcatatattcct
cgtacaacttgtcttgaacggcaggctctccggctattatccagatggcccagaggaacaggttgctgacgaccggaaagccaccg
ataaggtcctcgacgatgacatcgacgtcgatctgatcgagtgtgccctcgttagacttgttagcggccgcgtggttacggaggtacag
cagcaggatgtcggtgatgtcgcgggggtcctcctcgtggccatcgaggctgtgttcgtgctcctcgatcatgcgactcgtgaattggct
gatttcacccgccatcgagttcagctcatttagccgcttctggtagaacggctttagccagggcatgacgtcgatggcgaaccccttgaa
caactcgtgaaatacctcgttgtatagctcaactatatgctggtaggttttgtcgctccagtcgaaagtggtactgcagaagaagtcgtag
aacacgttgccgactgcatagaggataagccgtcggggttccagcg 
 
>G9NSEKQ02H49GX|cytochrome p450 2u1-like 
gatcaccagttggtacgtggtattgcctccatttttcatagatcgtttgaattctgatctgaatgcctaaagccctcgtctcggtacggcgagt
gttaagagctaaatatttatcaatgtgaatacactggttgtgaaaaacatcagcctacaagaactaaccgggacaaatacgtttttgtgc
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agatcaacgcaggagatatacgtgaaaggttaccgcattcccaaaggagcgattgtggtctcctgtatctggtccatccacaacgacc
caaacctttgggagaaaccagataagtactggcctgagcg 
 
>G9NSEKQ01BOP9S|cytochrome p450 2j6-like 
aacttgttgaagtagaaaaatactacacggatcatgtgttgttataggctatacttcggatcgcgctatgtagtatgcctggcggagttcca
gaccatgaaggaggtgttcaacaaggatgtcgtccttgaacggccgccagaagttccgtttgccatctaccacgaatcaatgagtcag
tattgacgtttcaaacgtttttgatttttaagttgactgttattcaacaaatttagtttaccaatttaaactacaatgtaaaaatggagaggcaa
aacgttcgccgcaacatgtcatattgattgtggcgcaaaccttgt 
 
>G9NSEKQ01DPKQ3|cytochrome p450 2j6-like 
tgacgatgaacgggccgttctggcaggaacagcgccgctatgctgttcagctctttaaggaatttgcctttaccgacaaaactctcgag
caccacatccaggtgaatgtgaaacagaggccgccagtccgatggctttactgctgctgctgatagctagacgacccagctaatgtg
agaagcgcgtgcttagaaaaatatgatcgttgtggatctcaattgactagtgaattcttataagtgttctttttctcgctcttcgtc 
 
>G9NSEKQ01EB707|cytochrome p450 2j6-like 
tgacgatgaacgggccgttctggcaggaacagcgccgctatgctgttcagctctttaaggaatttgcctttaccgacaaaactctcgag
caccacatccaggtgaatgtgaaacagaggccgccagtccgatggctttactgctgctgctgatagctagacgacccagctaatgtg
agaagcgcgtgcttgaaaaatntgatcgttagtggatctcaattgactagtgaattcttataagtgttctttttctcgctcttcgtcaattaatat
taaaatgtttagtattagttagcagcatttaccacttgaggagcacgtcgcctttaacttaacatgacaactca 
 
>G9NSEKQ01EFBC3|cytochrome p450 2j6-like 
ggaaaactcatcaacacggaaaaggtgtgggcgttctcaataggcaaacgtgcatgccctggtgagagtctggcagttctcgaggtg
tttctatattttgcgaatctccttcagcacttcaccatcgcttcagaacaacctgg 
 
>G9NSEKQ02FXXOU|cytochrome p450 2j6-like 
cgttttgcctctccattttttacattgtagtttaaattggtaaactaaattttgttgaataacagtcaaacttaaaaatcaaaaacgtttgaaac
gtcaatactgactcattgattcgtggtagatggcaaacggaacttctggcggccgttcaaggacgacatccttgttgaacgcctccttcat
ggtctggaactccgccaggcatactacatagcgcgatccgaagtatag 
 
>G9NSEKQ02H70EH|cytochrome p450 2j6-like 
accgtcacgcgcactgttatgctgcccgcttgaaagaaacccatggcgttgccactgaccaacgcatccgtaaagtgtgcatctttttctt
gctcgataagataatagtcaataaaatctcgtggattgtctttgtcgatgcttttacgatgatcgagaatttcgttctcaactaacttccggaa
tcttttaatcacgtccgttagcttcgctccaatgccaatgttcagtttgtaaaggatctttaacagtttgggaatgaatgctacaacgatgatc
cttccactctcgttattgaacgccgtcagcagatagtccaactccttcctcttcggatggtcgtacggaagtcgttcgccaaacaccgag
cgacgcaatgtcgtttgacgtcgaggtaaccaggaggtcctgagagttaaacggct 
 
>isotig08808|cytochrome p450 2j6-like 
atatagtaggtcaacagaaatgaaacagcacttggctcgcgcttggtctgatgttgacttttcaatgcgtacgagcatttcctctgcttcttc
ctgcttctcttccccctcattctactctttctcgcgatcgtctccctgttttttttgccgcccctctctctgtgagcctgtgtagatgatacgaaaag
agtccagcgacccatttggtgtacagatgctgtacgacacggcgcgacatgagcagcagtacggcataaacataccgggctgtcttc
tagtgcaggtttaatacagctttgttctcgatggttcatgttcttccgtccttctccacctgtcgtttgcgtaatctctctcatcagtatatacacat
cattatcagcattgtcctcaccattacaaacaccactaccatcattaccatcatcatcatcaatacaatcatcaccataatcattcgtgag
ctcccaatcactgtttgtcgagcagtgcgcctatgtgcatctctctacgcgcgcatagtgtcaccgcctgccgagggcaatgccagatta
actatcactgttaacgtagcgccatagcggttgcttgagttctcccgctaacgttcgcgcatatcgtgcgacgacagccagctgagtgac
tgcgttctagcagacccccattcagcgccgagtgcatatcgttgtcctatcgttgttccacaactagcccagagttgttgagaggtgttattt
gtgtgcctgtggaacaccaccctaaagcgattgggcagtgttggtgtggtgttagagccgcctacgtgtacaatacccgcgaacgtgtc
caatacctacctaaccatctattcagctggctggtcgcattatccgcaataacagatcctgaaatgattccgaacagttagaagaagca
gtcctcatcgagaacacagtggtgtgtgaacgacatgtaaacttgaagttagcatagcgccttcgtcagcgtcaatctcgtcgcgttggt
attctgctggctgccttttctgcgccttgcccttctcgactgtcttcgagccatcatcactctgtgctcgcttgctactcacctcacgcgaggcg
gcaaaggcggccagcatgtttgagctggttgtcttcctggcggttctgctgggcgtctacacgtaccggcggttctgcacaaacctgccg
ccgggtcccatatgctggtaccctttcgtgggctacctgccgttcctcaccaaagacccgccgaggcatctcgataagcttcgtcagaa
gtatggaaacgtcttcgggctatacttcggatcgcgctatgtagtatgcctggcggagttccagaccatgaaggaggtgttcaacaagg
atgtcgtcct 
 
>G9NSEKQ01C6FVT|cytochrome p450 2j2-like 
cagtccgcgtgactctcgagtacctcctgcatttaatggcaaaccgaccagaggtgcagtgccgtgttcaagcggaaatcgacgaag
tcaccggacgctctcgtgaagtgacctgggctgacagtcggaacatgatctacacgatggccgtcatcgctgaacgacaccgatacg
tcacagtggcacccttggcgtcagcagaaggacgctgcacgcaactgcactctggtggatacgatatcggccgcacgagggtgtgc
tactagacatcgaatccgtacactacg 
 
>isotig08806|cytochrome p450 2j2-like 
atatagtaggtcaacagaaatgaaacagcacttggctcgcgcttggtctgatgttgacttttcaatgcgtacgagcatttcctctgcttcttc
ctgcttctcttccccctcattctactctttctcgcgatcgtctccctgttttttttgccgcccctctctctgtgagcctgtgtagatgatacgaaaag
agtccagcgacccatttggtgtacagatgctgtacgacacggcgcgacatgagcagcagtacggcataaacataccgggctgtcttc
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tagtgcaggtttaatacagctttgttctcgatggttcatgttcttccgtccttctccacctgtcgtttgcgtaatctctctcatcagtatatacacat
cattatcagcattgtcctcaccattacaaacaccactaccatcattaccatcatcatcatcaatacaatcatcaccataatcattcgtgag
ctcccaatcactgtttgtcgagcagtgcgcctatgtgcatctctctacgcgcgcatagtgtcaccgcctgccgagggcaatgccagatta
actatcactgttaacgtagcgccatagcggttgcttgagttctcccgctaacgttcgcgcatatcgtgcgacgacagccagctgagtgac
tgcgttctagcagacccccattcagcgccgagtgcatatcgttgtcctatcgttgttccacaactagcccagagttgttgagaggtgttattt
gtgtgcctgtggaacaccaccctaaagcgattgggcagtgttggtgtggtgttagagccgcctacgtgtacaatacccgcgaacgtgtc
caatacctacctaaccatctattcagctggctggtcgcattatccgcaataacagatcctgaaatgattccgaacagttagaagaagca
gtcctcatcgagaacacagtggtgtgtgaacgacatgtaaacttgaagttagcatagcgccttcgtcagcgtcaatctcgtcgcgttggt
attctgctggctgccttttctgcgccttgcccttctcgactgtcttcgagccatcatcactctgtgctcgcttgctactcacctcacgcgaggcg
gcaaaggcggccagcatgtttgagctggttgtcttcctggcggttctgctgggcgtctacacgtaccggcggttctgcacaaacctgccg
ccgggtcccatatgctggtaccctttcgtgggctacctgccgttcctcaccaaagacccgccgaggcatctcgataagcttcgtcagaa
gtatggaaacgtcttcgggctatacttcggatcgcgctatgtagtatgcctggcggagttccagaccatgaaggaggtgttcaacaagg
atgtcgtccttgaacggccgccagaagttccgtttgccatctaccacgaatcaatgaatctaatgacgatgaacgggccgttctggcag
gaacagcgccgctatgctgttcagctctttaaggaatttgcctttaccgacaaaactctcgagcaccacatccagctggaagtgtctcatt
tgctcaaagaaattgacaaacgagtcggcgagccaattgaacccactactctgctcataccctcgatgtcgaacatcatctcatcgcta
gccttcggcaaaagatttgaatatgacgatcctgaccgtattatgctggacaatctgatcatggagattcctcggcgcgctggccaggtt
gcgtacgtccactacatgccatgggtgaagaggatcgctctatggcttaaatggggctcatgcaacaaacttcgggaagctctcatcc
gacgtgaagagttctgcgagaaacgcgtaagggcgcacgaagcaacatttgaggacggcgtgtttcgcgactacattgactacttctt
gcatgagatgcgcaaaggcaataagggtccgtcgttcaaacgaaacgtcctggtcggaaatgtgtcgtcgttcttcggtgccggctcc
gagacggtgcgtacgaccatcgactggcttctgcttgtctgtgctgcttttcctgacgtacggcaacgggtgcaagccgaaatcgacga
ggcgatcggcgacaggacacccgtctgggatgacaaccgaaccatgccctacacaatggccgtcatttgggagctcttccgatgga
aaccgatcaaccccatcaacatcctgcgcagatcaacgcaggagatatacgtaaaaggttaccgcattcccaaaggagcgattgta
gtctcctgtatctggtccatccacaacgacccaaacctttgggagaaaccagataagtactggcctgagcgattcctaaagaggtccg
aaaccggcgagctcaaggtccacaagccggacaacctcattccattctcatttggcaagcgctcctgtccaggtgaagtgatcgcca
agatggaggtctttatctacctcgtatcgatccttcagaagttcgatatccttcctctgcctggaaagacgatctcgtttgacgaggaagttg
gagtttcgcttcggccggtttcacaagacgtcatgttccgtcggcgagtcatttcttagggccgagactagaacacgacacgacgaac
gaatgtgcaggccagataaatactccgcaacacagcgaagctctgccgcagaggggtatcttgcgccgccttaccctctgcctcggc
caatggctatgccgacgaatgccccacgagaaatactgcccgatactagaataatgtgcatatgtgacaacaggaccccactgcca
cagatgcggtcgttttgacgactctgatacattgtcgtcgtggtacagctttgaccgacgaagatcaaaaccgcataaagaataaggg
caagtgtgtccagagcgggacgtgaatagaatgcatttgatcaaatcatcaaaatacatgctcaaaagcgactgcgataactcggca
aaccaacaaaacctaacagctgctaatgtcaactgcagacgaatcatacaactcagctcaactgttgtttaataaatatatgagtcaac
ctggtacaacggctaccgactg 
 
>isotig08807|cytochrome p450 2j2-like 
gtatctagtggtgtgtgaacgacatgtaaacttgaagttagcatagcgccttcgtcagcgtcaatctcgtcgcgttggtattctgctggctg
ccttttctgcgccttgcccttctcgactgtcttcgagccatcatcactctgtgctcgcttgctactcacctcacgcgaggcggcaaaggcgg
ccagcatgtttgagctggttgtcttcctggcggttctgctgggcgtctacacgtaccggcggttctgcacaaacctgccgccgggtcccat
atgctggtaccctttcgtgggctacctgccgttcctcaccaaagacccgccgaggcatctcgataagcttcgtcagaagtatggaaacg
tcttcgggctatacttcggatcgcgctatgtagtatgcctggcggagttccagaccatgaaggaggtgttcaacaaggatgtcgtccttg
aacggccgccagaagttccgtttgccatctaccacgaatcaatgaatctaatgacgatgaacgggccgttctggcaggaacagcgc
gctatgctgttcagctctttaaggaatttgcctttaccgacaaaactctcgagcaccacatccagctggaagtgtctcatttgctcaaaga
aattgacaaacgagtcggcgagccaattgaacccactactctgctcataccctcgatgtcgaacatcatctcatcgctagccttcggca
aaagatttgaatatgacgatcctgaccgtattatgctggacaatctgatcatggagattcctcggcgcgctggccaggttgcgtacgtca
ctacatgccatgggtgaagaggatcgctctatggcttaaatggggctcatgcaacaaacttcgggaagctctcatccgacgtgaaga
gttctgcgagaaacgcgtaagggcgcacgaagcaacatttgaggacggcgtgtttcgcgactacattgactacttcttgcatgagatg
cgcaaaggcaataagggtccgtcgttcaaacgaaacgtcctggtcggaaatgtgtcgtcgttcttcggtgccggctccgagacggtgc
gtacgaccatcgactggcttctgcttgtctgtgctgcttttcctgacgtacggcaacgggtgcaagccgaaatcgacgaggcgatcggc
gacaggacacccgtctgggatgacaaccgaaccatgccctacacaatggccgtcatttgggagctcttccgatggaaaccgatcaa  
ccccatcaacatcctgcgcagatcaacgcaggagatatacgtaaaaggttaccgcattcccaaaggagcgattgtagtctcctgtatc
tggtccatccacaacgacccaaacctttgggagaaaccagataagtactggcctgagcgattcctaaagaggtccgaaaccggcg
agctcaaggtccacaagccggacaacctcattccattctcatttggcaagcgctcctgtccaggtgaagtgatcgccaagatggaggt
ctttatctacctcgtatcgatccttcagaagttcgatatccttcctctgcctggaaagacgatctcgtttgacgaggaagttggagtttcgctt
cggccggtttcacaagacgtcatgttccgtcggcgagtcatttcttagggccgagactagaacacgacacgacgaacgaatgtgcag
gccagataaatactccgcaacacagcgaagctctgccgcagaggggtatcttgcgccgccttaccctctgcctcggccaatggctat
gccgacgaatgccccacgagaaatactgcccgatactagaataatgtgcatatgtgacaacaggaccccactgccacagatgcgg
tcgttttgacgactctgatacattgtcgtcgtggtacagctttgaccgacgaagatcaaaaccgcataaagaataagggcaagtgtgtc
cagagcgggacgtgaatagaatgcatttgatcaaatcatcaaaatacatgctcaaaagcgactgcgataactcggcaaaccaaca
aaacctaacagctgctaatgtcaactgcagacgaatcatacaactcagctcaactgttgtttaataaatatatgagtcaacctggtaca
acggctaccgactg 
 
>G9NSEKQ02GSTOH|cytochrome p450 2e1-like 
agtctcgccgagttgcgaccgagcgagacgacgccaacgacttcattgaagctgtgatgcgagtgaaatccggcgacgaaacgca
gctgttccttcaggaagtggccccatttctcattgtggcgaactttcacacgtccgtcgcgacgctgagcgtcttgcttgtgtatctggcagc
gtatcccgagtaccagaaaaaggtcgtcgacgaaatcgggaacattgtcggaacggagccgcccaacatgagccactacgagaa
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aaatggcactttacgaaagcgttcatacacgaacgatatcggatgttaccacccatttcgtacgtgggacgtctcacgacagagccca
ctagcattgggggatatcaggtatcggctaaccag 
 
>isotig10412|cytochrome p450 2c29-like 
agtccctgttgagcttgactctagtctgactttgacccgatgagactttgtttgtcttgtcatcttgttcctatttttctccgctcctccttttcttgacg
gtgggggatcatagaccggctgtggccctttccttccccatcggctggctgcaaacaataagcacggcgcccagcacagactgcgta
attccgtcgttgcaatccacacacatcctctctggctatggcgtgttgatggtcttgacaataaccatcctctcacggtctctgacagttgtg
cgtctctgcgtcatccagcgttgaccgtcgtctcgatcggcaatgtagaacggtgtttgcttgtttgctccttcaagtggcactttaaagaag
tggtacttcgtggtatactatcggttggttgctgcggttcgacccattgccgatgcgtcatcgcgcaccccgctgttgagggggtaaccta
gtgtcagtaagactaattggagtaagtacattgacgcaacagcagccaaacgttacgataaggtgaacgaaccccttgtgggagact
tctgacgagagcaaggacaaagttcatcgtcgaagtcgtcgtcgtcgcgacaatgtggttacagctgtgcatggttttcgcgttcgccct
gtggctggcgcactggtgtctgtggcgtggcttcctatcgaagaagaggcttccgccaagctactacggtttcccgctcgctggggttct
gccgttcatgttctggaagaaagaccagcttcagatgtgccaagacatcgttgataagcgcggacccgtttttcgagtccgcatgggctt
gtcggacgtggttttggttaacggatcgacagcagtgaaggaggccctacgaaacgatgaccttcttggtagaccgagactcgccttct
tcgaactccttaggaagatcatgcacgccgacccgtttgtgattatggagggcgaatcgtggaagacaatccgcaatttttccgtgcac  
gctttaaaagaccttggattcgggaaggcaccagcgatggaaggcaaagttcaggaggaaattgcgtatctattagatgatctgaag
cgcgcctcaagctcgccatatgatcctcgtcaatcgatgttggcgtccgtatcaaacaatattgcgattctggtgtttggtgaccggctgcc
gtatgaccacccccgccgaaaggaccttaaccggtttctgttcggttttattcaagcggcgtcgaccttcatggtgtttaactttgctccgat
cctgctttacgtgctgaacttcatcggcatcaaggcggctaagaagtttttagccgaggccgaagtcggaaagcgtgtctttgtgcaag
agaccgaacagcatctaaacaactttgacgcgaacgacaagcgtgacttcctcgatgagctcatcggcaagcagaaagaggatcc
cgagatctttacacctcaagttgtacgcggctcctgtatcgtgttttttggggccggtagcaacacgacaaggattggcgtggagtacctc
gtgcagctaagcgcggcctatcccgatcttcaggagcagatgcatcaggaaattgtgcgcgtcgtaggggatgctcgcctaccctgtt  
gggcagatcgagaaaacctccatctggtaaatgcattcattcaggagcgacatcgcatcttcccgatagcaccattgggaatctttaga
agggcactacgcgacacaaaggtgtcgggctttgacgtacaacgaggcacagtcgtcatctacaacatcgaaagcgtccactttga
caaaacggtgttcgaaaaccccgccgattttaagccgggaagatttctagatgcggagggaaagttcgtcgcgtcgaataacgttatt
cccttcgccattggaaaacgtgcctgtccaggcgaagtttttgcgacgttcgagatttttctctacttctctgccattcttcaacgttttagagtc
gaagctttgtcgaagagtcaagaagtgaaactcacaaaagcatcccagttcttttcggagccgatcccgcagccattgcgtttcattag
ccgaatttgagatacaccataagtgtcggttttaactgtcgagggtttcgctgacaagttatgaatgtgaaaagtgccttttttgcgacaact
gctacaaaggccaacgacgtaagattcaaacttgtattgggcttccgatgtggtcttaacacatacactgaagtatgtatgttaagtccat
atctggggctatgaacctaacattcatacatgaaggcaaaatgcagattgtctgattcaaggtacgtgctagttttcctcaaattagattta
cttatatatgcgaataggatttagaaaccggctaaagtctgtaactatctcctacctaccgctgataatgtttgactcgtataatatatgtcta
atcagatatatctgcgccttattttcttttgggcatggcaaaggctatactagttgaccctgctcctgaagacagctgcaagtcatttgaatg
tgctttgttgtcttcagcgagaaaataaaaagaatgtctagtacgttccatcaaagtgaaatagtgtgtccttagcggactctaaatgccgt
ggatgttcaccaggaacccaattggcgttggactaataagaacgaataaaattaaaatgaattgaactgcaaatccac 
 
>isotig11837|cytochrome p450 2c29-like 
actataagtggtggaagtcgtctttgcgcttcgagtccggtacatcgtacggctaattggtcgctagtggcctgcctttctaacaacaaca
gcaacaacagaggcaagaacgacgtagaccagctgcattcatgtgctctcgaaacgccgcaactcgagatcatcgcagttgatctt
cgcagctagcttctactgcgttcagaaaataagtgatgggggagccccccccctgcgttcttgctcgatgtcttgaggtaggatgagag
atctggtgatctgaacagtggtagaaatagtagctgaacgagtagtaggtgtgtatctaacgctataacagcagcagcagcgataga
cccgcactagaagaggtgaacgcgtcaatgcagacagcaaccgaacttctggagtcgtgaattcttgtggacttcagtggcagtgaa
cgcgtgtgtgacgctgttggtactgttgctgttgttatcgtcaacgtcgtagccttcgtcttcactgcggtcatcatgtgggcacagctgtgcg
ctgtgtttgcgctggctctgtggctggcgcactggtgtttctggcgtggctttttgtcgaacaagaaactgccaccgagctactacggtttcc
cgctcgttggtgtcttcccgttcctgctctggaataaggacctcgtcgagacgtgcaaaggcatcgtcgacaaacgtggacccgtcttcc
gagctcgggtaggctggaaggacgtcgtggtgg  
tgaacggatcgactgcagtaaaggaggctctacgaaacgatgatcttcttggcaggccaaacctcggcctctttgagctcatcaagaa
agtcatgaactgcgaccctgtggttgtcatggaaggcgagcgatggaagacaatccgcaatttctctgtacatgcgctaaaaaacctt
ggatttggtaagacacctgcaatggaaaacaaacttcgggaagaaatcgcgtttttctggacgatctgaagcgtgcctcgacctcgcc
atacgatcctcgcgcgtcactgctggcgtccgtgtcaaataacgttgccacacttgtatttggcgatcgcctaccgtacgatcatccccg
gcgaaaggaccttaaccagtttcttcttggctttcttcaggcgacgtctgccttcatgctagttggctttgttccattcttgctcaatctgctaatt
tttttaagggtcaaggcggctaggaagtttgcagctgacgccgaaatgggaaagcgcgccttcacacgggagaccgaacagcatat
caacaattttgatccgaacgacaaacgtgactttcttgatcagctaattggcaagcagaaggaagaccccgaaactttcacaccccg
agtggtgcgcggtgcctgtatcgggttcttcggagccggcagcaacacaacgaggattgccatggaatacctgctgcagctatgtgcg
gcctatcccgatcttcaggagcagatgcatcaggaaattctgcgtgtggtaggcgatgctcgccttccctgttgggcagatcaagaaga
tctccacctggtgaatgcgttcattcaggaacggcatcgcatctttacgattgcaacatttggtggcttaagaagggcactgcgcgatac
aaggatggccggctttgacatcccgcgtggcacgatcgtcgtctacaacctacagagtgcccactatgacgagtcggtgtttgaaaac
cccgctgattttaggccgggcaggtttctcagtgcggaggggaaatttgtcgcctcaaatgacgttataccattcgctctcggaaagcgc
gcctgtccaggtgaagcgtttgccaggatggaaatctttctctacctcgcggctgtccttcagagcttccgaatcgaagcagtgaagggt
gaagaagtaaaacttacccgtgcgtcccagttcttatcggagcctattcagcagcccttgcaatttaggagccgacattaagataaactt
cataagctgtatcagctgttaaggttgtactggaacatacatttacgtaatatttatagcctctatggccgagtaagtgtcttaataggaca
gcagtgcaagaataaagctacacgaggcataaaccaca 
 
>G9NSEKQ02H8J23|cytochrome p450 1a1-like 
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tcatcggcgatgtgaagcaatgcgaagcacaacgaggatcggctggttgacgttccgccggtgaaaacatcgaacaccgtctggcg
aaggtttgccagagtgagatacttagccgaatctcgggcttcggcgattagctgatcgcgcgcgttgagtaacatgtctgtgaagtgtcg
cagcggttctcctgggacgcaggtgccagctgccctgtcaaacatcttgtcctgaatgtccatgtagttgcgcattatgctaatgcagtatt
gctcttttcggtagaagatccagccgagaacaggtagaatatccgaaggcagaccgctaccaagctctttgataaactcgtcagttata
tcccttaatc 
 
>G9NSEKQ01C04RO|cytochrome p450 
ctgtttcttgccaacgaccctgaactgcaggaagagctccgggcagaaatagtcgacgtctgcggccatgacaggatgtgcaccagt
tcggatcgctcaagactgccaaaagtcgactctttcatacaagaagttattcgcttctttccgccggcgcccttggcgatgccaagaagg
gccacgactgatgtcttgataaatggccgacttgtgccgaaaggccgtgcgcttcttaccaacgtttacgcagtcaatcgtgacacaaa
cgtttggggtcccgacgccggtacgtttaatccgaaaagatttactcagcgccagtgctgag 
 
>G9NSEKQ01CABE7|cytochrome p450 
aggccatcttcgacatcttcggcgctggcatcggaaccagcaagactgttagttttgcatttctgtttcttgccaacgaccctgagctgcag
gaagagctccgggcagaaatagtcgacgtctgcggccatgacaggatgtgcaccagttcggatcgctcaagactgccaaaagtcg
actctttcatacaagaagttattcgcttctttccgccggcgcccttggcgatgccaagaagggccacgactgatgtcttgataaatggcc
gacttgtgccgaaaggcctgtgcgcttcttaccaacgtttacgcagtcaatcgt 
 
>G9NSEKQ01CFKHD|cytochrome p450 
cgacccgcttgtgaagagcgtgggctcaatcattgacgctcgaaaagagagcgacgttaaacgcggcgacatcatcgataacctcc
tctacaaaaatatcctaggtcgacctatgactcggtcagaagtgattgccaacgcaacggtggcgtttttcgcgggttttgaaacgaccg
cgatcacgcttgctttgaccacatttcggctggcccaacatcccgagtggcaggagaagctccgagctgagatcaaagagttatggg
atgacaccgagccgtacgacagcttatgcagactgaagacgctcgatatgatcacttgcgagaccctaagactggatccgcctgcac
cagcgttcgtctacgcgaagcc 
 
>G9NSEKQ01EASYF|cytochrome p450 
caccgtaagggcggtttcggctatacgtcgtccaatacaggcacgtgccccgagccgaacggcaacgaggtgtagtcgggtgaagt
tcctgcgtccagccaacgctcgggaaggaactcgttcgcgcgagtgaaataccgctcctgcacggacgctacctgattctgagtaaat
atcttagtccctgccggaacgtggtaaccgctcaatacgagatctcgtggagtaacccgaaatactcctggtaaaacaggtcgcagc
cgaagggtc 
 
>G9NSEKQ02FU529|cytochrome p450 
aaacgctatgagagtgttgttgctataaaattctcgaagagcattcgctaattgttctaagcttgcctccagctcgactatggtatatgatac
tggccgaacgctgaagtgaatgaattgagtggaattggacgtacgataacctcgtcaacaggccgcaggttgccctgtttaccgcga
agggtgaccttgaggggcgactggaagccgacgccgggccgaaagcgcatttcgcgcagtaaatgcacgacggctagttttacca
ctagggcgacgaacctcgaaccgatacatgaccgcggccctaatccaaacggcaagtattgtgccggatgtcgcaatggttgcatg
gtcgacaacgattcgctattcgtaaagcgttctgggcaaaattcgttgggtgccacccacaattgtgggtcacgatgtacatgaaagac
gggtacgagaaccgagca 
 
>G9NSEKQ02G2LAB|cytochrome p450 
cgtgaaaaagacgatctgctggtggttccggttgaaacgatccattatttgccgaagtacttcaaagatccgcacgcctttcggccgga
gcggttcatcgatgaagaggtcgatcccataacattccagcccttcgggaatgggcctcgaaattgcattggcatgaggtttgcacaga
tggaaataaagctgacgttggcgaaattgcttctaaagtatcggcttgagcctacaccggagacgcgacccgagattgcttatgagac
aacgattaatctccagagaccagtcgacggcgtatttacgaagcttgtcaaagtttgccgtgacagatgcgtcaacgc 
 
 
>G9NSEKQ02GI8R0|cytochrome p450 
cgttcaacaaatacgtgcgtctgagcggcagacatctgtggatctgctcgaagcaatgcttcgaggggacgcgcccgtttccgagac
cgaagccgtcgacagcggcattctcaacatacttacagggtacgagacgacgtcgagtgcgttatgtttcatcacaaacatgctgattc
gccatccaaacgtgcaggaccgacttcggcaagagctcatgagtgtcgtgggttccagcgccgacagcaccaacacaacccatca
acagagaaaccctgaaccagacgctcttgcgaactgccgctatcttgacgccgtaatcaaggaaactcttcgcatgtatccg 
 
>G9NSEKQ02HK6GU|cytochrome p450 
agagcgacgttaaacgcggcgacatcatcgataacctcctctacaaaatatcctaggtcgacctatgactcggtcagaagtgattgcc
aacgcaacggtggcgtttttcgcgggttttgaaacgaccgcgatcacgcttgctttgaccacatttcggctggcccaacatcccgagtgg
caggagaagctccgagctgagatcgaagagttatgggatgacaccgagccgtacgacagcttatgcagactgaagacgctcgata
tgatcacttgcgagaccctaagactggatccgcctgcaccagcgttcgttctacgcgaagccgctgaagattaccaatacgacaacct
tttgatcccgaagggaacctcgatacaagcgccagttacactactgcagcgtgaccctacg 
 
>G9NSEKQ02HNEGU|cytochrome p450 
cagatcttcgcatcgctgcttcagccgcacgccgataagaaggccgtcgatattgtgcccttcataacgatgtgcacccccgatattattt
gtgagacggctatgggcgtcaaggtaggcgcgcagcaagactcgaactcgcattacgttcgggcgctctatgaggtcggcgagacg
ttcatggcacgtatcatgcggccttggctatggcccacaaagctgcttttcatgtccgccaggggccgccgatttcaagagaacctcag
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ccatttacataacttcacccgaaaggtgatccaagatcggaaagcagagctgttgaaagagaagaatggtgaactggagattacag
agaacccagaacaccacataggagttaagcg 
 
>G9NSEKQ02ITOAH|cytochrome p450 
atcgccgatcggctagccgcgcgaatgctggcctgcgcgaacgacaacaaggaccttaacccggccctatactcgcagtgctacac
cattgaagtgaccgcctcaattgcgtttagcctggaggtcgacgcactggcgaacccagagaacccgtttgttcgcaacggcaacaa
catgttcgggcctagcgtcggcctgtcgctgctttcagcggccccgtggcttgtgaagtacattccatttgtgcattttccgccgaagtcgg
ccactgacttttttcagggcttcacggagacgctgatcaagcagcgacgacagagcgggcggccttcaacggatccggatattctag
acctgtggttggaggagcagaagaacaggcccgagttcaccgacgaattgatcgcc 
 
>isotig15492|cytochrome p450 
cgataatggcgtgtttattttgactttcagatattacgatattaagacgcagaatgagagctctgttatcaaattcaaattgatatggctaatg
atagccatataatttgtgttcgccacgcaagtgagttggtaagaaattgttcaggagcgtagccaaatgtaagtaaatgtatgcttcctgc
atattttgttgcagcgcgaatgggatgaacgttgtccacgtgtgcacaaagacagcgataaggcgattgctgaacctgtgcccactata
ccataaaatggccgaacacatgttgctaatagcgaggccttcccaacgtgccgcttaacttgagaacactgatctctaaatggtctact
aaacattgtttaaaatgcccatgcgctaggatcctcgttccaagacggtgcgccgtccggcacaccgaggtgcgtcccattggaacgt
gcctgtgagcgattcagtagcgcaatgaatggagtctctagagccagcgttcggcattacgttagtggcggctaaggtttaacgggga
acgagtcgaacaacgacaggcttcttctcaaacgtagtgaagtacagtccggacctgacagagagcggaactggcgtttcgggatc  
ccgatcgattcgaaacttcaacagaaggtttgccgcgagtgtctgtatgttcattagggcaagacgacgacccacacattgtttgggcc
cagaaccaaacaaaaagaacgcactgttctcctgatcgacgcctccctttagaaaacgttccgggcgaaagcgttgcggttcggca
aagttgctcggattcctgtgaatagctgctaccggtatctggatgaccatgcccttttgaatcggtatgccgcttatctgcgtgtcggccgtg
cagacgcgatccagtatgccgaccattggagccaatcgaagacactcaagaatgcatgcctgcacgtacttcatttcttggatatcctc
gtactgtatataggtacggcccttcgtggctgccatcacttcgtcgtatgccgtgtcctgaacctcaggatgaagtgccaactggtaaaa
cagaagggtgagcgctatcgttataccgtcgattcccgcaatcaggaagaggagcgcctgggatgcgagcgtctcgtcggaaatact
cgcatcgtttcgttgggctatcagatgaaggtcgagcatgtcggctgtgtcgtctgcaatgacctgatccagcatgggttttttcgactctat
ggcatgtctgccaacgcgtccgaagaactccgaggtcgctttcggcgggaagctaaggaagggcacgtacctcataagagctggtg
tgataaaaaagattagcatcgtgagacctggcttaagaagctcttcggaatgtttcgtgaacgcgctatccggatcttcgatacagttgg
cgtccattccgaacgagacagcggccatcgactcgacagcgtacgctttgacgtcttctcttggagtcaccgaacagccggaactttg
agtcattttttcatactttcggacgagcctctttgcgaccttgtcaaacttcggtacgattccgcgcatcttcgacgccgtcattgtgttgccca
taacggtgcgtagcgatttccactggtcgtagggcagcagcacgagaatgttgtcccacagcggatcgcccgtctgaaactcaagcg
tccgtttaaagaagttactgaactgcttgatgaacacttctttggcgaactccatgtcggagaccactagcatgggcttgaggccgctgta
gctgccgtacacgggcccgtaacgcttcacgtcctcctgaaccacctcaacgacgactctcgtcgggaacagccaaagcatgcggt  
agacataccgtggaaacgactcgtacggtataccgtatgacttccagaagagcgacactttgaccagcttgatggctacaagagcaa
caatcgtcaacagtagtattggccacatcgtgacgggggggggcagactttcgcgcgagaaaagtcctaacttaagggagcacgtg
tcgtgtctttgacgtctctaggcccggccgtagaagctctagaagctcgtcaagagccgtttccaagggccagcacgcacaacgcaa
agcagcactgtttggtgacttctgccttctgttcggtagtattgacgactgcggtcgtatgtctacggtcgcagtacaatcgccgtgtgccg
cgtaacaaccgaaacttgcccccgtccgtccttgatgtagatgaacgcacacaactattatccgtgaatgcgaaacagcaggcgagc
aactcggttgctactttatctggctgcccttgccggcactgagcacaagcgcagcaatggcttggtcgaaatcgaaagaatcgcgcgc
tgttcgcctcttcaagtgggcccctatgcgattgcacgtgaacgtagctctatgtcaagccgtgctgcagacgtccagaccatccacac
attgcttaattgcctactgatacgtgatacaccaaaccagtacactgttatttacacctctgtccactttcgatatgtttactctatctcttaaat
ctgtgttggtcttttcactcgtgtttcattcgattaagatttgccttaattttagtggatgcacttgtcagatgccgcttaaacgctgtattcgaact
ttcggttagatgacaaaagttagggtacactggtatctattatagggtaccgcgttccgtgttacgtcgtacaatgtcgcctgccacgattg
cactctgttcattagctgaacaggggagaagtatagaagcgcatcgttggtcatgatctaccagaaaatgtgcccttgctgcagttcccg
gcgcccat tggttt 
 
>isotig15493|cytochrome p450 
tggcgtgtttattttgactttcagatattacgatattaagacgcagaatgagagctctgttatcaaattcaaattgatatggctaatgatagcc
atataatttgtgttcgccacgcaagtgagttggtaagaaattgttcaggagcgtagccaaatgtaagtaaatgtatgcttcctgcatattttg
ttgcagcgcgaatgggatgaacgttgtccacgtgtgcacaaagacagcgataaggcgattgctgaacctgtgcccactataccataa
aatggccgaacacatgttgctaatagcgaggccttcccaacgtgccgcttaacttgagaacactgatctctaaatggtctactaaacatt
gtttaaaatgcccatgcgctaggatcctcgttccaagacggtgcgccgtccggcacaccgaggtgcgtcccattggaacgtgcctgtg
agcgattcagtagcgcaatgaatggagtctctagagccagcgttcggcattacgttagtggcggctaaggtttaacggggaacgagtc
gaacaacgacaggcttcttctcaaacgtagtgaagtacagtccggacctgacagagagcggaactggcgtttcgggatcccgatc  
gattcgaaacttcaacagaaggtttgccgcgagtgtctgtatgttcattagggcaagacgacgacccacacattgtttgggcccagaac
caaacaaaaagaacgcactgttctcctgatcgacgcctccctttagaaaacgttccgggcgaaagcgttgcggttcggcaaagttgct
cggattcctgtgaatagctgctaccggtatctggatgaccatgcccttttgaatcggtatgccgcttatctgcgtgtcggccgtgcagacg
cgatccagtatgccgaccattggagccaatcgaagacactcaagaatgcatgcctgcacgtacttcatttcttggatatcctcgtactgt
atataggtacggcccttcgtggctgccatcacttcgtcgtatgccgtgtcctgaacctcaggatgaagtgccaactggtaaaacagaag
ggtgagcgctatcgttataccgtcgattcccgcaatcaggaagaggagcgcctgggatgcgagcgtctcgtcggaaatactcgcatc
gtttcgttgggctatcagatgaaggtcgagcatgtcggctgtgtcgtctgcaatgacctgatccagcatgggttttttcgactctatggca  
tgtctgccaacgcgtccgaagaactccgaggtcgctttcggcgggaagctaaggaagggcacgtacctcataagagctggtgtgata
aaaaagattagcatcgtgagacctggcttaagaagctcttcggaatgtttcgtgaacgcgctatccggatcttcgatacagttggcgtcc
attccgaacgagacagcggccatcgactcgacagcgtacgctttgacgtcttctcttggagtcaccgaacagccggaactttgagtcat
tttttcatactttcggacgagcctctttgcgaccttgtcaaacttcggtacgattccgcgcatcttcgacgccgtcattgtgttgcccataacg
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gtgcgtagcgatttccactggtcgtagggcagcagcacgagaatgttgtcccacagcggatcgcccgtctgaaactcaagcgtccgtt
taaagaagttactgaactgcttgatgaacacttctttggcgaactccatgtcggagaccactagcatgggcttgaggccgctgtagctgc
cgtacacgggcccgtaacgcttcacgtcctcctgaaccacctcaacgacgactctcgtcgggaacagccaaagcatgcggtagaca
taccgtggaaacgactcgtacggtataccgtatgacttccagaagagcgacactttgaccagcttgatggctacaagagcaacaatc
gtcaacagtagtattggccacatcgtgacgggggggggcagactttcgcgcgagaaaagtcctaacttaagggagcacgtgtcgtgt
ctttgacgtctctaggcccggccgtagaagctctagaagctcgtcaagagccgtttccaagggccagcacgcacaacgcaaagcag
cactgtttggtgacttctgccttctgttcggtagtattgacgactgcggtcgtatgtctacggtcgcagtacaatcgccgtgtgccgcgtaac
aaccgaaacttgcccccgtccgtccttgatgtagatgaacgcacacaactattatccgtgaatgcgaaacagcaggcgagcaactcg
gttgctactttatctggctgcccttgccggcactgagcacaagcgcagcaatggcttggtcgaaatcgaaagaatcgcgcgctgttcgc
ctcttcaagtgggcccctatgcgattgcacgtgaacgtagctctatgtcaagccgtgctgcagacgtccagaccatccacacattgctta
attgcctactgatacgtgatacaccaaaccagtacactgttatttacacctctgtccactttcgatatgtttactctatctcttaaatctgtgttg
gtcttttcactcgtgtttcattcgattaagatttgccttaattttagtggatgcacttgtcagatgccgcttaaacgctgtattcgaactttcggtta
gatgacaaaagttagggtacactggtatctattatagggtaccgcgttccgtgttacgtcgtacaatgtcgcctgccacgattgcactctgt
tcattagctgaacaggggagaagtatagaagcgcatcgttggtcatgatctaccagaaaatgtgcccttgctgcagttcccggcgccc
attggttt 
 
>isotig18927|cytochrome p450 
gaaattttgtataaacacaatttatatattttcttctttctcctcctatataatagttacatgatttcaattcgtcgaaatactttttatatcaagcga
cagttagcgacagttgagatggccatcacactgcaaatactgagtgctctggtccgatgaacgaacacctgttacagacgagaaag
aatcactttctttcctacaagtgccccattatgttatactcacacgtcctctacttgtttgctgtcgctcaacatagtaccattgccgactgaac
gagtgtaatcctgtcctagctgccatactcttttgctggcttttgatgcgtaatgtagctgcaacagcattacagacgtcgagcaaagcac
actctgctcgagtactagagcatctcgtagttctgactgcccttttagacaaaatgcagtatcatgcattttgtggcaatcttcattgaaggg
ggcctcgtctctctccaaatggctgttagacaaaccgattctggcgacatcgatggtggcgatgctggcgctgtttgatgatcgcgcgtg
gcggacgaaccaaaccatcaaaacctgtggagcgcacaacgaaactgggactggaacagctgcgagtacatcatcgattcaaca
gcgggcaggatttggtcgcacgcttgctaggtctgtgcacgaggccgggccgtaacgtgaaggccctccgctgaacgggtcaccag
ttcaccgacaatgtgcaaatcgcttcggcggacttttgtttcaagccagagtttgcgaaagacccatgacagcacggctttctcttcattta
gcgcaaacttttgaccgatacagttgcggggaccggccgagaagggcacgtaggcgtagggatggcgctgccctgtgcgctcttcc
agaaaccgatcaggatcaaaacgctcaggatcaggaaaggatgctggatcacgatgcaatgaataaatactgacaattgccgtcgt
accgatgggaattttcgactttttgtatgcaatttcctccctgatagttcgcgcaacgagcggcaccgaggggaagagtcgctgagactc
ctttatacaggcctcaatatacttcatccgcacgatgtcctccattgtcgcatggcgatcggtgttatctgagaagatatcgtcaagttcctg
ttggaccttcctttgacaatccgggttctcggcaagtaaatatagagcccaggaaatgcccatggcggtggtatcgtgaccctcaaaca
tgaacgtatccacctcctctcgaatatcttcaagcgatacgctattattttcaaggtgtttctcaagcagaagatcgaggaatggttttcgcc
ttttctggccgacatcaaaggcagcgtccgtcgtcttcgccttaggcgttgctttatcgccgacctcattcgttgctgccgtgctgacccga
ggctgcttggatatgtccaacattgccttcactgcctcacgacgctctgcaatgacctttttggtgaagtcctgcagaactttaattgacttgt
tgaagctgcgactggcaggcgtattttggaagacaaattcaggccacaaccaaggccttgtgagtcgatttatgaagctctcacca  
accatatagatggcctgcacgtactccgagttggggtcactctgggcattcaa 
 
>isotig25497|cytochrome p450 
Ggcggaattccggacactgccgactggcgggacacgcgcaaagtaacgctagcggctctttacagactgtcgcgtcaagagattg
aagaccgagttctagacaccgtagactcgttcctcgccgaagtcgaaatgcatacaggcaaggaatgggacttcagcgacgagctg
gtgttttccaaggtgcaggaggcactttacttcaccgtcgggcaaacgatcgacaggaaggagatcgcgcccgtagttaccgccata
ggagcctacttcaagtacctcgtcgtgctcacgagcctgctgcagatcgtgccgataaacatcattcatctgctcaagtacgtgattccta
aatcgttgaatcctgtcgtgtactgtcgcgttgtaagtgccctcgtcgagcggttgcaacagcagcgcgtcaggccggaaaaccgaag
agatgccaaagatttcatcgaagccgtgatgcaggtcaaatcgccggaaaaagcacagcagctgattcgccaggtaacgccgggc
atactcgttggcagctatcacacgactagccagacgactgcccttctcgtacactacctggcagcctatcccgactaccagcaacgaa
ttttcaaagagattaaggccattgtcggcgacggcccgccgacgcttgatcactacgagaaaatgcacttcacgaaagcctttatcgct
gagcgctatcgaatgatgccgccggtctcgttcacgattcggatcacgacggctgccacgacactcggcggcta 
 
>isotig27043|cytochrome p450 
tcgagcttctgtctcttctcgtccagtgactgctttgcaacgctaccaaagaaattagagacattcttcggcggaaagtcgacaaacggt
atgtatttcatgagcttaggagccacaacgaaaagaaatactgacaagccgggtttcgaaagctcgccagcatacttcatgaacgcg
ttgtcgagattctcgatgctgttcggatcaaggccaaacgacacagctgtcatcgagtcgatagagtacgccctacagttcgacttgag
aacgacgagattctccgacgactgagccgagacttccagtttgttcactaatcgtttcgcgattttgtcgaatttaggaatcattccgcgca
ttttcgatgtcgtaaacgtgtatcccatgacagtgcgcatacacttccattcgttgtagggcaggttcatggcgatgttgtcccagagcgga
tcgccggtgctgaactccatgtttcgcttaaagaagttattgaactgtttgatgagcgcctctttggcaatctccatgtcggtgacaatcggg
gacggccgaaggccgtgatagctgccaaacaccgatccgtatcgtgcgacggtgtcccgaatcacgtcgttcaccacctgcgtattg
aactgccacacgatgcggtagaggtaccgagggagcggctcatat 
 
>isotig29271|cytochrome p450 
tgccttacttggatgcagtatgcaaggagtcactccgtctttatccgccacttccgttgattgcacgcgatataactcagtcaatccaagtt
ggagatatcgagattcctgcagggcctgttgctctaattcatatttacagcctgcatcgtaacccaaacgtatgggaacggccaaacga
gttcgttccggagagattcttggacccagcaaagaggagacacccctttgcgttcatacctttttcggctggacctagaaattgtattggg
caaaaatatgcaatgcaggaagacaaaattattctggcgcaaattgtcagaaattttaatataatttcctgtcacaagtcagaaggcctt
cgtctttctatggaactcattatgaggccgctgaacggacttcatattcagctacaagtgcgtacatagggagcaccaccaagtgacga
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ccaaaactattatatatatacatatatagcttgaagcgtattattaatgaaatcatttttctatttctatgtttgtaataaaggccgtgtcttctgta
aaccaaatgttttaac 
 
>G9NSEKQ01BNWVK|cytochrome p-450 
atacaaagatatatgtatttgaattacttattaaaaagcagagacaaacaacaaaagtgcactggcaaagcctgaagcctgaatacg
ggcgtaagatacacgagcgacgaatagcgtaacaaaagttctacagttggtgaatcacgatgtcttgttgaacggggtcaagggaa
atgtcgccattggttgagctgaaattggccgttgcggggcctccaggacaggaaagtcgaactcgctgcaggaatcgtgtcaacacat
aggtgaagtccgcaagcgccatcttttctcccggacacgatcgagcaccgataccgaacgtcgtggttccacggctaag 
 
>G9NSEKQ02FQQSC|cytochrome p-450 
gcttgcaggccgccaagcttagattgagccctgcctgcaacgttatttcggtgaggccccgaaatgtccttaaacgaattggtagtgttg
gccacaataaaaggacgaggtccaacccacacagttataggatctccgaactgtttactccaggttatgcacttttcgtacataggacg
tggggcacgcaattctacaacaaaagagtcaaaatagattttcgggcacatattagatgatcttacgctatcacacgagcaaaaggc
atatccagcaaattgattttaagtttaaatggggcgagcttatcgtctgtgatctgtaccttggcgcttaggta 
 
>G9NSEKQ02I2IV5|cytochrome p-450 
attgcagtaacttaccacatttccccgtgcttgcagatcgccaagcttagattgagccctgcctgcaacgttatttcggtggggccccgaa
atgtccttaaacgaattggtagtgctggccacaataaaaggacgaggtccaacccacacagttataggatctccgaactgtttactcca
ggttatgcacttttcgtacatagggcgtggagcacgcaattctacaacaaaatagtcagaatagattttcaggcacatattagatgatctt
acgctatcacacgagcaaaaggcatatccagcaaattgattttaagtttaaatgggg 
 
>isotig34680|cytochrome p-450 
aatcgtccaccattcgaggacggctggccatcgattcgatcgctgacagccacagaatgaccaccctcttcttcttctcggagaccgtg
cttggtgtactctaccagccgctagtcgctgcaaccgctctactgacgtctgcagtggtcgtgtacgtagtgagctttctgtggcgtgtttgg
gcgctcccgccgggaccaccagcgctaccgttcattggaaacctactccaacttcgacacgctcgcccgctgtatatcgagtccgcgc
aatggagtcgtcactacggagatccgataacggtgtggatcggtccaaggcctgttgtcgttgtgtcatctacggagggcttccgcgatt
tgg 
 
>G9NSEKQ01CQREI|cytochrome p- 
ccagaacatctcggtttccttaacgactgcgacgagctggctgatctgattcttgctcgcatcatgacgttataccactggccggacaga
ctctacgagctatcgggtccatataagcaaatgcgcgcggtagctgatcgtatctcagactacgtctacaaggttattgactcacagata
gcgacgtttatgaaagcggacgtgagtgggcgcaaggatgcaaaaatatcagatcaaagcttcatgagcattctgctagatatgcatc
ggaatgggagcctcactcgacaggaaattcgagaccacgcggccacatttatcgttgggggcttcgataccacggcgacaagtact
gccttcacgcttcacc 
 
>G9NSEKQ02FIIQ4|cytochrome p- 
cggttcagggtgaagcccttcatggaatatctctacgactttcatttagagcagccagaaaccttcacggaacagcaagttcggaacg
aggtcaacggagccctattcgcaggccaggatacaatcgcggcatcgtgtgcgtttgccttgtatctgctcgggctatatcccgacattc
aagaaaaatgccgccaggaaatcttcgacgtcgtgggacacgatgatccgatggagccgctcacaaacgaacacctcaaagagc
tcaagtatactaacgcgtgcctactggagtcaatgcggcttttgccgccagtgccgctgatcggccgcgaacccgtcaccgacgtcca
cataaaaggt 
 
>G9NSEKQ02HBC6J|cytochrome p- 
gcatgtgcgatcgctcaagtacatggatgcggtgatcaaagagtcgcagaggatctacccctctgttcccattatcggaagggttcttga
ctatgacatgcagatcgatgggaagagtcccacgtggaaccgacgtcgtaatagccctattcggattgcatcgcgaccctgacgttttt
cctcgacccgatgaatttctaccggagcgtttctttaccgagtcagccaaacggagcccgtttgcattcgt 
gccgttttcgggcggaccacg 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
